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Bacteriophages (phages) belonging to the P335 lactococcal group are one of 
the most frequently isolated phages in fermentation processes using Lactococcus lactis 
strains as the primary starter culture. Despite efforts to prevent phage attack, problems 
caused due to phage infection during large scale milk fermentations are still regularly 
reported.  
Lactococcus lactis subsp. cremoris (L. lactis) 3107 is a dairy starter strain and 
host for the model lactococcal P335 phage TP901-1. Three derivatives of this strain 
that are resistant to TP901-1, while remaining sensitive to infection by another P335 
phage called LC3 were employed to define molecular players involved in the phage 
infection pathway. Comparative genomic analysis of L. lactis 3107 and its phage-
resistant derivatives identified several mutations that may cause the observed 
resistance. Complementation assays with one specific construct, termed pNZgtfA, 
restored phage sensitivity and lysogenization frequency in two of the derivative 
strains. pNZgtfA expresses the L3107_1442 gene (renamed here as gtfA) which 
encodes a predicted membrane-associated glycosyltransferase (GTF), GtfA. 
Interestingly, the mutant strains also exhibited reduced sensitivity to the rare 
lactococcal 949 group phages, 949 and WRP3, while complementation assays fully 
restored infectivity by these phages, thus suggesting that gtfA is also involved in 
phage-host interactions of these phages. TP901-1 escape mutants capable of infecting 
these phage-resistant derivatives possess mutations in the gene encoding the structural 
and/or lytic domain of the Tail-associated lysin in order to adapt to cells which have 
acquired phage resistance. 
Interestingly, the gene gtfA is ubiquitous among Lactococcus genomes, L. lactis 
subsp. cremoris NZ9000 harbours a 99 % identical homologue of gtfA3107 on its 
genome, referred to here as gtfANZ9000 (corresponding to locus tag LLNZ_08920). 
Therefore, a mutation (stop codon) was introduced into the coding sequence of 
gtfANZ9000 by targeted mutagenesis in order to expose the mutant strain generated to 
NZ9000-infecting 936 group phages. Results showed that a non-functional GtfA 
protein has no effect on phages belonging to the lactococcal 936 group. GtfA3107 
possess similar characteristics to proteins belonging to the GT-C family of GTFs which 
are known to be involved in glycosylation of substrates at the out-facing side of the 
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cytoplasmic membrane. Therefore, GtfA is presumed to glycosylate a substrate, most 
likely a cell envelope-associated glycopolymer, such as a cell wall polysaccharide 
(CWPS) or teichoic acid (TA). If gtfANZ9000 is involved in the modification of CWP 
components, the inactivation of this gene may have generated a mutant strain deficient 
in the glycosylation of PSP or rhamnan. In an attempt to identify the GtfA substrate, 
the biochemical composition and structure of CWPS components (rhamnan and PSP) 
of L. lactis strains 3107 and NZ9000, and a number of derivative strains were analysed. 
Results showed that derivatives possessing a non-functional gtfA or over-expressing 
gtfA do not possess any structural modifications in either the rhamnan or PSP 
components of the CWPS as compared to the 3107 or NZ9000 parent strains. In 
addition, the biochemical composition and structure of lipoteichoic acids (LTAs) in L. 
lactis 3107 and a representative phage-resistant derivative was also analysed, results 
revealed that gtfA is not responsible for terminal galactose substitution of LTA. 
Currently, further biochemical analysis of TA composition in L. lactis 3107 is being 
performed in order to identify the GtfA substrate and its relevance to phage infection. 
Attempts to generate LC3-resistant derivatives of L. lactis 3107 resulted in the 
isolation of lysogens of this phage that displayed resistance to multiple P335 phages. 
The LC3-prophage encoded superinfection exclusion (Sie) protein Sie2009/LC3, which 
is an identical (100 % identity) homologue of the previously identified Sie system 
Sie2009 was shown to be responsible for the phage resistance observed. Furthermore, 
superinfection immunity (Sii) against certain phages belonging to the P335 group was 
also exhibited in the presence of the LC3-prophage encoded repressor protein RepLC3.  
Overall this study has identified bacterial and phage-encoded protein(s) 
required for, or interfering with, the infection process of the dairy starter strain L. lactis 
3107 by phages belonging to the lactococcal P335 group, as well as 936 and 949 group 
phages. This study forms the basis for future studies aimed to limit the proliferation of 
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1.1 Introduction to bacteriophages 
Bacteriophages, also known as phages, are bacteria-infecting viruses; 
biochemically phages represent complex macromolecular assemblies which typically 
consist of proteins and nucleic acids. Bacteriophages were first discovered in 1915 by 
Frederick Twort (1) and in 1917 by Felix d’Herelle (2). Phages and their bacterial 
hosts are presumed to been subject to co-evolution, and although the precise time 
dimension of this is unknown, it may have been in operation for some 3 billion years. 
The fact that phages do not possess a universally conserved molecule that can be used 
as an evolutionary clock, combined with a complete lack of a fossil record, leaves us 
to rely solely on comparative phage genome analysis as a tool to understand phage 
evolution (3). Phages are ubiquitous and are considered to represent the most 
numerous biological entities in the biosphere, with our planet harbouring an estimated 
1030 to 1032 phage particles (4), thus outnumbering bacteria by ~ 10-fold (5). It was 
previously estimated that ocean water and sediment contains up to 107 phage particles 
ml-1 (6). Following a comparison between the number of bacteria and the vast number 
of phages coexisting in these niches, it has been suggested that ~ 1025 phage infections 
occur every second worldwide (7).  
Phages are obligate parasites, thus while they carry all information necessary 
to direct their own reproduction in a susceptible bacterial host, they require the 
replication machinery, energy and ribosomes of their host to propagate. Therefore, 
phages reside in any ecosystem where bacteria can be found (8), including soil (9, 10), 
water (11), and the human gastrointestinal tract (12, 13). Each phage typically infects 
a specific group of bacteria, which is often a (small) subset of one species, though 
several related species can sometimes be infected by the same phage (14). For 
example, the lytic Streptococcus thermophilus (St. thermophilus) phages DT1, DT4, 
MD1, MD2 and Q5 can only infect specific St. thermophilus strains (15), whereas the 
Lactobacillus plantarum (Lb. plantarum) phages 14-E10 and 22-A2 are capable of 
infecting Lactobacillus brevis as well as its host strain Lb. plantarum (16). 
Additionally, the virulent phage SH7 belonging to the T4 virus genus of the 
Myoviridae family has been shown to infect Escherichia coli (E. coli) 0157:H7, 
Salmonella Paratyphi, Shigella dysenteriae as well as its original host strain Shigella 
flexneri, all of which belong to the Enterobacteriaceae family (17). Phages maintain a 
dynamic balance among the wide variety of bacterial species due to their high-level of 
specificity, their ability to reproduce rapidly in suitable bacterial hosts, and long-term 
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infectivity as many phages can infect after decades of not encountering a host (18). 
Therefore, phages also play an important role in bacterial population dynamics, and 
represent an important driver of bacterial evolution (19, 20). Furthermore, phages 
affect bacterial pathogenesis (21, 22). In the past 90 years phages have been used as 
bactericidal agents to treat bacterial infections in humans, an application also known 
as phage therapy, and currently explored in Western medicine as an alternative to 
antibiotics (23, 24). Furthermore, phage-derived proteins are used as molecular 
machines (25), diagnostic agents (26), and therapeutic agents (26-28), and have been 
employed to aid in drug discovery (29). Moreover, temperate phages have been shown 
to be capable of transferring desirable or undesirable traits on their bacterial host 
strains. For example, lactococcal temperate phages may confer natural phage defence 
mechanisms on their host including adsorption inhibition, DNA injection blocking, 
abortive infection and restriction-modification systems (30-36). For more information 
on temperate phages and some of the traits they may confer on their lysogenized host 
see Section 1.5.3: Lytic or lysogenic phage cycle. Despite the many advantages of 
bacteriophages, these bacteria-infecting viruses are a major nuisance to various 
biotechnology processes that rely on bacteria to produce their high quality end 
products. For example, bacteria are required to manufacture fermented dairy products 
such as cheese and yogurt, or produce a pharmaceutical molecule (e.g. insulin) in 
large-scale, and in such cases phage infections may cause serious issues that can lead 
to production delays, low quality product or even completely arrest the fermentation 
process. Phage problems have previously been reported in the food, chemical, 
pharmaceutical, feed and pesticide industries (4). However, by far the most frequently 
documented phage problems are those occurring in the dairy industry, with the first 
incident of phages affecting a dairy starter culture being reported by Whitehead and 
Cox in 1935 (37). Since then phage contamination events in the dairy industry have 
been consistently reported to occur at any major milk fermentation facility across the 
globe (38-42).  
 
1.2 Bacteriophages and the dairy industry 
According to The Portal for Statistics website (https://www.statista.com; 
information relates to 2018), the economic value of the global dairy industry, including 
fermented and non-fermented products was estimated to be ~ 300 billion dollars, with 
cheese production accounting for 27 % of this value. The economic success of the 
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fermented dairy industry is dependent on the consistent and reliable activity of starter 
cultures composed of bacterial strains belonging to the Gram-positive, anaerobic, non-
spore forming lactic acid bacteria (LAB), which owe their name to the fact that they 
produce lactic acid as the primary metabolic end-product of hexose fermentation (43). 
LAB strains are currently among the most intensively studied bacteria due to their 
large-scale use in dairy starter cultures, being demonstrated by the fact that ~ 1014 
bacterial cells are required to produce a ton of cheese (8). The most commonly used 
LAB as starter cultures include strains of Lactococcus lactis (L. lactis), St. 
thermophilus, and various Leuconostoc and/or Lactobacillus species (8), which, like 
all bacteria, are susceptible to phage attack. The dairy industry has developed a series 
of strategies to prevent phage attack of starter cultures, such as improved factory 
design, enhanced sanitation, the use of specific starter cultivation media, strain 
rotation, and the employment of phage-resistant strains (8). Despite substantial and 
ongoing efforts to prevent this natural phenomenon from occurring, phage 
contamination in the dairy industry is still a very common phenomenon with a 
significant impact on the economic success of this industry (4, 44).  
The manufacture of cheese involves the inoculation of (typically, pasteurized) 
milk with a starter culture so as to initiate and perform the fermentation/acidification 
process and to obtain high-quality end-products (8). L. lactis is the major LAB starter 
species employed in the cheese industry. Lactococcal phages are ubiquitous in the 
dairy environment, as they reside in non-sterile raw milk, and are not fully inactivated 
by pasteurization treatments (4). This (relatively) low phage concentration of raw milk 
combined with the presence of phage-sensitive bacterial cells in a starter culture will 
allow the rapid development of a specific phage population. This will negatively 
impact on final product quality and production regimes, causing significant economic 
losses (31). The primary source of phage contamination in the dairy fermented 
industry appears to be raw milk, although other sources of phage contamination may 
include processed or recycled ingredients, starter cultures and air/surfaces (8). Phages 
may be present in processed or recycled ingredients such as whey proteins (45), which 
are added to improve the texture/taste, to increase the nutrient value, and to increase 
the yield of the final product. Moreover, the starter culture may itself act as a phage 
reservoir as many LAB strains harbour prophages (46, 47), which may be triggered to 
enter the lytic cycle during the fermentation process when exposed to heat, salts, 
antimicrobials, starvation, or UV (48, 49). For more information on prophages see 
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Section 1.5: The infection process and life cycle of a bacteriophage. The presence of 
airborne lactococcal phages in the fermented dairy industry has previously been 
documented (50-53) making the air and surfaces within a dairy factory another 
potential source of phage contamination. Studies have also shown that phages can 
persist as infectious particles over a long period of time in dairy factories (54, 55). 
Consequently, lactococcal phages have been the focus of intensive research for many 
years as a thorough understanding of how these problematic viral parasites interact 
with their hosts is necessary in order to devise strategies that would limit their negative 
impact. Such strategies may involve the construction of robust starter cultures through 
genetic engineering of LAB (56), thus creating mutant LAB strains resistant to specific 
phages, or the development of strain rotations/blends. 
 
1.3 Taxonomy of lactococcal phages 
The negative impact of lactococcal phages on dairy fermentations as well as 
their biodiversity in this ecological niche has led to the isolation and characterization 
of many lactococcal phages (57). Currently, the International Committee on 
Taxonomy of Viruses (ICTV) which classifies phages according to their phage 
morphology and genome organization has included lactococcal phages as members of 
the Caudovirales order of tailed phages, which represent over 95 % of all known 
phages (58). Phages of the order Caudovirales possess a nucleic acid-containing 
capsid, which may be isometric or elongated and a tail structure to recognize their 
bacterial host and to deliver their genome with high specificity (59). Phages belonging 
to the order Caudovirales are classified into three families (60): (i) the Siphoviridae 
family which represents bacterial viruses with long, non-contractile tails (e.g., Bacillus 
subtilis (B. subtilis)-infecting SPP1 phage (61)), and which comprises ~ 60 % of the 
characterized phages, (ii) the Myoviridae family which represents viruses with long, 
complex contractile tails (e.g., E. coli-infecting T4 phage (62)) and which constitutes 
around 25 % of the characterized phages, and (iii) the Podoviridae family which 
encompasses viruses with short non-contractile tails (e.g., Salmonella typhimurium-
infecting P22 phage (63, 64)), comprising ~ 15 % of the characterized phages. These 
families are further divided into genera and subgenera by criteria such as host range, 
genome size and genome configuration (linear, circular, and supercoiled) (60). All 
currently known L. lactis phages possess a double-stranded DNA (dsDNA) genome 
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and a non-contractile tail, making them members of the Siphoviridae family, with a 
small number belonging to the Podoviridae family (57).  
More than two decades ago, lactococcal phages were classified into 12 groups, 
based mainly on phage morphology and DNA homology criteria: 936, c2, P335, 949, 
P087, 1358, 1706, 1483, T187 and BK5T phage groups, which belong to the 
Siphoviridae family, and phage groups P034 and KSY1, which belong to the 
Podoviridae family (65-68). This classification method was employed to compare 
lactococcal phage isolates and revealed that most phage isolates from dairy settings 
belong to one of three main groups, i.e. the 936, c2, and P335 groups. Of note, based 
on genome analysis it has since been proposed to merge the BK5-T group with the 
P335 group (69), while in addition DNA-DNA hybridization studies have suggested 
to merge the 1483 and T187 group with the P335 group (69-72). Furthermore, 
lactococcal phages Q54 and 1706 were shown to be unrelated to known lactococcal 
phages leading to the emergence of new groups (57). Thus, the classification system 
for lactococcal phages, as based on their morphological and genomic analyses, 
currently distinguishes ten groups, as demonstrated in Table 1. To date, eight groups 
including the 936, c2, P335, 949, P087, 1358, 1706 and Q54 phages belong to the 
Siphoviridae family due to their long, non-contractile tails, whereas the P034 and 
KSY1 phage groups belong to the Podoviridae family due to their short tails (57). 
Examples of some of the published lactococcal phages with some of them including 
their genomic sequence are shown in Table 2. Members of the P335, 936 and c2 groups 
are still the most frequently encountered lactococcal phages in dairy fermentations 
globally (69). Consequently, lactococcal phage studies have in recent years mainly 
concentrated on members of these three groups. Currently, two multiplex PCRs are 
available to rapidly assign new phage isolates to one of these three main lactococcal 






























Table 2. Examples of lactococcal phages plus associated genome and host 
characteristics.  









Siphoviridae P335 BK5-T I ND NC_002796 (75) 
  4268 I ND NC_004746 (76) 
  C41431 I A & C KX160219 (77) 
  38502 I A KX160204 (77) 
  Tuc2009 II A NC_002703 (78) 
  P335 II B DQ838728 (79) 
  TP901-1 II C NC_002747 (80) 
  ul36 II A & C NC_004066 (79) 
  53801 II C KX160207 (77) 
  53802 II C KX160208 (77) 
  49801 II C KX160205 (77) 
  98103 II C KX160214 (77) 
  98104 II C KX160215 (77) 
  98102 II C KX160213 (77) 
  98101 II C KX160212 (77) 
  98204 II A KX160218 (77) 
  98202 II A KX160216 (77) 
  98203 II A KX160217 (77) 
  LC3 III C NC_005822 (81) 
  r1t III C U38906 (82) 
  Dub35A III C KX160220 (77) 
  Q33 IV A, B & C JX564242 (83) 
  BM13 IV ND JX567312 (83) 
 




50902 IV A KX160206 (77) 
  62502 IV A KX160210 (77) 
  62503 IV A KX160211 (77) 
  63301 ND ND KX456211 (84) 
  86501 III ND KX456212 (84) 
  50101 III ND KX456207 (84) 
       
 936 bIL170 N/A N/A NC_001909 (85) 
  sk1 N/A N/A NC_001835 (86) 
  jj50 N/A N/A NC_008371 (87) 
  712 N/A N/A NC_008370 (87) 
  P008 N/A N/A NC_008363 (87) 
       
 c2 c2 N/A N/A NC_001706 (88) 
  bIL67 N/A N/A NC_001629 (89) 
       
 949 949 N/A N/A NC_015263 (90) 
  bIL168 N/A N/A NC_011046 (91) 
       
 P087 P087 N/A N/A NC_012663 (92) 
 1358 1358 N/A N/A NC_027120 (93) 
 1706 1706 N/A N/A NC_010576 (94) 
 Q54 Q54 N/A N/A NC_008364 (95) 
    N/A   
Podoviridae P034 ascc28 N/A N/A NC_010363 (96) 
       
 KSY1 KSY1 N/A N/A NC_009817 (97) 
 




1.4 General structure and function of a tailed bacteriophage 
In order to understand how tailed bacteriophages infect their hosts, we first 
need to understand their structure and the function of each component. Electron 
microscopy (EM) studies of single particles of model phages such as SPP1 (61), HK97 
(98), TP901-1 (99), and Tuc2009 (100) have shown that these nanomachines are 
composed of a phage capsid, connector, tail and baseplate (BP) or tail tip (Fig. 1.1), 
each of which will be discussed below in more detail. 
 
 
Figure 1.1. Complete structure of the lactococcal P335 bacteriophage TP901-1; 





1.4.1 The capsid (head) and head-to-tail connector 
The capsid (also known as the head) of a bacteriophage is a robust 
proteinaceous shell which allows phages to carry and protect their genetic material 
(101). The majority of known bacteriophages possess an icosahedral capsid which 
harbours dsDNA in a highly condensed state; the combined nucleic acid and capsid 
are known as the nucleocapsid (18). In many dsDNA phages, the assembly of the 
phage structure begins with the formation of the procapsid/prohead (which is a 
preformed protein shell). The procapsid structure is formed from multiple copies of 
the major capsid protein (MCP), which together with scaffolding protein forms a 
stabilising core until the DNA is packaged. Once it is filled with DNA, the procapsid 
undergoes maturation to form the mature phage capsid (102, 103). 
In general, following infection of the host, which involves release of the phage 
genome from the capsid into the host cytoplasm, viral genome replication leads to the 
accumulation of DNA concatemers, which are substrates for DNA encapsidation (i.e. 
the DNA packaging process). Most dsDNA phages pack their DNA into the cavity of 
the procapsid through the connector, with the aid of a packaging complex (composed 
of a small and large terminase subunit and the portal protein) (104, 105). The small 
subunit of the terminase possesses DNA binding activity, while the large subunit is 
required for procapsid binding, DNA translocation and DNA cleavage (106). The 
portal protein plays an important role in DNA packaging as this protein forms a 
circular oligomer which surrounds the channel through which DNA enters and exits 
the head. This portal structure ensures an efficient DNA packaging process and 
determines the length of DNA that will be packaged into the procapsid (107, 108). The 
interaction of DNA-terminases with the portal protein allows translocation of DNA 
into the procapsid (109, 110). The successful completion of DNA packaging depends 
on the recognition of a specific sequence called cos or pac (111). DNA packaging 
begins when the small terminase recognises and binds to the DNA (cos or pac site) 
and subsequently the large terminase cleaves the DNA and interacts with the phage 
portal protein where DNA translocation into the procapsid is driven by ATP hydrolysis 
(112). DNA is translocated unidirectionally and begins with the generated end 
following cleavage. When the head has been filled to capacity, a termination cleavage 
occurs at a specific (Lambda, T3, T7) or non-specific (P1, P22, T1, SPP1) site 
producing the mature form of viral DNA present in virion particles (112). The DNA 
concatemer is cleaved before and after packaging by the nuclease activity of the large 
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terminase, while the energy for the DNA packaging process is provided by ATPase 
activity (105).  
The pac site refers to a sequence which signals initiation of the phage DNA 
packaging process. The pac type phages, e.g. P2 (111), employ a headful approach 
mechanism whereby in the first round of replication the DNA is initially cut at the pac 
site and then translocated into the procapsid until it is filled, representing an amount 
of DNA that is greater than the length of a single complete genome. Each subsequent 
round of DNA replication results in the DNA being cut at non-specific sites 
downstream of the pac site releasing the packed DNA, resulting in packaging of 
circularly permuted DNA molecules with more than one unit length of genome. The 
end generated by the headful cleavage of the previous chromosome is the start of 
packaging events of the DNA, thus leading to the packaging of terminally redundant 
molecules (112). This so-called head-full packaging mechanism employed by pac-site 
phages appears to be a very tightly regulated process in order to prevent the formation 
of phages with unfilled or incompletely filled capsids (64, 98, 113, 114). The cos site 
refers to a specific cohesive end site on the phage DNA, cos type phages cut the DNA 
at the cos site generating single genomic units with self-complementary 3’ overhangs 
(105). For example, the cos site of phage Lambda is a 22 bp sequence that is cut 
asymmetrically to allow the concatemeric DNA to be packaged in a single genome-
specific, linearized manner into a prophage head leaving an overhang cos site at either 
end of the genome. Thus, when the DNA is injected into the cytoplasm the two 
cohesive ends anneal generating a covalently closed circular genome (111). 
Sequenced lactococcal P335 group phages have been reported to utilise the cos or pac 
method of packaging (115), while lactococcal 936 and c2 group phages utilise the cos 
method of packaging (87, 95).  
The head-to-tail connector is a ring-shaped structure which connects the phage 
capsid with its tail (Fig. 1.1), the connector is composed of the portal protein, head 
completion proteins and a stopper protein. The connector is involved in phage DNA 
packaging (116-118) and DNA ejection (119). The connector of phage Lambda has 
been well studied and is located inside the capsid of the phage at the vertex where the 
tail attaches (119). Morphogenesis of the icosahedral Lambda head has been suggested 
to begin with the assembly of the connector which is composed of molecules of the 
minor head protein gpB which are involved in DNA entry (120). Fusion and cleavage 
reactions take place to form the procapsid. Terminase then binds to the connector and 
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concatameric DNA, and packages linear monomers of the dsDNA genome into the 
procapsid. The packaged DNA within the head is stabilized by incorporating 
molecules of major head protein which prevents the loss of DNA after it has been 
packaged (120). The gpW protein then binds to the connector region, which allows 
the incorporation of gpFII (121). Lambda gpFII protein is located at the bottom of the 
connector, representing 8 % of the mass of the connector, and forming the site on the 
head to which the tail binds (120).  
 
1.4.2 The tail and baseplate / tail tip  
The assembly of the tail and associated base plate (BP, sometimes also called 
the tail tip) of phages belonging to the lactococcal P335 and 936 groups has been the 
focus of several studies (79, 122). The tail of a siphophage is located between the 
connector and the BP/tail tip, and represents a structure with a continuous central 
channel which is used as a genome ejection tunnel to allow efficient viral genome 
delivery into the target host cell cytoplasm (61, 123-127). The BP or tail tip, also 
referred to as the host adsorption device, is located at the distal part of the phage tail 
and is responsible for host recognition, attachment, and initiation of infection. The 
structure of this adsorption device varies among lactococcal phages depending on the 
phage type (79, 122). The tail tube of the lactococcal 936-group phage p2 is formed 
by stacking of the major tail protein (MTP) and a tail terminator hexamer at the point 
linking to the connector, the tail length is determined by the tape measure protein 
(TMP) (103, 128). In the case of phages belonging to the Myoviridae family, 
additional ring-like structures are formed around the tail tube to form a contractile 
sheath, this differ from Siphoviridae phages which possess non-contractile tails (129). 
The BP structure of phage p2 is assembled from the distal tail protein (Dit), tail-
associated lysin (Tal) and eighteen receptor-binding proteins (RBPs). The Dit is 
attached to the last (i.e. most distal relative to the head) MTP ring (130). The RBPs of 
the 936-group phage p2 appear to exist in an inactive or active form. In the presence 
of the cation Ca2+, the RBPs appear to undergo a change in orientation to rotate the C-
terminus 200° downwards towards the host cell receptor. This conformational change 
appears to activate the BP of p2 during attachment to the host as the binding sites are 
orientated towards the host, leading to the opening of a channel at the bottom of the 
BP for DNA passage ultimately resulting in DNA ejection (130). 
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The BP and tail assembly of the P335-group phage TP901-1 involves the gene 
products of dit (orf46), tal (orf47), bppU (orf48), and bppL (orf49) (131). The 
multicomponent BP structure of TP901-1 (99) (Fig. 1.2) consists of a Dit hexamer, 
which anchors an upper and lower BP disk composed of multiple copies of the upper 
BP protein (BppU) and lower BP protein (BppL), respectively, and a central tail fiber 
(Tal) protruding below the BP. The TP901-1 BP harbours an assembly of RBPs which 
recognize a specific saccharidic receptor located on the surface of a host cell, therefore 
the TP901-1 BP is fundamental for host infection as the BppL represents the RBP 
(131). The BP of TP901-1 harbours 54 RBP monomers (specified by ORF49) which 
are orientated towards the distal extremity and are not influenced by the presence of 
Ca2+ ions, indicating that TP901-1 is ready for host adhesion and does not need to 
undergo a conformational change to reach an activated state (as in the case of p2) 
(123). The RBP of TP901-1 is 163 amino acids long and forms a homotrimer which 
is composed of three domains, the N-terminal, β-prism neck, and C-terminal domain. 
The helical N-terminal domain comprises 63 residues, whereas the C-terminal domain 
is represented by residues 64-163 and is a six-stranded β-barrel which is also known 
as the head recognition domain. The β-prism neck domain is also known as the β-helix 
and is represented by residues 40-63. Fluorescence quenching experiments revealed 
that the RBP of TP901-1 exhibits high affinity for glycerol, muramyl-dipeptide, and 
other saccharides in solution (132).  
In contrast, the tail tip of the model B. subtilis-infecting phage SPP1 (61, 124, 
127) harbours a single component BP, also referred to as a “stubby end” which does 
not contain a sugar binding RBP. It has previously been suggested that such a discrete 
tail tip complex is found in phages adsorbing to proteinaceous receptors, such as SPP1 
(133) and the lactococcal phage c2 (134), due to the high-affinity and specificity of 
such protein-protein interactions (135). Further studies have demonstrated that the tail 
tip of some of the c2-group phages may be capable of attaching to a secondary 







Figure 1.2. Representation of TP901-1 baseplate structure and its components 
represented by different colours. Figure modified from (137). N-terminal (Nt).  
 
1.5 The infection process and life cycle of a bacteriophage 
The infection process of tailed bacteriophages involves a number of tightly 
controlled steps which need to be understood in order to gain a proper appreciation of 
how phages infect their specific bacterial hosts. 
 
1.5.1 Adsorption 
The first step involved in the interaction of a tailed bacteriophage with its 
specific bacterial host is the recognition of and attachment/adsorption to a specific 
component of the host cell envelope. This binding can occur as a reversible and/or 
irreversible interaction, and is thought to be mediated by the tail tip or BP structure 
which acts as an adsorption device that binds to specific host receptor molecules that 
are present at the host cell surface (61, 123, 138-140). The attachment of some phages, 
such as coliphages (141), the model Bacillus phage SPP1 (133), and a number of 
lactococcal phages (140), seem to involve two separate adsorption stages and two 
distinct receptors to achieve successful attachment to its bacterial host. In Gram-
negative bacteria the most common components of the cell envelope that act as host 
receptors for phages are porins, transporters and lipopolysaccharides (LPS). In 
contrast, in the structurally distinct cell envelope of Gram-positive bacteria receptor 
molecules for phages include cell wall polysaccharides (CWPS) (77, 140, 142-144), 
cell surface-exposed proteins and/or teichoic acids (TAs) (133, 145, 146), which are 
found in the outer regions of the thick peptidoglycan cell wall.  
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Particular external factors and the physiological state of the host appear to 
determine the adsorption efficiency of a phage to its host. For example, many phages 
require specific cofactors such as calcium or magnesium for attachment (147, 148), 
while the coliphage Lambda receptor is only expressed in the presence of the sugar 
maltose (149). Moreover, studies have shown that bacteria can develop resistance to 
specific phages through mutational loss or alteration of receptors (134, 150, 151). 
Phages in turn are capable of adapting to altered receptors or may even adapt to attach 
to a different receptor (152, 153). 
 
1.5.2 DNA injection 
Following attachment of the phage to its host, the next step is injection of the 
viral genome through the cell envelope and into the cytoplasm of the host. This event 
can be achieved in different ways, for example by tail contraction or the release of 
proteins which cause the bacterial cell membranes (in the case of a Gram-negative 
host) to become distorted/fused (141). Once the phage releases its viral genome from 
its capsid, it remains attached to the cell wall of its host as a “ghost” phage. Distinct 
mechanisms of DNA injection have been described for different phages. For example, 
phage T4 which has a contractile tail and a cell-puncturing device in the BP (154) has 
the fastest rate for DNA transport as its 169 Kb genome is ejected in 30 seconds (155, 
156).  In contrast, even though phage T7 has a smaller genome (40 Kb) than T4, its 
DNA ejection lasts 9 - 12 minutes. The T7 viral proteins gp16 and gp15 control the 
amount of DNA that enters the cell by first delivering 850 bp of the genome into the 
cytosol. This DNA includes three promoters which are recognized by RNA 
polymerase which then ‘pulls’ the remainder of the genome into the cytoplasm due to 
transcription-mediated template transfer. Thus, transcription provides the driving 
force for the entry of the T7 genome (157, 158). Another example of a DNA injection 
mechanism is the genome transfer of T5 (121 Kb) which is performed in two steps. 
First, 8 % of the DNA is transferred to the cytoplasm (159) where, during a 4 minute 
pause, two proteins (A1 and A2) encoded by this fragment are synthesized. Following 
the synthesis of these proteins the remaining DNA is transferred (160). The exact 
mechanism by which these proteins catalyse transfer of the remaining DNA is 
unknown, and it has been suggested that the DNA binding protein A2 may pull the 
remaining DNA into the cytoplasm (161). The push-pull mechanism of the DNA 
injection process of the Gram-positive-infecting B. subtilis phage 29 has been well 
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studied. Phage 29 has a non-contractile tail and a 19 Kb linear genome which is 
injected into the host cell using a tightly regulated two-step energy-dependent process. 
Once the phage recognizes its entry site in the membrane of the host, it first pushes ~ 
65 % of the phage genome with right-left polarity into the host cell at the expense of 
the packaging pressure built inside the viral capsid. Following this, synthesis of at least 
four viral proteins is expressed due to the early promoter present in the entered 
fragment. These proteins form a multiprotein complex which pulls the remaining DNA 
into the cell, thereby completing DNA injection. Unlike the other proteins forming the 
multiprotein complex, protein p17 appears to be the most essential protein for this 
second DNA entry step (162).  
 
1.5.3 Lytic or lysogenic phage cycle 
 Following entry of the nucleic acid into the host cell, the viral genome can 
propagate itself following either a lytic or lysogenic phage cycle (163). Bacteriophages 
that only replicate following the lytic cycle are known as lytic or virulent phages; 
once the phage multiplication cycle is completed the virulent phage causes lysis of its 
host in order to release newly produced phage particles (or virions). During the lytic 
cycle of propagation, the phage ‘hijacks’ (partly or completely) the RNA transcription, 
DNA replication and/or protein synthesizing machinery of the bacterial cell to make 
phage components. Once new phage genomes have been made individual genome 
units are packaged into the phage capsid, followed by the attachment of the phage tail 
to this DNA-filled capsid (163). Following assembly, the completed progeny viral 
particles release two proteins, the holin and lysin, encoded by the lysis cassette. These 
enzymes weaken the bacterial cell envelope leading to lysis of the host cell, i.e. rupture 
of the cell membrane and cell wall, and consequently the mature, infective phages 
make their way into the surrounding environment. Cell lysis is achieved as large 
pores/holes are formed in the cell membrane following the accumulation of holin 
proteins within the cell membrane and spontaneous aggregation at a genetically 
determined time-point. These pores provide the lysin access to its substrate, the cell 
wall peptidoglycan (164, 165). The lysin binds to a specific carbohydrate component 
of the cell wall using its C-terminal domain which ensures efficient substrate binding, 
while its N-terminal domain harbours the catalytic activity (166). The holin and lysin 
proteins are involved in the timed release of newly synthesized phage particles. This 
process varies among different phages and can be analysed with phage latent period 
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assays (which determine the time after infection before new phages are released). The 
latent period for dairy phages appears to differ depending on the phage. For example, 
the latent period for lactococcal phages has been reported to range from 40 - 90 min, 
for phages infecting St. thermophilus the latent period was reported to vary from 20 - 
40 min, while for phages infecting Lactobacillus a latent period of 30 - 100 min has 
been reported (93, 167).  
Previously it has been shown that lytic infection of L. lactis subsp. cremoris 
(L. lactis) UC509.9 with two distinct phages, the P335-group phage Tuc2009 and c2-
group phage c2, demonstrates a rather modest impact on host transcription, yet with a 
phage-specific host response to infection. This study revealed that most of the host 
gene transcription changes occur during the late infection stage, whereas during the 
immediate and early infection stages only relatively minor changes in host 
transcription occur. Host transcriptome alterations during infection appear to be 
specific to Tuc2009 or c2, with relatively few differentially transcribed genes shared 
between infection with these phages (168). Additionally, another study revealed the 
defence strategy of L. lactis subsp. lactis (L. lactis) IL1403 in response to infection by 
lytic phage c2. The host response to c2 phage-attack involves induction of membrane 
stress proteins, cell wall D-alanylation, maintenance of the proton motive force (PMF) 
and energy conservation. The phage presence appears to be sensed as an extra-
cytoplasmic stress as the host response is strongly targeted to the cell wall, thus 
affecting membrane integrity (169).  
Bacteriophages that are able to replicate using both the lytic and lysogenic 
cycle (163) are known as temperate or lysogenic phages. The major difference 
between these two phage replication cycles is that in the lytic phage cycle, the phage 
DNA does not undergo integration into the host genome, instead the viral genome 
exists as a separate molecule within the cytoplasm of the bacterial cell and replicates 
independently from the host bacterial DNA. This differs from the lysogenic cycle 
which involves the integration of the phage genome into the bacterial chromosome, 
following entry of the viral nucleic acid, resulting in a prophage. During the lysogenic 
cycle the bacterial host cell remains alive and undergoes its natural life cycle, during 
which the phage genome replicates as part of the bacterial host chromosome. 
However, at any stage the integrated phage can exit the bacterial chromosome entering 
the lytic cycle, thus replicating/proliferating and subsequently killing the infected 
bacterial cell (163, 170). The lysogenic state of a phage is highly evolved as a 
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coevolution event between the phage and its host, frequently conferring advantages to 
the host (18). The presence of a temperate phage in a bacterial genome can lead to 
significant changes in the properties of the host such as resistance to infection by other 
phages and antibiotics, as well as the acquisition of restriction-modification systems 
(167, 171-174).  
The lysogeny module of a temperate phage encodes genes involved in the 
process of genome insertion into the bacterial chromosome and maintenance of the 
temperate state. The lysogeny module encodes an integrase which facilitates the site-
specific recombination between the genomes of the phage and host at specific 
homologous attachment sequences known as attP (phage) and attB (bacterium) (175). 
For phages infecting LAB, the site-specific integration system was first identified in 
phage LC3, a member of the P335 lactococcal group (176), homologous systems have 
since been identified in other P335 phages (82, 177). To maintain the integrated 
prophage the lytic genes of the temperate phage must be repressed in order to prevent 
the prophage from entering the lytic cycle. This process is controlled by one of the 
prophage-encoded proteins produced during the lysogenic state, a repressor protein 
which blocks transcription of phage genes required for lytic infection. This repressor 
system is responsible for the lysogenic state of many temperate phage genomes (178-
180) including the majority of lysogenic LAB phages (181). For example, upon 
infection of the Lambda phage into E. coli, the phage encodes the transcriptional 
activator CII which is accumulated within the infected cell until a sufficient amount is 
present to activate the transcription of the repressor protein, CI, and the phage 
integrase. Following this, CI blocks the expression of genes required for lytic 
development by binding to an operator sequence within the intergenic region 
consequently blocking the transcription of the regulator protein, Cro, which prevents 
transcription of CI. The transcription of both CI and the integrase favours lysogeny 
allowing the phage genome to become incorporated within the host genome (179). The 
constitutive expression of these regulatory repressor proteins confers the lysogenised 
host with immunity to (secondary) infection by the same or related phages, this type 
of immunity is known as superinfection/repressor immunity (182, 183).  
Previous studies have shown that prophages from Gram-negative bacteria 
encode a variety of distinct adsorption inhibition systems which alter the cell surface 
or other cell envelope components thus preventing attachment of homologous phages 
to the cell (184-186). For example, the D3 prophage from Pseudomonas aeruginosa 
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harbours a three-gene operon encoding proteins which modify the O-antigen of the 
cell surface LPS of its host. This results in an alteration of its serotype, which prevents 
infection by phages which use the O-antigen as a receptor, including phage D3 itself 
(184). The E. coli prophages 80 and N15 express the cor gene producing the Cor 
protein which physically interacts with FhuA, this interaction prevents the infection 
of phages that require FhuA as a receptor (185, 186). Prophages from Gram-negative 
and Gram-positive bacteria can also encode superinfection exclusion (Sie) proteins 
which interfere with the phage DNA injection process following phage adsorption to 
the cell (187). For example, the E. coli prophage HK97 harbours a gene (15), which 
encodes an inner membrane protein capable of blocking (secondary) HK97 DNA entry 
into the cytoplasm. Phage-resistance to other phages using the same host receptor as 
HK97 is not conferred suggesting that this Sie system does not inhibit phage 
adsorption but interferes with DNA injection (188). Similarly, the SieA system 
expressed by prophage P22, from Salmonella typhimurium, prevents the DNA entry 
of phages L, MG178, MG40 and P22 itself (189), while an Sie system expressed by 
coliphage P1 provides phage-immunity against coliphages c, c4 and P1 itself (190). 
Sie systems encoded by prophages of (Gram-positive) LAB species have also been 
reported including the well characterized Sie2009 encoded by Tuc2009, the resident 
prophage of the dairy starter strain L. lactis subsp. cremoris UC509. The sie2009 gene 
encodes a membrane-associated protein that allows phage adsorption to occur while 
preventing DNA injection of specific phages belonging to the lactococcal 936 group 
(32). Additionally, Sie systems encoded by prophages of the lactococcal strains L. 
lactis subsp. cremoris (L. lactis) MG1363 and L. lactis IL1403 have demonstrated a 
similar spectrum of activity against members of the 936 group of lactococcal phages 
(191). The St. thermophilus prophage TP-J34 expresses a small lipoprotein, Ltp, that 
provides phage resistance against the 936-group lytic lactococcal phage P008, and TP-
J34 itself (192). This lipoprotein appears to block phage DNA injection by interfering 
with the process of DNA release from the head of the phage (32, 192). Another Sie 
system from an St. thermophilus prophage, Sfi21, is expressed by orf203 resulting in 
phage resistance against heterologous streptococcus phages (193). Prophages 
constitute 10 - 20 % of a given bacterial genome consequently playing an important 
role in the evolution of bacterial species as prophages can contribute important 
biological properties to their bacterial host such as boosting virulence of their host 
(194). Lysogenic phages are widespread among dairy starter cultures, and although 
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prophages may be an advantage to bacterial hosts, they may also pose a significant 
threat to the fermentation process (195).  
 
1.6 Structure of the bacterial cell envelope.  
The cell envelope of bacteria is a key element to phage-host interactions as 
specific components of the cell envelope act as receptors for specific phages (see 
above). To survive unpredicted and often hostile environments, bacteria have 
developed a complex, multi-layered structure known as the cell envelope, whose 
components are synthesised at the cytoplasmic membrane. The function of the 
bacterial cell envelope is to determine and maintain the shape of the cell, to protect the 
cell from lysis by osmotic pressure, and to allow selective passage of nutrients from 
the outside environment and waste products from within the cell (196). Bacteria can 
be classified as either Gram-negative or Gram-positive depending on the structure of 
their cell envelope. Gram-negative bacteria (Fig. 1.3) possess a cytoplasmic 
membrane that is surrounded by a thin peptidoglycan layer and an outer membrane 
containing LPS, whereas Gram-positive bacteria (Fig. 1.4) are surrounded by a thick 
peptidoglycan layer and lack an outer membrane (18). The cell envelope of bacteria 
has been most thoroughly studied in the Gram-negative E. coli (197-199) and Gram-
positive bacterium B. subtilis (200, 201) and Staphylococcus aureus (S. aureus) (202, 
203), with some studies also involving Gram-positive LAB (142, 204, 205).  
 
1.6.1 The cell envelope of Gram-negative bacteria. 
The structure of the Gram-negative cell envelope was first clearly observed in 
1969 by Glauert and Thornley (206), which revealed that the Gram-negative cell 
envelope is composed of an outer membrane, a peptidoglycan cell wall and a 
cytoplasmic or inner membrane. The aqueous cellular compartment in the space 
between the inner cytoplasmic membrane and the outer membrane was first named the 
periplasm in 1961 by Peter Mitchell (197), which was isolated in 1967 with its distinct 
set of proteins being characterized (198). Furthermore, in 1968 and 1972 the 




Figure 1.3: The structure of the cell wall of Gram-negative bacteria (18). 
 
1.6.1.1 The outer membrane.  
The outer membrane of the cell envelope of Gram-negative bacteria is the first 
layer encountered starting from the outside and proceeding inward. This is a key 
bacterial structure in phage-host interactions as the outer membrane harbours porins, 
affinity transporters and LPS which have been shown to act as Gram-negative host 
receptors for phage infection (141, 150, 208-210). The outer membrane is essential for 
survival of the cell and represents a protective barrier making Gram-negative bacteria 
generally more resistant to antibiotics and harsh environments when compared to 
Gram-positive bacteria (196). Many antibiotics target intracellular processes of 
bacteria such as replication, nucleic acid and protein biosynthesis, protein folding, and 
cell division, and therefore must penetrate the cell envelope in order to be effective 
(211). The outer membrane contains phospholipids, which are essentially confined to 
the inner leaflet, and glycolipids, principally LPS (212), which are confined to the 
outer leaflet. Most proteins of the outer membrane can be divided into lipoproteins or 
β-barrel proteins. Lipoproteins contain lipid moieties which are attached to an amino-
terminal cysteine residue (213), and which allow such lipoproteins to become 
embedded in the inner leaflet of the outer membrane. E. coli contains one hundred 
distinct outer membrane lipoproteins, although the function of most of these are 
unknown (214). Most of the integral, transmembrane proteins of the outer membrane 
adopt a β-barrel conformation. These outer membrane proteins include the OmpF and 
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OmpC porins (215), which allow passive diffusion of amino acids and small molecules 
such as mono- and di-saccharides across the outer membrane. Together, these porins 
are present at ~ 250,000 copies per cell. Other outer membrane porins include LamB 
(216), which is responsible for the diffusion of maltose and maltodextrins, and PhoE 
(215), which allows the diffusion of anions such as phosphate across the outer 
membrane. Another abundant outer membrane porin is the outer membrane protein A 
(OmpA) which is monomeric and can exist in two different conformations (217), 
meaning that it exists either as an active or inactive porin. Outer membrane porins 
larger than β-barrels are also present but at much lower levels and are responsible for 
high affinity transport of large ligands such as Fe-chelates or vitamins such as vitamin 
B-12 (218). The outer membrane of E. coli contains a small number of enzymes 
including phospholipase (PldA) (219), a protease (OmpT) (220) and an enzyme that 
modifies LPS (PagP) (221). LPS consist of a hydrophobic domain, a nonrepeating 
oligosaccharide core and an extended polysaccharide (PS) chain known as the O-
antigen (222). LPS in the outer membrane protects the cell from hydrophobic 
molecules and porins control the diffusion of hydrophilic molecules larger than ~ 700 
Daltons, making the outer membrane of Gram-negative bacteria a very effective and 
selective permeability barrier (218). 
 
1.6.1.2 The peptidoglycan cell wall.  
The peptidoglycan layer consists of chains, each of which consist of a polymer 
of the disaccharide N-acetyl-glucosamine (GlcNAc) and N-acetyl-muramic (MurNac) 
acid, and which are crossed-linked by short peptides to make a two-dimensional sheet 
(223). The glycan chains of the peptidoglycan layer appear to be located perpendicular 
to the long axis of rod shaped bacterial cells (224), therefore determining the cell shape 
due to its rigidity. The peptidoglycan layer in Gram-negative bacteria is attached to 
the outer membrane by lipoproteins known as Lpp, murein/Braun’s lipoproteins (225). 
This protein is the most abundant protein in E. coli with more than 500,000 molecules 
per cell. Moreover, the porin OmpA is important for outer membrane stability as 
OmpA is responsible for non-covalently association of the outer membrane 




1.6.1.3 The periplasm 
The periplasm which is only found in Gram-negative bacteria is an aqueous 
cellular compartment located in between the outer membrane and inner membrane, 
and is densely packed with proteins as demonstrated by a higher viscosity compared 
to that of the cytoplasm (227). The role of the periplasm is to sequester potentially 
harmful degradative enzymes such as RNAse which can interfere with DNA 
replication (228). The first enzyme protein to be identified in the periplasm was 
alkaline phosphatase. Alkaline phosphatase cleaves inorganic phosphate (required for 
cell growth) from external phosphomonoesters for transportation to the cytoplasmic 
membrane (229, 230). In addition, many periplasm transport proteins responsible for 
the transport of substrates (e.g. sugars, amino acids, peptides, metals, etc.), chemotaxis 
and chaperon-like molecules which play a role in envelope biogenesis are found in the 
periplasm (231). Other functions of the periplasm involve protein folding and 
oxidation, important signalling functions, cell division regulation, and secretion of 
lipoproteins, glycerolphospholipids and uniquely structured β-barrel proteins to the 
outer membrane (232). 
 
1.6.2 The cell envelope of Gram-positive bacteria.   
The first cell envelope structure of a Gram-positive bacteria, that of Bacillus 
cereus, was visualized by electron microscopy by Chapman and Hillier in 1953 (233). 
As mentioned above, Gram-positive bacteria do not possess an outer membrane, 
which plays a role in protecting Gram-negative bacterial cells from the environment, 
and also indirectly stabilizes the inner membrane of Gram-negative organisms, thus 
explaining the presence of just a thin peptidoglycan layer in the latter bacterial group. 
In contrast, the lack of an outer membrane in Gram-positive organisms has led to the 
evolution of a 30 – 100 nm thick peptidoglycan layer containing many sheets of 
peptidoglycan polymers that surround the cell in order to withstand harsh 
environmental conditions (196). It has been shown that in B. subtilis changes in 
environmental and growth conditions lead to a dramatic change in the composition of 
surface-expressed proteins, illustrating the role of the cell envelope in adapting to new 
environments (200). The four main components of a Gram-positive cell envelope 
outside of the cytoplasmic membrane are peptidoglycan (also known as murein), lipo- 
and/or wall-teichoic acids (LTA or WTA, respectively), PS and, though not present in 
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all bacteria, an S-layer. Previous studies have demonstrated that all of these 
components, are recognized by specific phages as target host receptors for phage 
infection (83, 87, 133, 135, 143-145, 234, 235), and therefore understanding of the 
structure and composition of each of these cell envelope components is necessary in 
order to gain a better understanding of how phages interact with their specific hosts.  
 
 
Figure 1.4: Cell envelope structure of Gram-positive lactic acid bacteria (NB. The 
CWPS structure is not indicated in this image) (204).  
 
1.6.2.1. The peptidoglycan layer 
The peptidoglycan layer, also known as sacculus, is composed of a PS with 
individual covalently cross-linked chains. The sacculus is therefore a single huge, 
covalently-linked macromolecule which is made up of parallel glycan threads 
connected by short elastic peptide crosslinks which reinforce this structure (196). The 
peptidoglycan layer has the ability to expand and contract when necessary with 
extraordinary elasticity and tensile strength. Thus, molecules can enter and exit the 
cell as required by the plasma membrane (236). It has been shown for the cell wall of 
E. coli and B. subtilis that each peptidoglycan layer allows bacterial cells to exclude 
molecules larger than 55 KDa (237). 
In LAB, like in all eubacteria, the basic components of a glycan thread in the 
peptidoglycan envelope are GlcNAc and MurNAc resulting in a polymer of 
disaccharide N-acetyl-glucosamine-β(1-4)-N-acetyl-muramic acid. During 
peptidoglycan synthesis GlcNAc and/or MurNAc may undergo three different 
modifications, following polymerization and incorporation into the peptidoglycan 
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envelope. The three modifications include the following; (i) Studies involving bacilli 
(238, 239) and Lactobacillus fermentum (Lb. fermentum) (240) have revealed that 
removal of the acetyl groups from GlcNAc and MurNAc causes increased sensitivity 
to autolysis and external lysis procedures (241, 242), as well as increased susceptibility 
to phages (243). (ii) Other studies involving species of Gram-negative and Gram-
positive bacteria, including S. aureus and several LAB species such as Enterococcus 
faecalis (244), Lactobacillus casei (Lb. casei) (245), Lactobacillus acidophilus (246) 
and Lb. fermentum (247) have demonstrated that MurNAc residues in the 
peptidoglycan envelope can be 6-O-acetylated (i.e. an acetyl is added to the C-6 
hydroxyl group of MurNAc residues). O-Acetylation of the MurNAc moiety of 
peptidoglycan is typically associated with bacterial resistance to lysozyme and in some 
bacteria, such as Bacillus anthracis, this process is combined with N-deacetylation to 
confer resistance of cells to lysozyme (248). (iii) C6 of MurNac has also been reported 
to be substituted by cell WTA and teichuronic acids which will be further discussed 
below (204).  
 
1.6.2.2. Teichoic acid (TA) 
TAs, first discovered in 1958 in the LAB Lb. plantarum (249), are present in 
most cell envelopes of Gram-positive bacteria comprising half of the weight of the cell 
envelope (204). TAs are synthesized on the outer face of the cytoplasmic membrane 
as long polymers which thread through the peptidoglycan sacculus. These polymers 
show distinctly different molecules and are anchored in different positions in the cell 
envelope classifying them into cell wall teichoic acids (WTAs), lipoteichoic acids 
(LTAs) and lipoglycans. Depending on, among others, the bacterial species or strain, 
stage or rate of growth of the cell, the pH of the medium and carbon source it is 
exposed to, and phosphate availability, TAs will vary in structure and abundance (250-
253).     
 
1.6.2.3. Cell wall teichoic acid (WTA) 
Cell WTAs include poly-glycerol/ribitol phosphate TAs which are covalently 
attached to the peptidoglycan cell wall. These molecules share the same overall 
structure composed of a chain of phosphodiester-bound glycerol or ribitol residues 
attached to a “linkage unit”, which allows the covalent attachment to the peptidoglycan 
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(204). In LAB, despite the wide variety of TAs, the structure of the linkage unit is well 
conserved. It is composed of the disaccharide N-acetylmannosaminylβ-(1-
4)glucosamine followed by glycerol phosphate, however, differences may occur in the 
nature of the molecules (glycosyl or D-alanyl) which decorate the main chain of the 
TAs and number of glycerol phosphate residues (254). A poly (glycerol phosphate) 
TA has been identified as an important carbohydrate component of the cell wall of the 
LAB strain L. lactis IL1403 (255). However, not all LAB appear to contain WTAs, 
such as Lb. casei (256) and L. lactis subsp. cremoris (257), which relies on LTAs for 
the anionic character of the cell envelope. Teichuronic acids are phosphate-free and 
the main chain is composed of sugar monomers directly linked by glycosidic bonds 
(204). The nature of the sugar monomers varies according to the species studied. 
Teichuronic acids have been described for several Bacillus species (258, 259). 
Considering the phylogenetic relatedness of members of the genus Bacillus to LAB, 
it is possible that teichuronic acids are present in the cell wall of LAB as well.   
 
1.6.2.4. Lipoteichoic acid (LTA) 
Unlike WTAs, polymers known as LTAs and lipoglycan remain attached to 
the cytoplasmic membrane through a lipid anchor, however, a fraction of them are 
found free in the cell wall or even released into the medium (260). LTAs were first 
discovered in 1970 in the LAB Lb. fermentum (261). In LAB, LTAs are widely 
distributed and have been found in lactobacilli, lactococci, enterococci, leuconostocs, 
and streptococci (252). The main component of the hydrophobicity of the cell 
envelope is provided by LTAs which may be involved in bacterial adhesion (204). The 
main chains of cell WTAs and LTAs are decorated with glycosyl or D-alanyl 
substituents which greatly influence the functionality of these anionic polymers. 
Altering the substitution process of glycosyl or D-alanyl through genetic means has 
been shown to cause changes in the phenotype of the mutant strains such as phage 
resistance (145, 262-264). TAs are potent immunogens which are able to weakly 
stimulate cytokine synthesis, a process inhibited by removal of the D-alanine 
substituents. Additionally, TAs are involved in the functionality of the cell, for 
example when phosphate is scarce WTAs composed of polymers of glycerol- or 
ribitol-phosphate act as a phosphate source (265). Furthermore, cell WTAs are 
believed to maintain the correct ionic environment for cation-dependent membrane 
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systems as these anionic polymers provide a constant reservoir of bound cations (266). 
Moreover, LTAs (267), TAs and teichuronic acids (268, 269) have been shown to 
influence the activity of autolysins which are required by the lytic phage cycle to 
induce lysis of the bacterial host in order to release virions. Interestingly, TAs have 
been shown to act as receptors for phage adsorption (133, 145, 146), which will be 
further discussed in Section 1.8: Phage-host interactions of Gram-positive bacteria.   
 
1.6.2.5. Cell wall polysaccharides (CWPS) 
The cell envelope of many Gram-positive bacteria is known to contain or is 
covered by CWPS, which have been classified into: (i) capsular PS which decorate the 
outside of the cell envelope and are either covalently bound (246) or loosely associated 
(270) with the peptidoglycan, and (ii) extracellular polysaccharides (EPS) which do 
not remain attached to cells and are released into the cell surroundings (271). CWPS 
are complex structures which vary according to the nature of sugar monomers, 
modification (e.g. acetylation and reduction), mode of linkage, branching, and 
substitution. The structure has also been shown to depend on growth conditions (272). 
In several LAB, rhamnose has been shown to be a constituent of CWPS, in strains 
including lactobacilli (246, 272-274), streptococci (275), and lactococci (257). 
Furthermore, in L. lactis strains a novel CWPS, the so-called pellicle (PSP), has been 
reported (205). Moreover, studies have shown that specific CWPS structures act as 
receptors for the adhesion of specific phages (140, 142, 144, 257, 274, 276-278) which 




A variety of proteins are also present at the surface of the peptidoglycan layer, 
some of which are analogous to proteins located in the periplasm of Gram-negative 
bacteria (279). These proteins may contain membrane-spanning helices; be attached 
to a lipid anchored in the membrane; bind to TAs; or be covalently attached to or 
associated tightly with the peptidoglycan layer (280). The S-layer is a surface layer 
composed of protein subunits which are non-covalently, yet strongly anchored to the 
underlying peptidoglycan. The function of the S-layer is unknown but studies have 
shown that it might be involved in virulence in the case of pathogenic species (281) 
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and/or in adhesion (282). With regards to LAB, the S-layer has only been identified in 
the cell wall of certain members of the genus Lactobacillus (283-285).  
     
1.7 Phage-host interactions of Gram-negative bacteria.   
As mentioned above, the first step involved in the interactions of a phage with 
its specific host is the recognition of and adsorption to a specific cell surface-exposed, 
host-encoded receptor. Adsorption of the phage to its host may require binding of the 
phage to one or more host encoded receptor(s) in a reversible or irreversible manner. 
Currently, the adsorption process of phage to host-encoded receptors in certain Gram-
negative bacteria has been studied in detail. As mentioned above, Gram-negative host 
receptors are present in the outer membrane which contains surface-exposed 
proteinaceous or saccharidic structures, such as pili, flagella or LPS. The most 
common Gram-negative outer membrane components that act as host receptors for 
phages are porins, affinity transporters and LPS (141). Following reversible binding 
to a primary receptor, irreversible binding to a secondary receptor occurs, which 
triggers DNA release, resulting in phage DNA transfer through the bacterial cell 
envelope into the host cell cytoplasm where phage DNA replication can begin. Though 
the process of viral DNA injection is reasonably well understood for a small number 
of phages infecting Gram-negative bacteria (286).  
The DNA injection process of Gram-negative bacteria has been shown to vary 
among morphologically similar phages. For example, phage Lambda requires host 
proteins to orchestrate the formation of the channel required for DNA translocation 
(287), whereas phage T5 relies on its own phage-encoded proteins to form the channel 
for DNA transport (288). Previous Gram-negative bacterial studies have shown that 
specific bacterial gene products are involved in phage genome injection as specific 
phages require either the activity of a host membrane-associated protein (151) or the 
protein itself to trigger viral DNA ejection (208). For example, in vitro assays with 
purified LamB from E. coli have shown that this outer membrane protein, responsible 
for producing transmembrane channels, inactivates phage Lambda DNA injection, 
thereby providing the first evidence of the involvement of this protein in DNA transfer. 
It has not only been shown that the outer membrane protein LamB acts as a phage 
receptor for the Siphoviridae phage Lambda, but it has also been revealed that the 
bacterial inner membrane PtsM complex, responsible for the transfer and 
phosphorylation of sugars, is involved in the phage infection process (208). Similarly, 
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the protein FhuA, an outer membrane-bound ferrichrome transporter of E. coli, acts as 
a receptor for the Siphoviridae coliphage T5 (289). Furthermore, other E. coli phage 
receptors including LPS or porin proteins (e.g. OmpC) are recognized by coliphages 
belonging to the Myoviridae T4 superfamily, where this particular phage-host 
interaction occurs as a reversible event (290). Additionally, phages C1 and C6 have 
been shown to first adsorb to the E. coli proteins DcrA (inner membrane protein) and 
DcrB (periplasmic protein), respectively, where such an initial adsorption appears to 
trigger formation of diffusion channels across the outer membrane of E. coli. 
Following this, a secondary adsorption to the outer membrane protein receptors BtuB 
and FhuA occurs, which in turn triggers phage DNA injection (150). Similarly, 
coliphage T1 irreversibly binds to the outer membrane protein FhuA, but it requires 
the activity of the inner membrane protein TonB for successful DNA injection (209, 
210). 
Moreover, phage HK97 encodes a gp15 moron element, within its 
morphogenesis region, which encodes a novel Sie protein (as previously mentioned). 
The HK97 prophage actively expresses gp15 which is responsible for the resistance 
of the bacterial host cell to phages HK97 and HK75. Furthermore, the construction of 
a HK97 hybrid phage showed that the TMP is involved in the susceptibility of HK97 
to inhibition by gp15, demonstrating that gp15 acts to prevent the entry of HK97 DNA 
into the cytoplasm of the infected cell (188). A model for the in vivo genome injection 
process of the temperate phage HK97 has been proposed based on a study involving 
single deletions in E. coli genes predicted to encode membrane-associated proteins. 
Results revealed that the activities of the protein PtsG (a membrane-associated glucose 
transporter protein) and FkpA (a periplasmic chaperone) act as host receptors for 
phage HK97. A potassium efflux assay, which is used to detect phage-membrane 
penetration, confirmed that deletion of these specific genes prevented the passage of 
the phage genome through the cell envelope (160, 291). This study did not only 
identify FkpA and PtsG as host receptors required for phage injection, it also 
genetically mapped the determinants for these requirements to the HK97 phage TMP. 
Additionally, the specific region of the HK97 TMP that is sensitive to DNA injection 
inhibition by the gp15 superinfection exclusion protein was identified. Construction 
of hybrid HK97 phages carrying TMP regions from other phages revealed that the 
TMP region required for PtsG interaction is also involved in gp15-mediated 
superinfection exclusion (151).  
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Overall, these studies demonstrate that even within a common Gram-negative 
bacterial host different host-encoded receptors can be involved in DNA injection by 
specific bacteriophages. Furthermore, the fact that different phages require distinct 
inner membrane proteins as host receptors for phage infection shows that such 
receptors are involved in the genome entry process of phage. These proteins may either 
act as channels to allow the viral DNA to pass through the cell envelope, or may anchor 
a region of the TMP of the phage to the inner membrane of the host cell allowing 
efficient passage of the viral genome through the cell wall into the cytoplasm of the 
infected cell.   
1.8 Phage-host interactions of Gram-positive bacteria.   
Unlike Gram-negative bacteria, the extent of knowledge regarding phage 
interactions with their Gram-positive bacterial hosts is much more limited. In order 
for a phage to successfully infect its Gram-positive bacterial host it must first 
attach/adsorb to exposed receptors and penetrate the cell wall to allow the viral DNA 
to enter the cytoplasm of the infected bacteria cell. The process by which this occurs 
is not well understood. Siphophage SPP1 and the interaction with its B. subtilis host 
has been studied in considerable detail, allowing this phage to become a model for the 
process of DNA infection for phages infecting Gram-positive bacteria. It has been 
reported that the protein encoded by the B. subtilis gene yueB is involved in 
irreversible binding of SPP1, following an initial reversible binding to a carbohydrate 
moiety on the cell surface. This was demonstrated by introducing deletions within the 
yueB gene which led to the formation of a B. subtilis mutant strain which was resistant 
to SPP1 (292). Following this particular study the extracellular region (ectodomain) 
of the YueB protein (a 36.5 nm long fiber) was purified using metal affinity and size 
exclusion chromatography (293). Incubation of SPP1 virions with purified YueB 
ectodomain revealed that viral DNA ejection was triggered in vitro following 
irreversible binding of SPP1 to the ectodomain of YueB. SPP1 DNA ejection was 
confirmed by the reduced number of plaques and the decreased amount of phage DNA 
remaining in the capsids of SPP1 following the interaction of SPP1 virions with 
purified YueB ectodomain. This was the first receptor to be purified from a Gram-
positive bacterium that was actively capable of triggering viral DNA ejection in vitro. 
The SPP1 bacteriophage possesses a long non-contractile tail composed of a tube and 
a tail tip acting as the adsorption device. The head-to-tail connector of SSP1 is 
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composed of gp6, gp15 and gp16 dodecameric rings, with the gp16 ring being 
responsible for closing the portal channel structure to prevent DNA exit from the 
nucleocapsid (294, 295). It has been suggested that one end of the dsDNA which is 
coiled within the capsid is bound to gp16, when ejection of the SPP1 genome is 
triggered, and that this is the first DNA segment to exit the SPP1 phage capsid (296). 
Additionally, a further study determined the structure of the SPP1 tail before and after 
DNA ejection, revealing extensive structural rearrangements during this process (61).    
Only a small number of phages infecting Gram-positive bacteria have been 
shown to adsorb to a membrane-bound proteinaceous receptor. For example, protein 
purification and chromatography techniques have revealed that the membrane-
associated protein PIP (phage infection protein), which is encoded by the Gram-
positive L. lactis subsp. lactis C2 (L. lactis C2) is required for phage c2 infection (134). 
Moreover, irreversible binding of the phage to this membrane protein occurs following 
an initial and reversible adsorption to a cell wall carbohydrate (140).  
Studies have shown that specific phages which infect Gram-positive bacteria 
recognize TA structures as receptors for phage infection (133, 145, 146, 262, 297). 
Furthermore, the modification of the WTA or LTA structures has been shown to result 
in phage-resistance (145, 298, 299). For example, the presence of a galactose-
containing moiety in lipoteichoic acid prevents phage adsorption to L. lactis subsp. 
cremoris SK110 (145). Phage-resistant S. aureus mutants revealed that glycosylated 
cell WTAs act as a receptor for siphovirus 47, Sa2mw, 13, and 77, while non-
glycosylated TA acts as a receptor for myovirus K and 812 (146). The major target for 
the model phage SPP1 is glucosylated TAs to which SPP1 first reversibly adsorbs to 
before irreversibly binding to YueB (133). Other phages infecting B. subtilis also 
adsorb to glucosylated polyglycerol TA, and thus phage-resistance has been reported 
in B. subtilis mutant strains deficient in glucosylation of their TAs (298). Furthermore, 
the lack of GlcNac in TA of Listeria mutant strains also results in phage-resistance 
(299). Additionally, phage P35h4 was previously shown to directly adsorb to 
galactosylated WTA in Listeria monocytogenes (300).  
 
1.9 Lactococcal phage-host interactions 
Lactococcal phage-host interactions are (like any other phage-host system) 
determined by two factors, the phage-encoded RBPs and the host-encoded target 
receptor molecule(s), which may be a saccharidic, proteinaceous and/or TA 
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component of the cell envelope (141). It had previously been revealed that rhamnose 
present in the CWPS in L. lactis subsp. cremoris KH acts as a receptor for the 936 
bacteriophage kh (257). Furthermore, it was shown that seven c2-group lactococcal 
phages infecting L. lactis C2 adsorb to a rhamnose component of the CWPS (140). 
Fluorescence quenching experiments demonstrated that the RBP of the P335-group 
phage TP901-1 displays high affinity for saccharides in solution (301). Further phage-
host recognition and attachment studies using phages belonging to different 
lactoccocal phage groups also suggest that their primary receptor is saccharidic in 
nature. These phages include P335 phages Tuc2009 (278) and TP901-1 (132), 936 
phages p2 (302) and bIL170 (303), and the 949, P087 (144), and 1358 phages (142, 
304).  
Over a decade ago it was shown that infection of the 936 phages bIL170 and 
645 requires the L. Lactis IL1403 rgpE and ycaG genes, and the L. lactis subsp. 
cremoris Wg2 ycbB and ycbC genes, respectively. The rgpE and ycbB genes encode 
putative glycosyltransferases, while ycbB and ycbC encode putative membrane-
spanning proteins with unknown functions for phage adsorption. Interestingly, these 
genes were predicted to be involved in CWPS biosynthesis, suggesting that both 
phages bind to different CWPS structures (305). The structure and biological functions 
of the CWPS have previously been investigated in certain lactococcal strains (255, 
306-311). The lactococcal CWPS consists of two covalently-linked constituents: the 
surface-exposed polysaccharide pellicle (PSP) and the recently described rhamnan PS, 
which is embedded within the peptidoglycan layer. Analysis of the structural 
components of the cell envelope of L. Lactis MG1363 reported the presence of a novel 
layer forming an outer pellicle surrounding these Gram-positive cells (205, 307) and 
acting as a host receptor of (certain) 936-group phages (205). Such a PSP structure 
was also reported in L. lactis subsp. cremoris strains 3107 (309) and SMQ-388 (142). 
A bioinformatic study based on the comparative genome analysis of six lactococcal 
genomes revealed that the CWPS-specifying DNA region contains a highly conserved 
region, as well as a region of diversity. This led to the classification of L. lactis CWPS-
associated genotypes into three major groups (types A, B and C) based on the 
differences in the gene cluster that is presumed to be involved in the CWPS pellicle 
biosynthesis. Moreover, a direct correlation was reported between the CWPS pellicle 
genotype of a given L. lactis host strain and the host range of tested 936-group phages, 
with 936 phages infecting lactococcal strains belonging to the B- and C-type CWPS. 
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The comparative genome analysis of the eleven lactococcal 936-group phages used in 
this particular study also revealed a direct correlation between the 936-group phage-
encoded RBP genotypes and the host-determined CWPS genotype (143). The variable 
genetic locus that is responsible for the biosynthesis of the PSP has been identified 
and partially characterized in a number of strains (77). The subtle differences in the 
biochemical make-up of PSP structures exhibited by different L. lactis strains appears 
to act as receptors to determine host specificity of many lactococcal phages (309). The 
variable PSP has been identified as the principal phage receptor for the industrially 
significant lactococcal phage groups P335 and 936, as well as the 1358, 949 and P087 
(142, 144, 278, 309).  
The genetic locus encompassing the CWPS biosynthesis operon of eight 
strains of L. lactis belonging to the C-type CWPS genotype have been analysed (309) 
(Fig. 1.5). The results revealed the presence of a variable region among the C-type 
CWPS biosynthesis cluster which contain genes encoding glycosyltransferases that 
display low or no sequence homology between the strains leading to a sub-
classification of this C group into five subgroups, subtype C1 – C5 (309). As recently 
discussed CWPS is composed of the ‘pellicle’ and the rhamnan component. In strains 
exhibiting an A- and B-type CWPS, this structure is isolated as a single polymer (255, 
311), while in strains exhibiting a C-type CWPS, the pellicle and rhamnan are isolated 
separately due to the chemically labile phosphodiester linkage (309). Based on the 
variable regions (PSP) of the C-type CWPS biosynthesis cluster (Fig. 1.5) the L. lactis 
strains 3107 and MG1362 have been classified as subtype C2 and C1, respectively 
(309). Genetic engineering was employed to achieve swapping of the sequence 
encoding the PSP structures, and results demonstrated that the subtype C2 PSP is the 
host cell surface receptor of the LC3 and TP901-1 P335-group phages and that various 
936-group phages require the PSP encoded by subtype C1 as their host receptor to 
accomplish adsorption. Moreover, the CWPS of L. lactis SMQ-388 strain was also 
identified as a C-type strain (142). Additionally, the CWPS of L. lactis IL1403 was 
identified as a type B (255) and the CWPS of L. lactis UC509.9 was identified as a 
type A (311). The unique CWPS structures of these strains validate the genetic 





Figure 1.5. Comparison of the variable regions in the C-type CWPS biosynthesis 
cluster of eight lactococcal strains (309). 
 
Lactococcal phages belonging to the P335 and 936 groups have been 
extensively studied due to their significant negative impact on the fermented dairy 
industry (83, 143). For example, by ethyl methanesulfonate exposure five 
bacteriophage insensitive mutants (BIMs) of L. lactis 3107 were generated that display 
different infection sensitivities to the P335-group phages LC3 and TP901-1 (312). All 
five mutants were resistant against TP901-1 infection, while two of these BIMs were 
also resistant to LC3. Furthermore, the adsorption efficiencies of TP901-1 and LC3 
for both LC3-resistant mutants were severely reduced, which suggest that their CWPS 
biosynthesis was affected. Interestingly, near normal adsorption properties were 
exhibited by the three TP901-1-resistant BIMs (which had remained sensitive to LC3). 
This particular study suggests that both P335-group phages TP901-1 and LC3 use the 
same primary receptor. This conclusion was reinforced by the fact that both P335 
phages require the CWPS produced by L. lactis 3107 (Fig. 1.5) as a host receptor (309) 
and the fact that the RBPs of both phages are almost identical at their respective C-
terminal regions (80, 81). This particular study also suggests that TP901-1 and LC3 
may adsorb to different molecules to trigger DNA injection (309). Further research 
involving bioinformatic analysis of these phage-resistant mutants along with 
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complementation assays may thus reveal novel gene(s) involved in phage-host 
interactions, hence expanding our knowledge regarding Gram-positive genes involved 
in lactococcal P335 phage infection.      
 
1.10 Classification of phage members of the P335 group 
Significant scientific attention has been directed towards the lactococcal P335 
phage group as phages belonging to this particular group have frequently been isolated 
in the dairy industry and are the most genetically diverse. During the past decade P335 
phages Tuc2009 and TP901-1 have been thoroughly studied at the molecular and 
structural level, and have consequently become model systems for P335 phage group 
infecting L. lactis (99, 100, 123, 131, 137, 139). The number of complete P335 
lactococcal phage genome sequences (excluding predicted prophages belonging to 
sequenced L. lactis genomes) on the NCBI public database (www.ncbi.nlm.nih.gov) 
is rapidly increasing, some of which are exhibited in Table 1. A common characteristic 
among lactococcal phages appears to be their genome plasticity which is a 
disadvantage to the dairy industry as it allows phages to rapidly adapt to the dynamic 
dairy environment (135, 313). Southern hybridization and morphological analyses 
followed by comparative sequence analysis confirmed that phages Tuc2009, TP901-
1, BK5-T, r1t, LC3, ul36 and 4268 all belong to the P335 phage group (57). Previous 
genome analyses revealed that among the P335 phages the genome sequences are 
rather divergent relying on the identification of sequence homology or analogous 
functional regions to classify members of the P335 group (57, 69, 79-81, 234). 
Identification of lactococcal P335 phage members has relied on the presence of a 
predicted dUTPase-encoding gene believed to be the only conserved genes among 
P335 phage genomes (69). However, the genome of the P335 phages 4268 and 
Dub35A do not exhibit a homologue of the dUTPase-encoding gene illustrating the 
polythetic nature of the P335 phage group (76). Currently, among all the phage 
genomes classified within the lactococcal P335 phage group there is not a specific 
genetic feature shared by all members (57). Previous functional analysis of TP901-1 
confirmed the suggestion that the functional synteny of coliphage lambda is a model 
comparator to lactococcal phages (86). This suggests that despite sequence divergence 
among the morphotype phages belonging to the Siphoviridae family, these phages can 
possess similar genomic regions encoding their morphogenetic functions.  
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Interestingly, the recently isolated P335 phages Q33 and BM13 were shown to 
be genetically distinct from previously sequenced P335 phage isolates (83). As a result 
morphological analysis combined with comparative genomic analysis of the genomic 
region encoding the “adhesion device” of P335 phages was perfomed. This led to the 
classification of these genetically diverse phages into four sub-groups (I – IV) based 
on their distinct morphological features (Figs. 1.6 and 1.7) and genetic lineages of their 
tail tip region which is presumed to be involved in interactions with the lactococcal 
host. Furthermore, a more recent study based on the genetic diversity of lactococcal 
prophages identified a novel morphotype of the P335 lactococcal phage group, thus 
adding an additional sub-group (V) to the classification of this P335 group (314). 
Examples of published P335 phages, the sub-group they belong to, and the CWPS 
type they infect are demonstrated in Table 1. Subgroup I represents phages possessing 
a long fibre protruding through their tail tip. Previously, BK5-T and 4268 were the 
only members of this sub-group (83). However, a recent study identified the novel 
38502 and C41431 phages as additional members of sub-group I due to their BK5-T-
like RBP structures determined by EM and sequence similarities in the region 
encoding the adhesion device (77). Sub-group II characterizes phages with a double-
disc BP structure, representatives of which include the model P335 phages Tuc2009, 
TP901-1, P335 and ul36. Other novel phages, shown in Table 2, exhibited a BP 
structure similar to that of Tuc2009 and TP901-1 (77). Sub-groups III and IV 
represent phages that exhibit a small “stubby” distal tail structure but which are 
genetically distinct. Sub-group III phage members include LC3 and r1t, including the 
recently assigned new phage member Dub35A which is highly identical to LC3 in the 
genomic region encoding the adhesion device. The P335 phage 50902 was classified 
as a sub-group IV member due to its shorter tail and small “stubby” tail tip which is 
typical of members of sub-group III or IV, further comparative genomic analysis based 
on overall proteomic content revealed sequence homology to the sub-group IV phage 
members (77). Sub-group V represents P335 phages which possess TMPs of different 
lengths, well conserved Dit proteins and large RBPs (314). Large Dit proteins also 
known as evolved Dits have been shown to harbour carbohydrate binding domains in 
phages belonging to sub-group I and V. The RBPs of the phages belonging to sub-
group V are comparable in size to that of phage BK5-t which belongs to sub-group I. 
Sub-group V phage members appear to encode a protein with fused Tal and RBP (Tal-
RBP), this is consistent with BK5-t as distinct genes encoding the RBP and Tal 
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component are not observed in this sub-group I member. The combined Tal-RBP 
function has been shown to be limited to sub-group I and V phages as the genomes of 
sub-group II - IV phages possess distinct Tal and RBP encoding genes. Interestingly, 
it has been revealed that like phage BK5-t, phage members of the sub-group V possess 
a long tail fibre protruding through the tail tip region. Furthermore, it was shown that 
even though RBP sequences of the phages belonging to sub-group I and V are 
unrelated, perhaps similar roles and structural features are conserved between these 
P335 phages (314). The classification of the phage members of the lactococcal P335 
group (sub-group I - V) has provided a tremendous advancement in the current 
understanding of lactococcal phage-host interactions and the genetic complexity of 
this industrially significant lactococcal phage group, reinforcing the importance of 




Figure 1.6. Transmission electron micrographs of lactococcal phages representing 




Figure 1.7: Schematic depiction of the architecture of the distal tail regions of (a) sub-
group I, (b) sub-group II and (c) sub-group III/IV phages highlighting the domains 
identified by HHPred analysis (77).  
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1.11 Conclusions and future perspectives  
It is clear that in order to fully understand phage-host interactions we first need 
to study and understand the structure and genetics of both, the phage and host. Phage 
contamination in the dairy fermented industry is a naturally occurring phenomenon, 
therefore it will always be a persistent problem. However, gaining insights into 
lactococcal phage-host interactions is a rational approach towards improving current 
methods used to control phage contamination and even developing new approaches to 
reduce the frequency of contamination. New genome sequences of lactococcal phages 
and bacteria are continually emerging expanding our knowledge regarding their 
genetic information which will gradually fully explain the interactions between phages 
and their bacterial hosts. Furthermore, determining the specific host receptors of 
Gram-positive bacteria for specific phage infection and the bacterial genes responsible 
for the expression of these receptors is a key element in the development of 
transcriptomic tools. Additionally, the identification of more proteins and 
carbohydrates that lactococcal phage recognise as primary and secondary receptors is 
necessary to isolate phage-resistant strains as the target genes can be defined as genetic 
markers. These will allow the development of new strategies to control phage 
contamination of starter cultures, hence, reducing the economic losses due to phage 
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2 Abstract  
In the current study, the complete genome sequence of Lactococcus lactis 
subsp. cremoris (L. lactis) 3107, a dairy starter strain and host for the model P335 
bacteriophage TP901-1, is reported. The circular chromosome of L. lactis 3107 is 
among the smallest genomes of currently sequenced lactococcal strains. L. lactis 3107 
harbours a complement of six plasmids which encode traits including lactose 
utilization and casein metabolism, reflecting its adaptation to the nutrient-rich dairy 
environment. Additionally, an improved method for electrotransformation of L. lactis 
3107 and a multiplex PCR methodology for the identification of the plasmids of this 




2.1 Introduction  
The dairy fermentation industry relies on starter or adjunct cultures, 
predominantly composed of lactic acid bacteria (LAB), to produce high quality end 
products (1). Like all bacteria, individual strains of LAB are susceptible to infection 
by bacteriophages (phages), which are ubiquitous in the dairy environment, while they 
can be rather insensitive to pasteurization treatments (2). Therefore, phage infection 
of starter and adjunct strains during the fermentation process is a major concern for 
the dairy fermentation industry as this may negatively impact on the final product 
quality and production regimes, thereby causing significant economic losses (3). 
Among the LAB, strains of the industrially significant species Lactococcus lactis are 
particularly susceptible to infection by phages (4, 5). For millennia L. lactis has been 
safely employed as a starter culture in dairy fermentations, and for this reason it has 
been granted “GRAS” (Generally Regarded as Safe) status (6). 
The advent of so-called next generation sequencing (NGS) technologies has 
transformed life sciences, making genome sequence analysis easily accessible. This, 
for example, has facilitated the availability of some hundreds lactococcal genomes in 
the publically accessible NCBI (National Centre for Biotechnology Information) 
database. In the current study we applied Single Molecule Real Time (SMRT) (7, 8) 
and Illumina sequencing (9) to sequence the complete genome of L. lactis subsp. 
cremoris 3107, which is host for the model lysogenic P335 phage TP901-1 (10).  
SMRT sequencing, which was developed by Pacific Biosciences (7, 8), is one 
of the latest sequencing technologies and is currently the only technology which 
facilitates the detection of base modifications with primary sequencing analysis. 
Consequently, SMRT sequencing can be applied to determine the methylome of 
strains allowing the study of genome methylation by DNA methyltransferases 
(MTases). MTases are encoded by prokaryotes to confer base modifications known to 
be involved in a variety of processes including cell cycle regulation, DNA repair and 
pathogenesis (11). Studies have demonstrated that invasion of a bacterial cell by 
foreign DNA (such as a phage) may be prevented by restriction-modification (R-M) 
systems. A typical R-M system consists of an MTase linked to a cognate restriction 
endonuclease (REase) activity, where the MTase methylates ‘self’ DNA, while the 
REase targets invading non-methylated DNA (12-15), thereby preventing phage 
propagation. R-M systems have been classified into four different types (Types I - IV) 
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based on sub-unit composition, ATP (or GTP) requirements and cleavage mechanisms 
(16). 
In order to study the molecular events that underpin TP901-1 interactions with 
its L. lactis 3107 host, the cell wall polysaccharide (CWPS) biosynthesis operon of 
this strain was previously analysed (17). The L. lactis 3107 genomic region that is 
responsible for CWPS biosynthesis belongs to the so-called type C genotype, with its 
variable region (subtype C2) being responsible for the synthesis of a surface-exposed 
polysaccharide pellicle (PSP) component which acts as the TP901-1 phage receptor 
(17). Further studies focusing on the interactions of TP901-1 with its L. lactis 3107 
host have been limited as this strain is poorly transformable rendering it recalcitrant to 
genetic manipulation (18, 19). Here, the L. lactis 3107 genome was analysed in terms 
of its general genome characteristics, the traits imparted on the strain by its plasmids, 
its methylome, and impact of methylation on the transformability of the strain. 
Additionally, an optimised electrotransformation protocol was developed and 





2.2 Materials and Methods  
 
2.2.1 L. lactis 3107 growth conditions and plasmid 
L. lactis 3107 was routinely cultured at 30 °C in M17 broth/agar (Oxoid, U.K.) 
supplemented with 0.5 % glucose (v/v) (GM17 broth/agar) without agitation. The 
pNZ44 vector expressing a chloramphenicol resistance (Cmr) gene (20) was employed 
in electrotransformation assays.  
 
2.2.2 L. lactis 3107 genome sequencing   
For Pacbio sequencing, L. lactis 3107 cell pellets (from an overnight culture, 
see below) containing 109 colony forming units were provided to GATC Biotech Ltd. 
(Germany) to perform chromosomal DNA extraction, library construction and Single 
Molecule Real Time (SMRT) sequencing on a Pacific Biosciences RS (run 1) and RSII 
(run 2) sequencing platform. The library for PacBio sequencing was prepared using 
the SMRTbell Template Prep Kit with 8-12 kb inserts according to the manufacturer’s 
instructions (Pacific Biosciences, Menlo Park, CA, USA). De novo genome assembly 
of the SMRT sequencing data was performed using the RS_HGAP_Assembly.2 
protocol (default parameters) implemented in the Pacific Biosciences SMRT Analysis 
Portal (version 2.3.1). Quality filtering was performed automatically during assembly 
by the SMRT portal P-filter module. Two SMRT cells were used for PacBio 
sequencing to achieve an initial assembly of the derived 52,984 filtered reads into 23 
contigs with an N50 contig length of 337,497 bp and an average coverage of 60.37-
fold. 
For Illumina-based sequencing 5 µg chromosomal DNA from L. lactis 3107 
was extracted using phenol-chloroform based extractions as previously described (21) 
following overnight growth of the strain at 30 °C in M17 broth (Oxoid, U.K.) 
supplemented with 0.5 % glucose (v/v). Genomic libraries were constructed using the 
TruSeq DNA PCR-Free LT Kit (Illumina®) and 2.5 μg of genomic DNA, which was 
fragmented with a Bioruptor NGS ultrasonicator (Diagenode, USA) followed by size 
evaluation using Tape Station 2200 (Agilent Technologies). Library samples were 
loaded into a Flow Cell V3 600 cycles (illumina®) and draft genome Illumina 
sequencing was performed on a MiSeq genomic platform (Illumina, UK) at GenProbio 
srl. (Parma, Italy). The Illumina reads were mapped on corresponding PacBio 
scaffolds to provide confidence in the generated sequence quality and to resolve base 
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conflicts using Bowtie2 v2.2.7 achieving a mapping coverage of 847-fold for the 
chromosome and on average 4,776-fold for the plasmids. Remaining low quality 
regions or sequence conflicts were resolved by primer walking and Sanger sequencing 
of PCR products (Eurofins MWG Operon, Germany). 
 
2.2.3 General feature predictions  
Following final genome assembly, putative protein-encoding genes were 
identified using the prediction software Prodigal (version 2.0) (22). Protein-encoding 
genes were automatically annotated using a BLASTP v2.2.26 (cut-off E-value of 
0.0001) sequence alignments against the non-redundant protein (nr) database curated 
by NCBI (ftp://ftp.ncbi.nih.gov/blast/db/). Following automatic annotation, the 
obtained Open Reading Frames (ORFs) were manually inspected and refined using 
the genome visualisation tool Artemis v16 (23). Finally, ORF annotations were refined 
further where necessary using alternative functional searches using PFAM database 
(24), and the Clusters of Orthologous Groups (COG) database (25). Predicted transfer 
RNA (tRNA) and ribosomal RNA (rRNA) genes were identified using tRNA-scan-SE 
v1.4 (http://lowelab.ucsc.edu/tRNAscan-SE/) and RNAmmer v1.2 
(http://www.cbs.dtu.dk/services/RNAmmer/), respectively. Using Artemis v16, the 
predicted RNA-specifying loci were manually added to the genome annotation. 
PHASTER (26) analysis of the L. lactis 3107 genome was also performed to identify 
potential prophages.  
Additionally, DNA base modification analysis was performed by means of 
SMRT sequencing. This was performed using the 
RS_Modification_and_Motif_Analysis.1 protocol and the finished genome assembly 
as a reference file. 
 
2.2.4 Nucleotide sequence accession numbers and SRA accession number 
The complete chromosome and plasmid complement of L. lactis subsp. 
cremoris 3107 were deposited in GenBank under accession no. CP031538 
(chromosome), CP031539 (p3107A), CP031540 (p3107B), CP031541 (p3107C), 
CP031542 (p3107D), CP031543 (p3107E), and CP031544 (p3107F). The SMRT and 
Illumina raw reads have been deposited in Sequence Read Archive (SRA) under 




2.2.5 Multiplex PCR targeting L. lactis 3107 plasmids 
Primers employed in the multiplex PCR system targeting each of the six L. lactis 
3107 plasmids are presented in Table 2.1. Each primer pair was designed to generate 
differently sized products as detailed in Table 2.1. Primer characteristics were analysed 
using the online tool OligoCalc: Oligonucleotide Properties Calculator 
(http://biotools.nubic.northwestern.edu/OligoCalc.html).  
Multiplex-PCR was performed on an L. lactis 3107 colony using Thermo 
Scientific Phusion Green Hot Start II High-Fidelity PCR Master Mix (Fisher 
Scientific, Ireland) using the following PCR conditions: initial denaturation at 98 °C 
x 30 sec, followed by 30 cycles of denaturation at 98 °C x 10 sec, annealing at 50 °C 
x 30 sec and extension at 72 °C x 90 sec; and a final extension of 72 °C x 10 min. 
Following amplification, agarose gel electrophoresis using a 1 % agarose gel was 
performed using a standard procedure (27) to visualize generated amplicons, thus 
confirming the presence of all six 3107 plasmids which was indicated by a product of 
the appropriate size corresponding to each plasmid. 
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Table 2.1: Multiplex-PCR primers for Lactococcus lactis subsp. cremoris 3107 plasmids.    
 
Target Primer Name 
Primer 
Sequence 
Annealing Temp. Product Size 
  (5’ to 3’) (oC) (bp) 
L. lactis 3107 plasmid     
p3107A p3107A_F GGAAGGTGGCAGAGCATA 50.3 
857 
 p3107A_R CGTGTCCTGGTTTGCTAT 48.0 
     
p3107B p3107B_F GGGAGTGAACCAGTAACA 48.0 
740 
 p3107B_R CCAGGAGAAGAAGTACGA 48.0 
     
p3107C p3107C_F CGTCCCAATACCAACTGT 48.0 
417 
 p3107C_R GCGGTTCGTTTCTTCTCA 48.0 
     
p3107D p3107D_F GCGTATCTATGGCTGTCA 48.0 
228 
 p3107D_R GCGTCCTTTGATTCATGAG 48.9 
     
p3107E  p3107E_F GCCGTGTCTTGCATTGAT  48.0  1,012 
  p3107E_R GGCTTGCACCTTTACCTC  50.3  
     
p3107F p3107F_F CCGAAGAGCCACCGAAAG 52.6 
616 
 p3107F_R GCTTGTAGCTGTTGTCGT 48.0 
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2.2.6 Electrotransformation of L. lactis 3107 
This procedure was performed as described previously (28, 29) with the 
following modifications: 50 mL of M17 (Oxoid, U.K.) broth supplemented with 0.5 
M sucrose (w/v), 0.5 % glucose (v/v) and 1 % glycine (v/v) was inoculated with 6 % 
fresh overnight culture. This culture was incubated at 30 °C until an approximate 
OD600nm of 0.6 – 0.8 was reached. Following centrifugation at 1900 × g for 15 minutes 
at 4 °C, the pellet was washed twice in an ice-cold wash solution composed of 0.5 M 
sucrose (w/v) and 10 % glycerol (v/v). The obtained cell pellet was re-suspended in 
500 µl wash solution, aliquoted and used immediately or frozen at -80 °C. 45 µl of 
fresh or thawed competent cell suspension was mixed with 5 µl of pNZ44 plasmid 
DNA and electroporated with an Electro Cell Manipulator® Precision PulseTM (BTX® 
Harvard Apparatus, Massachusetts, U.S.A.) at 2 kV, 200 Ω and 25 µF in an ice-cold 
0.2 cm electroporation cuvette (Cell Projects Distributor, Kent, U.K.). Cells were re-
suspended in 950 µl ice-cold recovery media composed of GM17 broth supplemented 
with 20 mM MgCl2 and 2 mM CaCl2. Following this, the mixture was incubated at 30 
°C for 2.5 hours. The recovered cells were centrifuged at 1,900 × g for 1 minute, 
resuspended in 100 µl of the recovery media, spread plated on GM17 agar 
supplemented with 2.5 mM CaCl2, 2.5 mM MgCl2 and 2.5 µg ml
-1 Cm for the selection 
of pNZ44, and were then incubated anaerobically at 30 °C for 48 hours. The presence 
of pNZ44 in the generated transformants was confirmed by PCR amplification of a 
500 bp specific to the p44 lactococcal promoter and multiple cloning site (MCS) 
sequence of pNZ44 using pNZ44_F 5’-CTAATGTCACTAACCTGCCCCG-3’ and 
pNZ44_R 5’-GCTTTATCAACTGCTGCT-3’ primers. Following this, selected 
colonies were cultured overnight in GM17 broth supplemented with 5 µg ml-1 Cm. 
Additionally, a multiplex-PCR using the primers presented in Table 2.1 was performed 






2.3.1 General chromosome and plasmid features of L. lactis 3107 
In this study the L. lactis 3107 genome was sequenced (30). The complete 
genome sequence of this dairy starter strain consists of a single circular chromosome 
of 2,378,982 bp (35.82 % G+C content) in length, while the strain also harbours six 
plasmids ranging in size from 2,232 – 60,216 bp (Table 2.2). General feature analysis 
of the chromosome of L. lactis 3107 identified a total of 2,380 predicted CDS (Coding 
Sequences) of which 101 (4.24 %) are pseudogenes, which is comparable to the 
number of pseudogenes present in other L. lactis subsp. cremoris strains (31). Further 
genome analysis demonstrated that 80.2 % of the CDS can be functionally assigned 
using BLAST (Basic Local Alignment Search Tool) based on in silico predictions, 
while the remaining 19.8 % are assigned as hypothetical proteins. The genome of L. 
lactis 3107 contains 164 insertion sequence (IS) elements/transposase-encoding 
genes, including 20 copies of IS712H and 31 copies of IS982B. Prophage analysis 
using PHASTER (26) identified two intact prophages with lengths of 42.6 and 48.8 
Kb, and four (apparently) incomplete prophages ranging in size from 11 to 36.8 Kb. 
Methylome analysis of the genome of this strain did not reveal any methylated motifs, 
although restriction-modification (R-M) associated genes are present in the genome of 
3107. These results have been published in the REBASE Genomes database 
(http://tools.neb.com/genomes/view.php?genome_id=35512) and are presented in Table 
2.3.    
Analysis of the six plasmids harboured by L. lactis 3107 was also performed. 
This extra-chromosomal DNA represents a total of 161,686 bp and is predicted to 
represent 172 CDSs of which 29 (16.86 %) are annotated as hypothetical proteins. The 
G+C content of each plasmid ranges from 31.63 to 37.63 %, which is comparable to 
G+C content of previously reported L. lactis plasmids (32). Analysis of the plasmid-
encoded genes revealed that plasmids p3107A, p3107B, p3107C and p3107E harbour 
homologues of the replication gene repB. The 3107 plasmid-encoded RepB proteins 
show 58 – 100 % amino acid identity to the replication protein RepB, which has been 
associated with theta-type replication (33), a replication mechanisms used by the 
majority of lactococcal plasmids (32, 34). The two smallest plasmids, p3107D and 
p3107F, do not harbour a repB homologue, which may not be surprising as small 
plasmids (< 10 Kb) typically replicate via the rolling circle replication (RCR) 
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mechanism (32). The second largest plasmid p3107A encodes (predicted) traits such 
as lactose and casein metabolism, an oligopeptide permease system, a mobilisation 
protein MobA, a universal stress protein UspA, and aminoglycoside antibiotic 
resistance. The largest plasmid p3107B encodes putative functions such as an R-M 
type I system, mobilisation proteins MobC and MobD, as well as cold-shock response 
proteins. Plasmids p3107C and p3107E are predicted to encode supplementary 
mineral uptake systems including Mg2+ and Co2+ transporters. In addition, a 
homologue of this system (L3107_1068) is present on the 3107 chromosome. 
Furthermore, p3107C encodes the mobilisation protein MobC. The smallest plasmids 
p3107F and p3107D encode two and three proteins, respectively, putatively involved 
in plasmid replication.    
 
2.3.2 Multiplex PCR targeting L. lactis 3107 plasmids 
In order to accurately identify the presence of the six plasmids harboured by 
L. lactis 3107, to be used, for example, for verification purposes (for L. lactis 3107 
transformants), a multiplex PCR was developed which targets each of these six 
plasmids (Table 2.1). Each set of primers has a similar annealing temperature and was 
designed to amplify a specific DNA region of a distinctive size in each plasmid. 
Indeed, Figure 2.1 shows that DNA regions of the expected size were amplified where 

































genome 2,378,982 2,279 60 19 101 215 2 Int 4 Inc 35.82 65.01 846.88 
p3107A  50,160 52 - - - 12 - 35.64 228.24 1633.72 
p3107B 60,216 69 1 - - 19 - 33.38 230.17 1550.52 
p3107C 26,709 24 - - - 9 - 37.63 455.12 2467.09 
p3107D 2,232 3 - - - - - 33.56 615.77 11381.27 
p3107E 18,170 22 - - - 5 - 34.81 491.65 4443.82 
p3107F 4,199 2 - - - - - 31.63 332.51 7180.93 
 








Table 2.3: Restriction-Modification (R-M) associated genes present in the genome of L. lactis 3107.  




Type I     
 1148 R Type I restriction subunit (pseudogene) Unknown  
 1150 S Type I specificity subunit Unknown  
 1153 S Type I specificity subunit Unknown  
 1154 M Type I N6-adenine DNA methyltransferase Unknown  
 2087 S Type I specificity subunit Unknown  
     
Type II     
  0842 M Type II N4-cytosine or N6-adenine DNA methyltransferase Unknown  
 







Figure 2.1: Agarose gel image of amplicons generated following multiplex-PCR 
targeting L. lactis 3107 plasmids. Lane A exhibits a DNA Ladder (relevant sizes are 
indicated; Fisher BioReagents, Ireland); Lane B exhibits six PCR products of varying 
sizes representing each of the six L. lactis 3107 plasmids including p3107E (1,012 bp), 
p3107A (amplicon size 857 bp), p3107B (amplicon size 740 bp), p3107F (amplicon 



















2.3.3 Optimization of electrotransformation efficacy of L. lactis 3107 
In order to enhance the electrotransformation efficiency of L. lactis 3107, 
various parameters of previously described electrotransformation protocols (28, 29) 
were assessed (Table 2.4). Following modification of each parameter, the 
transformation efficiency of 3107 was determined using the high copy number vector 
pNZ44. First, analysis of growth of L. lactis 3107 in M17 broth supplemented with 
0.5 % glucose (GM17) or lactose (LM17) (data not shown) was performed, and based 
on the superior growth of L. lactis 3107 on GM17, this medium was selected as the 
growth medium to prepare this strain for electrotransformation. 
In order to enhance transformation efficacy, while maintaining sufficient cell 
viability, different concentrations of cell wall weakening agents (e.g. glycine, DL-
threonine and penicillin) were tested individually and in combination with various 
sucrose concentrations to create osmotic stabilization (Table 2.4). Results showed that 
at 0.5 M sucrose, the highest glycine concentration tolerated by 3107 is 1 % and 
following electroporation, the highest efficiency of transformation (5.60 x 104 ± 1.00 
x 103 Cmr colonies per µg of DNA transformed) was observed (Table 2.4), when 3107 
is grown under these conditions. Glycine levels above and below 1 % in combination 
with sucrose molarities at and below 0.5 M were also tested, although this did not 
improve transformation efficiency (Table 2.4).  
In addition to glycine, the cell wall weakening agent ampicillin was used in an 
attempt to further enhance cell wall permeability of the strain. However, exposure to 
ampicillin caused a 3-log reduction in the viability of the cells before electroporation 
(results not shown) suggesting that the already weakened cell wall due to the exposure 
to glycine cannot withstand further damage as it results in cell death. When DL-
threonine was applied instead of glycine a negative effect on the efficiency of 
transformation of 3107 was observed when compared to the number of transformants 
obtained when competent cells were prepared using glycine (results not shown).   
A 4 – 6 % inoculum of L. lactis 3107 overnight culture optimizes the growth 
of 3107 in the presence of 1 % glycine and 0.5 M sucrose without affecting the 
transformation efficiency of this strain (as 5.60 x 104 ± 1.00 x 103 Cmr colonies per µg 
of DNA transformed were obtained). Results also indicated that an OD600nm value 
between 0.6 and 0.8 represents the optimal range for the preparation of competent 
cells. A voltage of 2 kV yielded optimal transformation efficiencies compared to all 
other tested conditions (Table 2.4). 
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The impact of freezing the prepared competent cells at -80 °C prior to 
electroporation was also analysed. Results showed that storing 3107 competent cells 
at -80 °C negatively impacts cell viability and consequently reduces the efficiency of 
transformation.  
The presence of active R-M systems has a negative effect on the introduction 
of foreign DNA into strains (3). Based on this and the presence of R-M associated 
genes in the genome of 3107, the impact of these potentially active systems on the 
transformation efficacy of 3107 was assessed. Isolation of previously introduced 
pNZ44 into L. lactis 3107 and re-introduction of this plasmid into L. lactis 3107 had 
no effect on the transformation efficiency of this strain, suggesting that the R-M 
systems are not active in this strain or that they do not impair the transformation of 
this plasmid.  
Multiplex-PCR using the primers detailed in Table 2.1 performed on 
transformants confirmed the integrity of Cmr colonies as L. lactis 3107 derivatives, 
thus demonstrating successful electrotransformation of L. lactis 3107.   
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Glycine (%) 1 0.6-0.8 > 1 0.8-1.2 1 1 1 1 1 1 1 1 1 
Sucrose (M) 0.5 0.5 0.5 0.1-0.4 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.2 0.5 
3107  
(%) 
4-6 6 6 6 2 > 8 6 6 6 6 6 1 1 
OD600nm 0.6-0.8 0.6-0.8 N 0.6-0.8 N 0.6-0.8 0.5 -0.6 0.6-0.8 0.6-0.8 0.6-0.8 0.6-0.8 0.7 0.6 
Ampicillin (µg 
mL-1) 
- - - - - - - 5-20 - - - - - 
kV 2 2 2 2 2 2 2 2 1.5-1.9 2.1-2.5 2 2 1.7 
-80 °C - - - - - - - - - - Y Y Y 
No. of Cmr 
colonies per µg 
of DNA 
transformed 
5.60 x 104  
±  
1.00 x 103 
4.00 x 103 –  
5.00 x 103  
±  
1.00 x 103 
- 
4.00 x 102 –  
5.00 x 103  
±  
1.00 x 103 
- 0 
2.00 x 103  
±  
1.00 x 103 
3.00 x 103  
±  
1.00 x 103 
2.0 x 104 –  
4.00 x104  
±  
1.00 x 103 
1.20 x 104 –  
2.00 x 104  
±  
1.00 x 103 
6.00 x 103  
±  
1.00 x 103 
4.00 x 102 ± 
4.00 x 102 




N: necessary OD600nm not reached, -: not applied, Y: competent cells frozen at -80 °C prior to electroporation 
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2.4 Discussion   
Recent advances in NGS technologies have made it easier and faster to obtain 
a complete and high-quality sequence of a bacterial genome. Here, a combination of 
SMRT and Illumina sequencing technologies were applied to obtain the complete 
sequence of the L. lactis subsp. cremoris 3107 genome (30). The circular chromosome 
of this dairy-associated strain, which is the host for the model P335 phage TP901-1, 
is among the smallest genomes of currently sequenced lactococcal strains. The 
chromosomal features of this strain were assessed, revealing a genome which harbours 
a high number of pseudogenes and transposable elements. It also contains a number 
of apparently intact and incomplete prophages, which are common characteristics of 
L. lactis subsp. cremoris strains (31). The presence of such a high number of 
transposons and pseudogenes within this relatively small lactococcal chromosome 
suggests that the L. lactis 3107 genome has undergone significant genome decay while 
adapting to its milk environment. L. lactis 3107 is no exception in this respect, as 
various L. lactis subsp. cremoris strains isolated from the dairy environment have been 
reported to suffer from genome decay (4, 31, 36, 37). It has also been suggested that 
the high number of transposable elements and prophages present in L. lactis subsp. 
cremoris strains may be the outcome of industrial pressure (31). Thus, prophage-
containing starter strains represent a risk factor to the dairy fermentation industry and, 
therefore, demands a comprehensive functional assessment before their utilization for 
the production of fermented dairy products.  
L. lactis strains seem to have adapted to the dairy environment by the 
acquisition of additional metabolic capabilities and the loss of redundant functions. 
Studies (32, 38-41) have shown that dairy-associated L. lactis strains acquire specific 
plasmids, such as those encoding lactose and citrate metabolism for niche adaptation. 
Indeed, L. lactis 3107 harbours a complement of six plasmids, of which p3107A 
encodes lactose metabolism allowing this strain to rapidly ferment lactose (42), 
extracellular casein hydrolysis (43) and uptake of the resulting peptides (44). Plasmid 
p3107A also encodes intracellular peptidases to facilitate metabolism of casein-
derived peptides, which may contribute to the formation of aroma compounds and 
flavour development in the final product (45). Finally, p3107A encodes a universal 
stress protein (UspA) which is present in all sequenced dairy plasmids (32) and has 
been shown to be expressed in the absence of carbon and nutrients, heat exposure, 
oxidation and in response to other environmental stress conditions (46). Homologues 
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of the p3107B plasmid-encoded cold-shock protein have also been shown to enhance 
survival of the strain during harsh dairy fermentation conditions. This protein protects 
the cell from rapid temperature downshift by decreasing enzyme activity, efficiency 
of transcription and translation, among other functions (47). Additionally, cold-shock 
proteins have been shown to provide tolerance to osmotic, oxidative, starvation, pH 
and ethanol stress (48). Genes encoding stress-associated proteins are presumed to be 
acquired due to the conditions that dairy-associated strains endure during fermentation 
including changes in pH, temperature and osmolarity (49). The 3107 chromosome as 
well as plasmids p3107C and p3107E encode bivalent metal ion uptake systems 
including Mg2+ and Co2+ transporters which have previously been described as 
potentially beneficial dairy adaptations (32, 50). The expression of such systems 
inhibits growth of strains exposed to CoCl2 concentrations of > 2.0 mM, while its 
inactivation allows cells to grow above this concentration (51). Mg2+ and Co2+ 
transporter systems are present in some L. lactis strains (51). p3107A also encodes a 
putative aminoglycoside 3-N-acetyltransferase which has previously been associated 
with gentamicin antibiotic resistance (52, 53). Antibiotic resistance genes providing 
resistance to tetracycline have previously been identified on lactococcal plasmids from 
dairy strains (54, 55). This highlights the importance of genomic assessment and 
antibiotic testing as the increase in drug-resistant bacteria is a major health concern. 
Thus, before using dairy strains in food production antibiotic testing must be 
performed to avoid the undesirable spread of antibiotic resistance within the food 
chain. The plasmid complement of L. lactis 3107 harbours homologues of mobA 
(p3107A), mobC (p3107B/C) and mobD (p3107C) which have been shown to play a 
role in the mobilisation of plasmids in L. lactis (56, 57). During such plasmid transfer 
the plasmid receives a single stranded break by a nickase enzyme and the resulting 
linear ssDNA strand is passed to a recipient cell (58). The mobA and mobD genes are 
predicted to encode nickases, and mobC is predicted to encode a protein presumed to 
form a relaxosome with an associated nickase (56, 57). This type of naturally occurring 
DNA transfer process is advantageous in food grade applications to exert beneficial 
traits to industrial strains (56). 
Even though the L. lactis 3107 chromosome is predicted to contain R-M type 
I and II associated genes, SMRT sequencing did not detect any methylated DNA bases 
within the host genome. This suggests an absence of active R-M systems in 3107, 
though it should be kept in mind that SMRT sequencing mainly detects N6-
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methyladenine base modifications (59). In addition, isolating pNZ44 DNA from a 
previously transformed L. lactis 3107 strain and re-introducing it into the wild type L. 
lactis 3107 did not have an effect on transformation efficiency, which indicates that 
no active R-M systems are present in L. lactis 3107 that target pNZ44. In support of 
this latter observation, the gene predicted to encode a Type I restriction subunit was 
identified as a pseudogene (Table 2.3). 
Since L. lactis 3107 is the host strain for the model lactococcal P335 phage 
TP901-1, it is has featured in various phage-host interaction studies (17-19, 35). 
However, the lack of refined protocols for the efficient electrotransformation of this 
strain has restricted the genetic manipulation of the strain. Protocols for the 
electrotransformation of L. lactis subsp. cremoris strains (29) and other species of 
Lactococcus (28) are currently available. L. lactis 3107 displays a low efficiency of 
transformation using these methods (as shown in Table 2.4) (28, 29). Optimisation of 
the transformation protocol for this strain creates the possibility of adapting systems 
for the genetic manipulation of this dairy-associated strain. 
In conclusion, we determined the complete genetic make-up of L. lactis 3107, 
host for the model P335 group phage TP901-1. Additionally, protocols for efficient 
transfer of DNA into 3107 and for multiplex-PCR plasmid targeting were developed. 
Thus, this study introduces new possibilities for future studies focused on the 
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Three L. lactis subsp. cremoris 3107 derivatives, known as E119, E121 and 
E126, were previously shown to be resistant against phage TP901-1, while remaining 
sensitive to infection by another P335 group phage, LC3. It was suggested that the 
observed resistance to TP901-1 was due to an impairment in a step of the phage cycle 
beyond the initial recognition of and adsorption to the host cell. The genomes of the 
parent strain and the three TP901-1-resistant mutants were sequenced and compared, 
resulting in the identification of several mutations that may underpin the observed 
TP901-1 resistance. Subsequent complementation assays showed that introduction of 
a plasmid harbouring the L3107_1442 gene (renamed here as gtfA), encoding a 
predicted glycosyltransferase, in mutant strains E119 and E126 restored phage 
sensitivity. Furthermore, the lysogenization frequency increased about 100-fold, 
indicating significantly improved DNA injection efficiency. Moreover, silencing of 
gtfA by an anti-sense mRNA interference strategy was shown to interfere with 
infection by phage TP901-1 in L. lactis 3107. It was furthermore experimentally 
validated that gtfA is involved in one of the initial steps of the infection process of the 
lactococcal P335 phage TP901-1.   
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3.1 Introduction  
Lactic acid bacteria (LAB) represent a group of Gram-positive, anaerobic, non-
spore forming bacteria. Some component species are used extensively in dairy 
fermentations as starter or adjunct cultures due to their acidification activity as well as 
their contribution to flavour and texture characteristics of the final product (1). Among 
the LAB, strains of the industrially significant species Lactococcus lactis are 
susceptible to infection by bacteriophages (phages), which are ubiquitous in the dairy 
environment. These phages may originate from the incoming raw milk and may not 
be fully inactivated by pasteurization treatments (2). Phage susceptibility of starter and 
adjunct strains is a major concern for the dairy fermentation industry as phage attacks 
may negatively impact on the final product quality and production regimes, with 
concomitant economic losses (3). Therefore, a thorough understanding of how these 
problematic phages interact with their hosts is necessary in order to devise rational 
strategies that prevent or at least limit their negative impact. Such strategies may, for 
example, involve the construction of robust starter cultures or the development of 
knowledge-based phage-incompatible strain rotations/blends (3-5). 
The International Committee on Taxonomy of Viruses has classified 
lactococcal phages among the Caudovirales order of tailed phages, which includes 
over 95 % of all known phages (6). The Caudovirales order is comprised of three 
families: the Myoviridae (viruses with long, contractile tails), Siphoviridae (viruses 
with long, non-contractile tails) and Podoviridae (viruses with short tails). To date, 
morphological and genomic analyses have classified lactococcal phages into 10 
genetically distinct groups, of which eight belong to the Siphoviridae family and two 
to the Podoviridae family (2). Members of the P335, 936 and c2 phage groups of 
lactococcal phages (all Siphoviridae) are most frequently and globally encountered in 
dairy fermentations (7). Currently, the complete genome sequences of twenty seven 
P335 phages are available (excluding predicted prophages identified on sequenced L. 
lactis genomes), and among these phages are the ‘model’ P335 phages Tuc2009 and 
TP901-1, as well as LC3, BK5-T, r1t, ul36, 4268, Q33 and BM13 (8-18). Tuc2009 and 
TP901-1 have received significant research attention over the past decade and have 
become prototypes for the analysis of phage-host interactions in Gram-positive 
bacteria (19-24). The P335 phage group has been further divided into five subgroups 
(subgroups I through to V) based on their distinct genetic lineages and morphological 
features (14, 25). 
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The first step in lactococcal phage infection is the recognition of, and 
adsorption to, a surface-exposed, host-encoded receptor followed by DNA release 
from the phage particle, resulting in the translocation of the phage genome into the 
bacterial cytoplasm (26, 27). The first phage-host interaction event is dependent on 
two factors: (i) a host-encoded receptor molecule(s), such as a cell wall polysaccharide 
(CWPS), a surface-exposed protein and/or teichoic acid (TA) (26), and (ii) the 
corresponding phage-encoded receptor binding protein(s) (RBPs). A membrane-
bound proteinaceous receptor has been identified for certain Gram-positive infecting 
phages. For example, the model Bacillus subtilis siphophage SPP1 irreversibly binds 
to the membrane-associated YueB protein (28). Additionally, the purification of the 
extracellular region (ectodomain) of YueB was shown to trigger SPP1 DNA ejection 
in vitro (29). A membrane-associated protein, PIP (phage infection protein), is also 
required for bacteriophage c2 infection of L. lactis subsp. lactis C2 (30). Moreover, 
seven c2-like lactococcal phages, including c2, were able to reversibly bind to an L. 
lactis carbohydrate receptor moiety of unknown composition and then to irreversibly 
bind to PIP, causing the ejection of the phage genome (31). Furthermore, the primary 
receptors for members of the lactococcal P335 (32, 33), 936 (32, 34, 35), 1358 (36), 
949 (37) and P087 (37) phage groups are saccharidic in nature. More specifically, the 
variable, so-called PSP component of the CWPS of L. lactis strains has been identified 
as the phage receptor in a number of cases (32-34, 36-40). In the case of L. lactis 3107 
this PSP component was shown to act as the host cell surface receptor for the P335 
group phages TP901-1 (sub-group II) and LC3 (sub-group III) (32).   
Chemical mutagenesis of L. lactis subsp. cremoris 3107, which as mentioned 
above is sensitive to TP901-1 and LC3, culminated in the isolation of three distinct 
mutants, named E119, E121 and E126, which are resistant to phage TP901-1, while 
still susceptible to infection by phage LC3 (41). Subsequent analysis of these mutants 
showed that a step involving the TP901-1 DNA injection process into the host is 
impaired, suggesting that temperate phages TP901-1 and LC3 either utilize different 
pathways of injection or are differently triggered by their receptor (41). In the current 
study, the genomes of L. lactis 3107 and its derivatives were sequenced in order to 
identify gene(s) that underpin phage-host interactions between TP901-1 and its host. 
This resulted in the identification of L3107_1442, designated here as gtfA, which is 
predicted to encode a glycosyltransferase, and which is involved in one of the early 
steps of TP901-1 infection (42).   
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3.2 Materials and Methods  
 
3.2.1 Bacterial strains, growth conditions, phage preparations, and plasmids. 
Strains, phages and plasmids employed in this study are listed in Table 3.1. L. 
lactis strains were grown at 30 °C in M17 broth/agar (M17 (Oxoid, U.K.) 
supplemented with 0.5 % (v/v) glucose (GM17) and 5 µg ml-1 chloramphenicol (Cm) 
where necessary. Lactococcal phages were propagated in GM17 broth cultured with 
the host strain at an approximate OD600nm of 0.2 and supplemented with 10 mM CaCl2. 
TP901-1erm was induced from L. lactis subsp. cremoris NZ9000_TP901-1erm using 
0.5 µg ml-1 mitomycin C when the growing culture reached an OD600nm of 
approximately 0.2 (43). SM buffer (10 mM CaCl2, 100 mM NaCl, 10 mM MgSO4, 50 




Table 3.1 Bacteria, phages, and plasmids used in this study. 
    Description/purpose  Source 
Bacterial Strains   
 L. lactis subsp. cremoris   
 3107 Host strain for the P335 phages TP901-1 and LC3 (44) 
 E119 Phage TP901-1-resistant derivative of 3107 (41) 
 E121 Phage TP901-1-resistant derivative of 3107 (41) 
 E126 Phage TP901-1-resistant derivative of 3107 (41) 
 NZ9000 MG1363 derivative in which the nisRK genes have been inserted in the chromosome (45) 
 NZ9000Δ8915 NZ9000 harbouring a non-sense mutation in LLNZ_08915, homologue of L3107_14413107 This study 
 NZ9000ΔgtfA NZ9000 harbouring a non-sense mutation in LLNZ_08920, homologue of gtfA3107 This study 
 NZ9000Δ8915_ gtfA 
NZ9000 harbouring a non-sense mutation in LLNZ_08915 and LLNZ_08920, homologues of 
L3107_14413107 and gtfA3107, respectively.  
This study  
 NZ9000_TP901-1erm 
NZ9000 harbouring TP901-1 containing an erythromycin (Em) marker induced from L. 
lactis subsp. cremoris 901-1 
(43) 
    
 
L. lactis subsp. lactis 
IL1403 
Source of yieH which bears 84 % identity to gtfA3107 (46) 
    
 Escherichia coli EC101 Cloning host  (47) 
       
Bacteriophages    
 TP901-1erm Temperate P335 group phage infecting 3107, contains Emr marker (43) 
 TP901-1 Temperate P335 group phage induced from L. lactis subsp. cremoris 901-1 (48) 
 LC3 Temperate P335 group phage grown lytically on L. lactis subsp. cremoris 3107 (49) 
 Dub35A P335 phage group (25) 
 63301 P335 phage group (25) 
 58601 P335 phage group (25) 
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 86501 P335 phage group (25) 
 50101 P335 phage group (25) 
 07501 P335 phage group  (50) 
 62605 936 phage group (50) 
 62604 936 phage group (50) 
 62601 936 phage group (50) 
 66901 936 phage group (50) 
 66902 936 phage group (50) 
 66903 936 phage group (50) 
 jj50 936 phage group (51) 
 p2 936 phage group (52) 
 sk1 936 phage group (53) 
 712 936 phage group (51) 
 c2 c2 phage group (30) 
 P087 P087 phage group (54) 
 949 949 phage group (55) 
 WRP3 949 phage group (37) 
 L47 949 phage group (56) 
 LW81 949 phage group (57) 
        
Plasmids    
 pJP005 Derivative of pNZ8048, carries recT1 under control of nisin-inducible promoter PnisA; Cm
r (58) 
 pNZ44 Escherichia coli–L. lactis vector containing P44 promoter; Cmr  (59) 
 pNZgtfA Complementing plasmid; pNZ44 vector harbouring gtfA from L. lactis 3107 This study 
 pNZSgt41 
Silencing plasmid; pNZ44 vector harbouring gtfA from L. lactis 3107 in the anti-sense 
orientation 
This study 
 pNZ1441 pNZ44 vector harbouring L3107_1441 from L. lactis 3107 This study 
 pNZ1441_ gtfA pNZ44 vector harbouring L3107_1441 and gtfA from L. lactis 3107 This study 
 pNZyieH pNZ44 vector harbouring yieH from L. lactis IL1403 This study 
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3.2.2 Genome sequencing and general feature predictions of L. lactis 3107 and its 
derivatives E119, E121 and E126 
 The L. lactis subsp. cremoris 3107 genome was sequenced (18) using the 
sequencing technologies Single Molecule Real Time (SMRT) (60, 61) performed by 
GATC Biotech Ltd. (Germany) and Illumina (62) performed by Macrogen Inc. (South 
Korea) as described in Chapter II of this thesis (Sections 2.2.2). Following sequencing, 
the genomic features of 3107 were predicted as detailed in Chapter II of this thesis 
(Section 2.2.3). Similarly, the L. lactis 3107 derivatives E119, E121 and E126 were 
sequenced and their genomic features were predicted as described in Chapter II 
(Sections 2.2.2 and 2.2.3).   
 
3.2.3 Bioinformatic analysis of L. lactis 3107 and its derivatives E119, E121 and 
E126 
Single nucleotide polymorphism (SNP) analysis was performed between the genome 
sequence of L. lactis 3107 and the genome sequence of its derivatives to identify 
mutations that may have caused the observed phage-resistance. For this purpose, SNP 
analysis was performed using the L. lactis 3107 consensus sequence as reference for 
Bowtie2 alignment (63), followed by the use of SAMtools (64) to extract base variants. 
The sequence validity of randomly selected SNPs was confirmed by PCR 
amplification and Sanger sequencing of the relevant genomic regions.  
 
3.2.4 Bioinformatic analysis of mutated L. lactis 3107 genes 
In silico analysis of the potential L. lactis 3107 genes involved in TP901-1 
phage resistance, as identified by SNP analysis, was performed using the online 
bioinformatics software TMHMM v. 2.0 (65) and HHpred (66) to identify predicted 
transmembrane regions in the encoded proteins, and to predict protein function, 
respectively. The identified gtfA gene was further analysed using Artemis software 
(67) to assess its genomic context. Moreover, the presence and conservation of the 
gtfA gene in other lactococcal strains was analysed using BlastP (68).  
 
3.2.5 DNA manipulation and construction of plasmids 
 
3.2.5.1 Construction of potential complementing plasmids 
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Primers (listed in Table S3.1) were designed and generated to amplify targeted 
L. lactis subsp. cremoris 3107 genes. The amplicons and the chloramphenicol-resistant 
(Cmr) plasmid pNZ44 (3,396 bp) were restricted using the appropriate restriction 
enzymes (as indicated in Table S3.1). Restriction enzyme digestions, DNA ligations 
and agarose gel electrophoresis were performed following standard procedures (69). 
Ligated constructs were introduced into E. coli EC101 competent cells prepared using 
a previously described protocol (47). E. coli EC101 transformants expected to harbour 
the recombinant vector were isolated using LB agar plates (47) supplemented with 5 
µg ml-1 chloramphenicol (Cm). Recombinant plasmids were then identified by the 
presence of a cloned DNA fragment of the expected size following PCR with the 
pNZ44_F (Table 3.2) primer and the corresponding reverse primer, which was specific 
for the cloned DNA fragment, e.g. gtfA_R (Table 3.2). Sequence integrity of the 
generated constructs was determined by Sanger sequencing the plasmid insert 
(performed by MWG Eurofins Genomics, Ebersberg, Germany) and subsequent 
analysis using the Seqman Pro program (DNAstar v7.0) (70). Verified recombinant 
plasmids were individually isolated using a Pure Link DNA Purification 
(Thermofisher Scientific) kit and introduced into competent cells of L. lactis mutants 
E119, E121 and E126. To confirm the presence of the desired constructs, PCR 
reactions using construct-specific primers (Tables S3.1 and 3.2) were performed on 
the Cmr isolates.   
 
3.2.5.2 Transduction assays 
Transduction assays were performed in cases where particular plasmids could 
not be successfully introduced into L. lactis E119, E121 or E126 by 
electrotransformation. Such plasmids were first isolated from E. coli EC101 cells 
using a Pure Link DNA Purification (Thermofisher Scientific) kit and introduced into 
L. lactis 3107 by electrotransformation. Subsequently, LC3 was propagated on an L. 
lactis 3107 derivative harbouring such a plasmid. The lysate generated was then added 
to 50 mL of GM17 broth cultured with the desired host strain at an OD600nm of 0.2 and 
supplemented with 10 mM CaCl2. Every 30 minutes, 10 mL of this lysate-host mix 
was centrifuged at 1,900 × g for 10 minutes at 4 °C; the supernatant was discarded and 
the pellet was resuspended in 100 µl of GM17 and spread plated onto GM17 plates 
supplemented with 5 µg ml-1 Cm. The plates were then incubated at 30 °C for 48 h. 
PCR assessment using construct-specific primers (Tables S3.1 and 3.2) was employed 
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on resulting Cmr colonies to confirm the presence of the desired construct. Sequence 
integrity of the introduced plasmid was verified by sequencing plasmid DNA using 
MWG Eurofins Genomics (Ebersberg, Germany) followed by sequence analysis 
employing the Seqman Pro program (DNAstar v7.0) (70).  
 
3.2.5.3 Construction of the silencing plasmid pNZSgtfA 
The L3107_1442 (2,676 bp) gene, renamed here as gtfA, from L. lactis 3107 
was cloned in the antisense orientation into the pNZ44 vector by first amplifying the 
gene using primers SgtfA_F and SgtfA_R (Table 3.2). The forward primer (SgtfA_F) 
incorporated the restriction site KpnI as well as the native ribosome binding site (RBS) 
AGGAGG, whereas the reverse primer (SgtfA_R) incorporated the restriction site PstI 
(Table 3.2). The amplicon was digested with KpnI and PstI, ligated with similarly 
digested pNZ44, and introduced into E. coli EC101 by electroporation. The desired 
plasmid, designated pNZSgtfA, was verified by sequencing and then introduced into 
L. lactis 3107 and L. lactis NZ9000. 
 
3.2.5.4 Construction of pNZyieH, pNZ1441 and pNZ1441_gtfA 
The yieH (2,676 bp) gene from L. lactis IL1403, the L3107_1441 (786 bp) 
gene, and a DNA fragment encompassing the L3107_1441 and gtfA (3,465 bp in total) 
genes from L. lactis 3107 were amplified using appropriate primers (listed in Table 
3.2). The resulting amplicons were restricted with appropriate enzymes, ligated into 
similarly restricted pNZ44, and following this the ligation mixture was introduced into 
E. coli EC101 by electroporation. The desired recombinant plasmids, designated 
pNZyieH (6,070 bp), pNZ1441 (4,180 bp) and pNZ1441_gtfA (6,859 bp) were verified 
by sequencing. Following this, pNZyieH was introduced into L. lactis E119 and E126, 
while pNZ1441 and pNZ1441_gtfA were individually introduced into L. lactis 
NZ9000.   
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Table 3.2: Primers used in this study; introduced restriction sites are underlined. 
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3.2.6 Mutant generation by means of recombineering mutagenesis 
Recombineering mutagenesis was performed as described previously (58, 71, 
72) with some minor adjustments. Briefly, recombineering oligonucleotides designed 
to mutate L. lactis NZ9000 genes LLNZ_08915, LLNZ_08920 (gtfA) and LLNZ_08925 
are listed in Table 3.3. These oligonucleotides are approximately 85-bases long and 
are partly identical to the lagging strand of the targeted gene with nucleotides 
introduced within the coding sequence of each targeted gene to incorporate an EcoRI 
(GAATTC) site immediately downstream of a “T” to create the stop codon TGA, and 
then followed by the incorporation of additional nucleotides to create a second TAA 
stop codon (see Table 3.3). Additionally, each mutational oligo contained 5’ 
phosphorothioate modifications to prevent endonuclease and exonuclease degradation 
of the oligo following introduction into lactococcal cells. Cells were allowed to 
recover for 1 hour after electroporation prior to spread plating the relevant dilutions 
on GM17 agar. Screening for mutants was performed by PCR amplification using 
primers (Table 3.2) incorporating the overlap region spanning the mutated segment. 
Colonies harbouring the expected mutation were purified to ensure a pure genotype. 
PCR amplification was performed on the colonies using primers (Table 3.2) targeting 
the DNA region spanning the mutated segment. The expected mutated sequence of the 
amplified region of each mutant phage in the genome of L. lactis NZ9000 was 
confirmed by Sanger sequencing using MWG Eurofins Genomics (Ebersberg, 




Table 3.3: Recombineering oligonucleotides designed to introduce mutations in specific L. lactis subsp. cremoris NZ9000 genes; introduced 
mutations are underlined. 
Mutant strain ssDNA Oligonucleotide sequence (5’ – 3’) Mutation Source 














LLNZ_08925NZ9000 This study 
 
Nucleotides introduced within the coding sequence of each targeted gene are underlined, the incorporation of an EcoRI (GAATTC) site after a “T” 
created the stop codon TGA followed by the incorporation of additional mismatches to create the stop codon TAA. The asterisks represent 5’ 
phosphorothioate modifications in the mutational primers.  
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3.2.7 Electrotransformation of L. lactis cells 
L. lactis 3107 competent cells were prepared and used for 
electrotransformation as described in Chapter II (Section 2.2.6). Similarly, 
electrotransformation of L. lactis 3107 derivative strains E119, E121 and E126 was 
performed as previously described (Chapter II, Section 2.2.6) with the exception that 
these mutant strains were inoculated in 50 mL of GM17 broth supplemented with 0.6 
– 0.8 % glycine. L. lactis NZ9000 competent cells were prepared and used for 
electrotransformation as previously described (73).  
 
3.2.8 Phage assays 
 
3.2.8.1 Efficiency of plaquing (E.O.P.) 
To determine the E.O.P. of a particular phage on a specific host, solid and semi-
solid agar was prepared using GM17 broth supplemented with 1.5 % (w/v) or 0.7 % 
(w/v) bacteriological agar, respectively, plus 10 mM CaCl2, and 0.5 % glycine (w/v) 
where necessary (as E119, E121 and E126 strains are intolerant to glycine), and 
employed according to a previously described method (74). Lawns of the 
corresponding indicator strain were plated with progressive 10-fold phage dilutions 
that had been prepared in SM buffer. The E.O.P. was determined as the ratio of the 
titre obtained from the test strain to that of the control strain (L. lactis 3107).  
 
3.2.8.2 Lysogenization assays 
These assays were performed as previously described (41) with the following 
modifications. Briefly, 10 mL GM17 broth was inoculated with 2 % of the required 
strain until an approximate OD600nm of 0.2 was reached. 500 µl of the culture was then 
infected with 500 µl of TP901-1erm at a multiplicity of infection (MOI) of 0.5 and the 
mixture was incubated at 30 °C for 1 hour to allow one round of infection to occur. 
Following incubation, the cells were diluted as necessary and plated on GM17 agar 
supplemented with 1 µg ml-1 Em. Lysogens were observed following anaerobic 
incubation for 48 hours at 30 °C. The frequency of lysogenization was determined by 
calculating the total number of obtained erythromycin resistant (Emr) lysogens per 
millilitre, divided by the total colony forming units per millilitre (CFU ml-1) obtained 




3.2.8.3 Reversible and irreversible adsorption assays 
Reversible and irreversible adsorption assays were performed as previously 
described (41) with the following modifications. Briefly, 10 mL GM17 broth was 
inoculated with 2 % of the appropriate strain until an OD600nm of approximately 0.5 
was reached. The culture was supplemented with 10 mM CaCl2, following this 700 µl 
of the mixture was added to an equal volume of phage lysate (at a multiplicity of 
infection [MOI] of 0.01), and the mixture was incubated at 30 °C for 10 minutes. As 
a control 700 µl GM17 broth supplemented with 10 mM CaCl2 was mixed with 700 
µl of the phage lysate and incubated at 30 °C for 10 minutes. Following incubation, 
irreversible adsorption was determined by diluting samples 1:100 in ice-cold quarter-
strength Ringer’s solution supplemented with 1 M NaCl. Cell-free supernatants were 
prepared by centrifugation of the samples at 6,000 × g for 1 minute and phage numbers 
in the supernatants were determined by standard plaque assays using L. lactis 3107 as 
the indicator strain. Following incubation, reversible adsorption was also determined, 
samples were centrifuged at 6,000 × g for 1 minute to pellet cells and the supernatant 
was diluted 1:100 in quarter strength Ringer’s solution supplemented with 1 M NaCl. 
Phage numbers in the supernatant were determined by standard plaque assays using L. 
lactis 3107 as the host strain. Adsorption was measured as percentage of total phages 
attached to the host when compared to control phage titre (which lacks bacterial cells) 
using the following formula: [(Control phage titre – Free phage titre in supernatant) / 
Control phage titre] x 100.  
 
3.2.8.4 Lysis-in-broth assays 
50 mL of GM17 broth was inoculated with the desired (host) strain and 
incubated at 30°C until an OD600nm of approximately 0.2 was reached. The culture was 
then supplemented with 10 mM CaCl2 and infected (by adding 10
8 pfu ml-1 phages) 
of the desired lactococcal phage and incubated at 30 °C. Following this, every 30 
minutes, OD600nm readings of the infected culture were performed for four and a half 
hours.   
 
3.2.9 Generation of TP901-1erm escape mutants 
In order to isolate phages that have gained the ability to infect the TP901-1-
resistant L. lactis 3107-derived strains E119, E121 and E126 the following experiment 
was performed: 10 mL of GM17 broth was inoculated with 2 % fresh overnight culture 
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of one of the three afore-mentioned strains, i.e. E119, E121 or E126, and incubated at 
30 °C until an OD600nm of approximately 0.2 was reached. The culture was then 
supplemented with 10 mM CaCl2 and 1 mL of a TP901-1erm lysate containing 10
8 
pfu ml-1, and incubated at room temperature overnight. The resulting mixture was then 
filtered using a MF-Millipore™ Membrane Filter of 0.45 µm pore size (Merck, 
Ireland) to remove bacterial cells and obtain a cell free supernatant (CFSN) that had 
the potential to contain TP901-1erm escape mutants. E.O.P. assays were then 
performed using this CFSN to allow the detection of TP901-1erm escape mutants (if 
present) that were capable of infecting the strain with which they were co-incubated 
with. In the absence of visible plaque formation, the generated CFSN was exposed 
repeatedly to the same TP901-1-resistant strain until TP901-1erm escape mutants were 
isolated by screening the CFSN produced in each round. This process was repeated 
twice using each TP901-1-resistant strain (i.e. E119, E121 or E126), and in total six 
TP901-1erm escape mutants were isolated.  
 
3.2.10 Phage DNA extraction, genome sequencing, assembly and bioinformatic 
analysis 
Phage genomic DNA was extracted from TP901-1erm escape mutants and 
TP901-1erm WT using a Phage DNA Isolation Kit (Norgen Biotek, Canada). Phage 
genomic DNA sequencing was performed by the commercial sequencing service 
provider Probiogenomics Lab (Parco Area de la Scienze, Parma, Italy) which uses 
Illumina sequencing based on a MiSeq platform. Subsequently, comparative genome 
and SNP analysis was performed between the phage genome sequence of TP901-1erm 
escape mutants and that of the sequenced TP901-1erm WT to identify potential 
mutations that may have caused these mutant phages to overcome the TP901-1 phage-
resistance of 3107 mutant strains E119, E121 and E126. Identified SNPs were 
confirmed using PCR and Sanger sequencing. Furthermore, in order to verify the 
integrity of the mutations identified in the genomes on the TP901-1erm escape 
mutants, a comparative and SNP analysis was performed using the data of the newly 
sequenced TP901-1erm genome and the published TP901-1 genome (9), thus 
discarding any mutations observed as potential causes for overcoming phage 
resistance. In silico analysis of the potential TP901-1 genes involved in overcoming 
phage resistance was performed using the online bioinformatic software HHpred (66) 
to predict protein function.  
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3.3 Results  
 
3.3.1 Genome sequencing of L. lactis 3107 and its derivatives 
Chemical mutagenesis of L. lactis subsp. cremoris 3107, a strain sensitive to 
P335 group phages TP901-1 and LC3, had previously resulted in the isolation of three 
distinct TP901-1-resistant mutants (41). Adsorption of TP901-1 to these mutants was 
unaffected suggesting that a step beyond initial host recognition and attachment is 
impaired in these mutants (41). The genomes of L. lactis 3107 and its three derivatives, 
E119, E121 and E126, were sequenced in order to identify the gene(s) that is (are) 
responsible for the observed phage resistance phenotype. The genome of L. lactis 3107 
(wild type) is 2.38 Mbp in length with 2,491 predicted protein-coding regions, while 
it also harbours six plasmids ranging in size from 2.2 to 60.2 kb (18). The genome of 
L. lactis 3107 has a 35.82 % G+C content, which is in keeping with those of other 
lactococcal strains (75). As expected, the genomes of the derivatives exhibit near 
identical characteristics to that of the parent strain and carry an identical plasmid 
content. Comparative genomic analysis did not reveal deletion or insertion events, and 
therefore a SNP analysis was undertaken to identify point mutations that may have 
caused the observed phage-resistance phenotype. This resulted in the identification of 
36, 15 and 21 SNPs on the genomes of E119, E121 and E126, respectively, and the 
detailed results of this analysis are presented below. 
 
3.3.2 Bioinformatic analysis and construction of potential complementing 
plasmids 
Sequence differences were identified following comparative genome and SNP 
analyses of L. lactis 3107 and its three derivatives, E119, E121 and E126. In total, 72 
SNPs (Table S3.1) were identified with seven of these SNPs occurring in more than 
one of the L. lactis 3107 mutant genomes, and with some genes containing more than 
one mutation in a given genome. Previous studies have demonstrated that Gram-
positive-infecting phages utilize membrane-bound receptors for their infection process 
(28, 30, 31). Therefore, each of the proteins encoded by L. lactis 3107 genes that were 
carrying SNPs in E119, E121 and/or E126, and thus potentially involved in TP901-1 
phage resistance, was analysed using the online bioinformatics software TMHMM v. 
2.0 (65) to identify predicted transmembrane regions, and employing HHpred to 
investigate its homology and predicted structure (66) (Table S3.1). A total of 31, 15 
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and 17 genes were mutated in the genomes of strains E119, E121 and E126, 
respectively, with 5 of these genes mutated in both E119 and E126. In order to identify 
the mutated gene(s) responsible for the TP901-1-resistant phenotype of the three L. 
lactis 3107 derivatives, pNZ44 derivatives were constructed each carrying a gene, 
which had been amplified from L. lactis 3107 WT, and which had been shown to be 
mutated in E119, E121 and/or E126, and predicted to encode a membrane-associated 
protein (Table S3.1). Out of the 58 identified mutated genes, a total of 33 different 
recombinant plasmids (each carrying an L. lactis 3107 gene) were constructed prior to 
identifying a gene involved in TP901-1 phage infection. 14, 15 and 5 individual 
recombinant plasmids were introduced into strains E119, E121 and E126, respectively, 
using electroporation or transduction utilizing LC3 (Table S3.1). Following the 
verification of the presence of each construct in the corresponding mutant strain(s) by 
PCR, the resulting 34 strains were subjected to efficiency of plaquing and 
lysogenization assays to assess if the introduction of the recombinant plasmid 
(containing a gene that had been shown to be mutated in such a mutant) resulted in the 
restoration of a TP901-1-sensitive phenotype. One recombinant plasmid, pNZgtfA, 
appeared to restore the phage sensitive phenotype for two of the three L. lactis 3107 
mutants, E119 and E126. None of the generated recombinant plasmids restored 
TP901-1 sensitivity of mutant E121, which does not harbour a gtfA mutation, thereby 
indicating that this mutant is affected in a gene that is different from that in mutants 
E119 and E126, and showing the involvement of a secondary factor for successful 
TP901-1 infection.   
 
3.3.3 Confirmation of restoration of phage-sensitivity phenotype through 
efficiency of plaquing (E.O.P.) assays 
In order to verify if, and to what extent, phage sensitivity was restored in L. 
lactis E119 and E126 in the presence of pNZgtfA, quantitative plaque assays were 
performed. The E.O.P. of TP901-1 was determined on L. lactis 3107, as well as the 
E119 and E126 mutants harbouring pNZgtfA or the empty vector pNZ44 as a control. 
As expected, TP901-1 was not able to form visible plaques on E119 and E126, nor on 
the mutant strains harbouring pNZ44, yielding an E.O.P. of ≤10-8. However, in the 
presence of plasmid pNZgtfA, TP901-1 was able to form plaques on these two mutants 
with the same E.O.P. as on L. lactis 3107 (Table 3.4). To further confirm that the 
presence of the pNZgtfA construct caused the reversion of the TP901-1 phage 
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resistance phenotype, the mutants harbouring pNZgtfA were passaged several times in 
the absence of Cm and then plated in order to cure the complemented mutant strains 
of pNZgtfA. The absence of the pNZgtfA plasmid was confirmed by the inability of 
the cured E119 and E126 mutants to grow in the presence of Cm (while also being 
negative for the presence of this plasmid as determined by PCR). As anticipated, 
TP901-1 was incapable of forming visible plaques on any of the obtained pNZgtfA-
free mutant strains, exhibiting an E.O.P. of ≤10-8. Phage LC3 formed visible plaques 
on all strains, including those harbouring the complementing plasmid, with the same 
efficiency as on wild type L. lactis 3107 (Table 3.4).   
 
3.3.4 Lysogenization assays 
Lysogenization assays were performed to support the results of the infection 
assays outlined in the previous paragraph. To this end TP901-1erm, a derivative of 
phage TP901-1 containing an erythromycin-resistant (Emr) marker (43), was 
employed to determine the frequency of lysogenization by establishing the number of 
erythromycin-resistant colonies obtained per infecting phage (see Materials and 
Methods). As expected, the lysogenization frequencies of the two L. lactis 3107 
mutant strains, E119 and E126, were lower than that of the WT strain (10-3 vs. 10-6, 
Table 3.4). Interestingly, the approximately 100-fold increase in the frequency of 
lysogeny observed for E119 and E126 derivatives harbouring pNZgtfA (3.03 x 10-4 ± 
4.93 x 10-6 and 4.17 x 10-4 ± 3.58 x 10-4, respectively) as compared to E119 and E126 
(5.54 x 10-6 ± 2.93 x 10-7 and 5.39 x 10-6 ± 2.11x 10-7, respectively) represents a 
statistically significant increase (p-values of <0.05). This shows that the efficiency of 
infection and associated lysogenization frequency of TP901-1erm significantly 
improved in the presence of pNZgtfA, though the latter was not fully restored to the 
level of the WT strain 3107. The cured E119 and E126 mutant strains and the mutants 
harbouring the empty pNZ44 vector exhibited the same frequency of lysogenization 
(10-6, Table 3.4) as the E119 and E126 mutant strains indicating that pNZ44 has no 
impact on internalisation or lysogeny, and that in the absence of the complementing 
plasmid the ability of TP901-1erm to lysogenize E119 and E126 is substantially 
reduced.  
 




To further validate that gtfA is involved in host interactions of phage TP901-1, 
a gene silencing plasmid (pNZSgtfA) was constructed by cloning the gtfA gene from 
L. lactis 3107 in the antisense orientation into pNZ44. The resulting plasmid, 
designated pNZSgtfA, was introduced into L. lactis 3107 in an effort to reduce gtfA 
expression by antisense-mediated silencing. The effects of gtfA silencing were 
assessed using TP901-1erm lysogenization frequencies and E.O.P. assays (Table 3.4). 
Interestingly, L. lactis 3107 harbouring the silencing plasmid exhibited a two log 
decrease in lysogenization frequency compared to the strain 3107 (5.71 x 10-5 ± 1.79 
x 10-6 vs 5.53 x 10-3 ± 4.10 x 10-4). This decrease is of statistical significance with a p-
value of <0.05. Plasmids pNZ44 and pNZgtfA were transformed into L. lactis 3107 as 
controls and the resulting two strains displayed frequencies of lysogeny that were 
comparable to L. lactis 3107 (Table 3.4). Interestingly, the introduction of pNZSgtfA 
caused a minor, but statistically significant reduction (p-value of <0.05) in the plaquing 
efficiency of TP901-1, and a noteworthy reduction in plaque size (Table 3.4). To 
confirm that the presence of pNZ44 did not affect TP901-1 plaquing efficiency or 
plaque size, plaque assays were also performed on L. lactis 3107 harbouring pNZ44 
or pNZgtfA separately. The E.O.P. and plaque morphology of TP901-1 on all of these 
strains appeared to be similar to that of L. lactis 3107. As expected, LC3 was able to 
infect all tested strains, including L. lactis 3107 harbouring the silencing plasmid, with 
the same efficiency as observed for the control L. lactis 3107 (Table 3.4). Furthermore, 
the silencing plasmid (pNZSgtfA) was transformed into L. lactis subsp. cremoris 
NZ9000, which harbours an almost identical (99 % identity) homologue of gtfA3107 on 
its genome. Plaque assays were performed using the NZ9000-infecting 936 group 
phages jj50, p2, sk1 and 712 and the namesake of the c2 group (Table 3.1, data not 
shown) and no obvious changes in E.O.P. or plaque size were observed. Moreover, 
lysis-in-broth assays were performed to further analyse the effects of silencing gtfA on 
TP901-1 phage development in liquid cultures. Figure 3.1A highlights that gtfA 
silencing causes a delay in lysis allowing the strain to grow unaffected for a longer 
period of time as an extended exponential growth phase of the host was observed, 
similar to the uninfected control. Furthermore, the infection capability of TP901-1 
does not appear to be affected by the presence of pNZ44 as the lysis rate is similar to 
that of L. lactis 3107 in the presence of TP901-1 which is shown by the similar 
growth/lysis pattern observed for L. lactis 3107 and L. lactis 3107 harbouring pNZ44 
when each of these strains is infected by this phage. These results indicate that 
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decreased expression of GtfA in L. lactis 3107 interferes with the infection ability of 
TP901-1. As a control lysis-in-broth assays were performed using LC3 as shown in 
Figure 3.1B, which demonstrates lysis of the control and test cultures in congruence 
with the plaque assay data (Table 3.4). Furthermore, adsorption assays were performed 
to analyse if the complementation of the mutant strains, as well as the mutation and 
silencing of gtfA had an effect on the reversible and/or irreversible binding of TP901-
1 (Table 3.5). TP901-1 adsorbs reversibly and irreversibly to L. lactis 3107 and its 
derivatives with a high efficiency (Table 3.5). Mutation or silencing of gtfA has a 
negative impact on TP901-1 irreversible adsorption (p-values of <0.05). Furthermore, 
when L. lactis strains E119 and E126 harbour the complementing plasmid (pNZgtfA) 
an 8.1 ± 0.2 % and 14.5 ± 1.1 % improvement in irreversible adsorption by TP901-1 
is observed, respectively, showing a statistical significant (p-values of <0.05) increase. 
In all, these findings indicate that Gtf41 is involved in the first stages of infection, 




Table 3.4: Restoration of phage sensitivity phenotype of L. lactis 3107 mutants E119 and E126 and silencing of gtfA. 




L. lactis subsp. cremoris     
3107 1 1 5.53 x 10-3 ± 4.10 x 10-4 
E119 ≤10-8 0.71 ± 0.10 5.54 x 10-6 ± 2.93 x 10-7  
E119_pNZ44 ≤10-8 0.71 ± 0.08 5.23 x 10-6 ± 2.52 x 10-7 
E119_pNZgtfA 0.86 ± 0.01 0.76 ± 0.07 3.03 x 10-4 ± 4.93 x 10-6 
E119_pNZgtfA cured ≤10-8 0.78 ± 0.08 3.00 x 10-6 ± 5.00 x 10-7 
E126 ≤10-8 0.71 ± 0.09 5.39 x 10-6 ± 2.11 x 10-7 
E126_pNZ44 ≤10-8 0.71 ± 0.06 4.40 x 10-6 ± 4.00 x 10-7 
E126_pNZgtfA 0.86 ± 0.01  0.77 ± 0.07 4.17 x 10-4 ± 3.58 x 10-4 
E126_pNZgtfA cured ≤10-8 0.75 ± 0.04 4.93 x 10
-6 ± 3.06 x 10-7 
3107_pNZ44 0.76 ± 0.12 0.70 ± 0.07 4.37 x 10-3 ± 3.29 x 10-4 
3107_pNZgtfA 0.75 ± 0.12 0.66 ± 0.06 4.44 x 10-3 ± 2.12 x 10-4 
3107_PNZSgtfA *0.10 ± 0.01 0.69 ± 0.05 5.71 x 10-5 ± 1.79 x 10-6 
*hazy plaques and plaque size reduction was observed 
TP901-1 and LC3 E.O.P., and TP901-1erm lysogenization frequencies for L. lactis 3107, its derivatives harbouring the complementing plasmid (pNZgtfA) or the empty vector 








Figure 3.1: Effects of silencing ORFgtfA3107 for TP901-1 phage propagation. TP901-
1 (A) and LC3 (B) lysis-in-broth assays performed on L. lactis 3107 WT, L. lactis 











































Table 3.5: Adsorption (%) of phages TP901-1 to L. lactis subsp. cremoris 3107 and 
its derivatives.  
 Adsorption of TP901-1 (%) 
Strain  Reversible  Irreversible 
L. lactis   
3107 98.0 ± 0.2 97.5 ± 0.3 
3107_pNZ44 97.7 ± 0.2 97.2 ± 0.1 
3107_pNZgtfA 94.0 ± 0.6 93.1 ± 0.9 
3107_pNZSgtfA 92.4 ± 0.1 85.9 ± 1.5 
E119 94.7 ± 0.4 75.2 ± 1.5 
E119_pNZ44 91.3 ± 0.8 73.2 ± 0.8 
E119_pNZgtfA 94.1 ± 0.8 83.3 ± 0.2 
E126 95.7 ± 0.7 68.2 ± 0.8 
E126_pNZ44 90.3 ± 0.5 66.6 ± 1.7 
E126_pNZgtfA 95.7 ± 0.1 82.4 ± 1.1 




3.3.6 Involvement of gtfA in infection of representatives of the P335, 936, P087 
and 949 lactococcal phage groups   
In order to determine if gtfA is also required for infection by other lactoccocal 
phages capable of infecting L. lactis 3107, a number of phages belonging to the P335 
(Dub35A, 63301, 58601, 86501, 50101 and 07501), 936 (62605, 62604, 62601, 
66901, 66902 and 66903), P087 (P087) and 949 (949, WRP3, L47 and LW81) groups 
(Table 3.1) were tested on the following strains: L. lactis 3107 WT; L. lactis 3107 
harbouring pNZgtfA, pNZSgtfA or pNZ44; L. lactis E119 and E126; strains E119 and 
E126 harbouring pNZgtfA or pNZ44.  
Phages 949 and WRP3 were shown to infect E119 and E126, although the 
E.O.P. of these phages was reduced by 4 orders of magnitude compared to the WT 
strain 3107 (Table 3.6). Furthermore, the observed statistically significant E.O.P. 
reduction (p-values of <0.05) in these mutants was reverted to WT levels when E119 
and E126 harboured plasmid pNZgft41. Silencing and overexpression of gtfA in the 
WT background appeared to have no impact on the E.O.P. or plaque size of 949 and 
WRP3, nor did the presence of the control plasmid pNZ44 cause any effect on these 
two parameters of infection. This indicates that these phages employ GtfA as a 
component of their infection pathway. No obvious changes in E.O.P. or plaque size 
were observed for the assessed P335, 936 and P087 phages, or for 949 phages L47 and 
LW81 (data not shown). 
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Table 3.6: Testing the 949 phages, 949 and WRP3, on L. lactis subsp. cremoris 3107 
and its derivatives.  
L. lactis subsp. 
cremoris 
                       E.O.P. of phages belonging to the 949 phage group* 
949 WRP3 
3107 
1                                                                                    
(0.5 mm) 
1                                                      
(0.6 mm) 
3107_pNZ44 
0.83 ± 0.14 
(0.5 mm) 
0.72 ± 0.29                                                          
(0.6 mm) 
3107_pNZgtfA 
0.78 ± 1.0.02 
(0.5mm) 
0.69 ± 0.33                                                    
(1 mm) 
3107_pNZSgt41 
0.36 ± 0.08 
(0.5 mm, slightly hazy plaques) 
0.32 ± 0.07                                                     
(0.6 mm) 
E119 
5.82 x 10-4 ± 9.06 x 10-5                                                                             
(1mm) 
9.11 x 10-4 ± 2.59 x 10-4                                                   
(1.1mm) 
E119_pNZ44 
6.06 x 10-4 ± 1.06 x 10-4                                                                           
(1.1 mm) 
1.04 x 10-3 ± 2.69 x 10-4                            
(1.2 mm) 
E119_pNZgtfA 
0.19 ± 0.01                                                                            
(0.6mm) 
0.36 ± 0.05                                                        
(0.9mm) 
E126 
9.80 x10-4 ± 1.15 x 10-4                                                                               
(1mm) 
1.19 x 10-3 ± 1.87 x 10-4                                              
(1mm) 
E126_pNZ44 
8.13 x 10-4 ± 7.66 x 10-5                                                                            
(1.1 mm) 
9.33 x 10-4 ± 1.20 x 10-4                                                      
(2 mm) 
E126_pNZgtfA 
0.64 ± 0.05                                                                               
(1mm) 
0.89 ± 0.19                                                    
(1mm) 
 
*The E.O.P. of phage applied and the plaque size in mm is shown in brackets.    
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3.3.7 In silico analysis of GtfA 
L. lactis 3107 derivatives E119 and E126 both carry a mutation in gtfA that introduces 
a stop codon in the middle of this gene thus likely rendering gtfA defunct in these 
mutants (Fig. 3.2). HHpred modelling (66) of the deduced protein product of gtfA3107 
predicts that GtfA is an integral membrane protein (with fourteen predicted 
transmembrane regions), possessing a glycosyltransferase domain and a carbohydrate 
binding domain with high probabilities of 96.8 % and 61.2 %, respectively. GtfA 
characteristics are similar to members of the GT-C family of glycosyltransferases 
which are characterized by 8 – 13 transmembrane helices and an extracellular loop 
(76). GtfA may thus be a member of the GT-C family of glycosyltransferases, which 
are known to be involved in glycosylation of substrates at the periplasmic side of the 
cytoplasmic membrane (77). In silico analysis using BLASTp (68) was performed to 
analyse the presence and conservation of the gtfA gene in other lactococcal strains, 
revealing that it is present and conserved in all assessed L. lactis genomes. gtfA 
homologues in subsp. cremoris strains bear 99 % identity to that of gtfA3107, while its 
equivalents in all assessed L. lactis subsp. lactis strains have a reduced sequence 
identity of 84 % indicating a subspecies-specific sequence for this gene. Inspection of 
the genomic region surrounding gtfA3107 suggests that this gene is part of a tricistronic 
operon with a gene upstream and downstream of gtfA3107, represented by L3107_1441 
and L3107_1443, respectively (Fig. 3.2). A previous transcriptome analysis performed 
on the genome of L. lactis MG1363 revealed that its homologue of gtfA3107, which is 
designated LLMG_RS08685, is indeed part of a tricistronic operon with a promoter 
identified directly upstream of the coding sequence of the homologue of L3107_1441, 
LLMG_RS08680 which is found upstream of the gtfA3107 homologue (78). 
L3107_1441 is predicted to encode a galactose-1-phosphate-uridylyltransferase 
(GalT) with a high probability (100 %) based on HHPred analysis, while L3107_1443 
is predicted to encode a protein exhibiting one transmembrane helix of unknown 
function. Similar to the gtfA gene, L3107_1441 is also present and conserved in all L. 
lactis genomes sequenced to date and homologues of this gene in L. lactis subsp. 
cremoris strains bear 99 % identity to that of L3107_1441. In contrast, L3107_1443 is 
not present in all L. lactis genomes sequenced to date, yet homologues of this gene are 
present in all assessed L. lactis subsp. cremoris and the majority of analysed L. lactis 
subsp. lactis strains bearing 94 - 100 % identity to that of L3107_1443. The GalT 
enzyme catalyses the reversible transfer of an uridine 5’-monophosphate (UMP) 
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moiety from uridine 5’-diphosphate (UDP)-glucose to the phosphate group of 
galactose 1-phosphate to form UDP-galactose. Following the binding of UDP-glucose 
to the GalT enzyme, an uridylylated enzyme intermediate is generated, and glucose 1-
phosphate is released. Subsequently, galactose 1-phosphate binds to the active site and 
the UMP moiety is transferred to generate UDP-galactose (79). Based on the predicted 





























Figure 3.2: Schematic representation of the genomic region surrounding of gtfA in L. lactis 3107 and derived mutants E119 and E126. Predicted 
promoter elements -10 and -35 are located upstream L3107_1441; both mutations lead to the incorporation of a stop codon in gtfA, the position of 
which is indicated by a circle. 
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3.3.8 Restoration of the phage-sensitivity phenotype using a homologue of gtfA 
from L. lactis subsp. lactis IL1403 
The identified homologue of gtfA on the L. lactis subsp. lactis IL1403 genome, 
designated as yieH, was cloned into pNZ44 (resulting in plamid pNZyieH) and 
introduced into L. lactis 3107 mutants E119 and E126. Plaque assays were performed 
in order to determine if these mutants harbouring pNZyieH restored their phage-
sensitivity phenotype (Table 3.7). The results revealed that TP901-1 was indeed able 
to form plaques on E119 and E126 mutants harbouring pNZyieH with the same E.O.P. 
as on the L. lactis 3107 and L. lactis 3107 harbouring the pNZ44 empty vector. 
Furthermore, as expected, following the loss of pNZyieH from strains E119 and E126, 
TP901-1 was incapable of forming visible plaques on cured mutant strains, exhibiting 
an E.O.P. of ≤10-8, confirming that the presence of the pNZyieH construct caused the 
TP901-1 phage sensitivity phenotype to be restored in both mutants. These results 
demonstrate that the expression of yieH (which bears 84 % sequence identity to gtfA) 
in E119 and E126 restores their TP901-1-sensitivity phenotype. As anticipated, phage 
LC3 formed visible plaques on all strains with the same efficiency as on the L. lactis 





Table 3.7: Effects of expressing yieH on infectivity TP901-1 and LC3. 
Strain  E.O.P. of TP901-1                          E.O.P. of LC3 
L. lactis subsp. cremoris    
3107 1 1 
E119 ≤10-8 0.71 ± 0.10 
E119_pNZ44 ≤10-8 0.71 ± 0.08 
E119_ pNZyieH 0.85 ± 0.01 0.75 ± 0.06 
E119_ pNZyieH cured ≤10-8 0.76 ± 0.02 
E126 ≤10-8 0.71 ± 0.09 
E126_pNZ44 ≤10-8 0.71 ± 0.06 
E126_ pNZyieH 0.85 ± 0.01 0.75 ± 0.04 
E126_ pNZyieH cured ≤10-8 0.78 ± 0.10 
 
TP901-1 and LC3 E.O.P. on (i) L. lactis 3107, (ii) L. lactis 3107 derivatives harbouring the 





3.3.9 Construction of L. lactis subsp. cremoris NZ9000 mutants 
 As previously indicated (Section 3.3.7), L. lactis subsp. cremoris NZ9000 
harbours an almost identical (99 % identity) homologue of gtfA3107 on its genome 
named LLNZ_08920, designated here as gtfANZ9000. Furthermore, the gene upstream 
(LLNZ_08915) and downstream (LLNZ_08925) of gtfANZ9000 represent near identical 
(99 % identity) homologues of L3107_1441 and L3107_1443, while the gene order 
was also conserved in the genomes of these strains. We had already shown that GtfA 
is not required for infection by L. lactis NZ9000-infecting 936 group phages as 
expressing the silencing plasmid pNZSgtfA in L. lactis NZ9000 had no negative effect 
on the sensitivity profile of the strain (Section 3.3.5). The targeted genes 
(LLNZ_08915, gtfANZ9000 and LLNZ_08925) and overall genome of L. lactis NZ9000 
is 99 % identical to that of L. lactis 3107. Therefore, by means of targeted mutagenesis 
using recombineering technology (58, 72) the homologues of gtfA3107 and/or 
L3107_1441 in the chromosome of L. lactis NZ9000 were mutated which resulted in 
the construction of three L. lactis NZ9000 derivatives, i.e. NZ9000Δ8915, 
NZ9000ΔgtfA, and NZ9000Δ8915_gtfA (Table 3.3). These derivatives were generated 
in such a manner so as to introduce stop codons (Table 3.3) into the coding sequence 
of LLNZ_08915, gtfANZ9000, or in both LLNZ_08915 and gtfANZ9000, respectively. Thus, 
these NZ9000 mutant strains are not expected to produce the predicted galactose-1-
phosphate-uridylyltransferase (LLNZ_08915), the GtfA glycosyltransferase 
(LLNZ_08920), or either of these two proteins, respectively. These NZ9000 
derivatives were then tested to assess if either or both of these mutated genes are 
involved in the infection process of NZ9000-infecting phages.   
 
3.3.10 Involvement of gtfANZ9000 and/or LLNZ_08915 in infection by 
representatives of the 936 and c2 lactococcal phage groups 
Quantitative plaque assays were performed in order to determine if, and to 
what extent, gtfANZ9000 and/or LLNZ_08915 are required for infection by lactoccocal 
phages capable of infecting L. lactis NZ9000 (Table 3.8). Phages belonging to the 936 
(jj50, 712, sk1 and p2) and c2 (c2) groups were tested against L. lactis NZ9000 and 
its derivatives NZ9000Δ8915, NZ9000ΔgtfA, and NZ9000Δ8915_gtfA. Furthermore, 
in order to determine if the overexpression of L3107_1441, GtfA, or a combination of 
GtfA and L3107_1441 has an effect on the infection characteristics of these 936 and 
c2 phages, these lactococcal phages were tested on L. lactis NZ9000 derivatives 
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harbouring pNZ1441, pNZgtfA and pNZ1441_gtfA, respectively. Plaque assays were 
also performed on L. lactis NZ9000 harbouring the empty pNZ44 vector as a control. 
The mutation and overexpression of gtfA and LLNZ_08915 in the L. lactis NZ9000 
background appeared to have no impact on the E.O.P. or plaque size of the assessed 
NZ9000-infecting phages, nor did the presence of the control plasmid pNZ44 cause 
any effect on these two parameters of infection. This suggests that these phages do not 
employ GtfA and/or LLNZ_08915 as a component of their infection pathway or 
perhaps an additional required component which is present in L. lactis 3107 is being 
utilized in combination with GtfA which is not present in L. lactis NZ9000.   
137 
 
Table 3.8: Testing lactococcal 936 and c2 phage groups on L. lactis subsp. cremoris NZ9000 and its derivatives; the E.O.P of phage applied and 
plaque size in mm is shown. 
  E.O.P of 936 group (plaque size)   
E.O.P of c2 group 
(plaque size) 
Strain jj50 712 sk1 p2  c2 
L. lactis subsp. cremoris       
NZ9000 
1.0 ± 0.00 
 (2 mm) 
1.0 ± 0.00 
(1.5 mm) 
1.00 ± 0.00 
(1.5 mm) 
1.00 ± 0.00 
(2 mm) 
 




0.98 ± 0.03 
(2 mm) 
0.81 ± 0.48 
(1.5 mm) 
0.80 ± 0.02 
(1.5 mm) 
0.86 ± 0.48 
(2 mm) 
 




0.92 ± 0.05 
(2 mm) 
0.88 ± 0.55 
(1.5 mm) 
1.33 ± 0.07 
(2 mm) 
0.95 ± 0.14 
(2 mm) 
 




0.93 ± 0.05 
(2 mm) 
1.18 ± 0.70 
(1.5 mm) 
0.82 ± 0.02 
(2 mm) 
0.94 ± 0.50 
(2 mm) 
 




0.41 ± 0.04 
(2 mm) 
0.74 ± 0.43 
(1.5 mm) 
0.58 ± 0.04 
(1.5 mm) 
0.39 ± 0.20 
(2 mm) 
 




0.53 ± 0.03 
(2 mm) 
0.65 ± 0.37 
(1.5 mm) 
0.67 ± 0.02 
(1.5 mm) 
0.88 ± 0.44 
(2 mm) 
 




0.76 ± 0.03 
(2 mm) 
0.59 ± 0.34 
(1.5 mm) 
0.76 ± 0.02 
(1.5 mm) 
0.77 ± 0.37 
(2 mm) 
 




0.41 ± 0.05 
(2 mm) 
0.69 ± 0.39 
(1.5 mm) 
0.49 ± 0.03 
(1.5 mm) 
0.52 ± 0.28 
(2 mm) 
  




3.3.11 E.O.P. and lysogenization assays of TP901-1erm escape mutants 
In an attempt to generate TP901-1 (so-called escape) mutants capable of 
infecting the TP901-1-resistant L. lactis E119 strain, TP901-1erm was repeatedly 
exposed to strain E119 (see Materials and Methods). This resulted in the isolation of 
two TP901-1erm escape mutants named TP901-1erm-E119A and TP901-1erm-
E119B. Similarly, exposure of TP901-1erm to strains E121 and E126 allowed the 
isolation of four additional TP901-1erm escape mutants named TP901-1erm-E121A 
and TP901-1erm-E121B, and TP901-1erm-E126A and TP901-1erm-E126B, 
respectively. The E.O.P. of each TP901-1erm escape mutant and the TP901-1erm WT 
was determined on L. lactis E119, E121 and E126, as well as the 3107 WT strain 
(Table 3.9). As expected, TP901-1erm was not able to form visible plaques on E119, 
E121 and E126, yielding an E.O.P. of ≤10-8. Interestingly, all TP901-1erm escape 
mutants, irrespective of the mutant strain used to isolate them, were able to form 
plaques on all three TP901-1-resistant strains, E119, E121 or E126, although with a 
minor yet significantly reduced E.O.P. (p-values <0.05) as compared to the L. lactis 
3107 WT (Table 3.9). The infection of both strains, E119 and E126 by TP901-1erm-
E119A/B and TP901-1erm-E126A/B was perhaps unsurprising as both strains carry a 
mutation in gtfA, but the infection of the E121 strain by these escape mutants and the 
infection of E119 and E126 by TP901-1erm-E121A/B was somewhat unexpected as 
E121 does not carry a mutation in gtfA. This suggests that the three TP901-1-resistant 
strains (E119, E121 and E126) harbour mutations involved in the same pathway of 
infection by TP901-1, though a different step of the pathway is mutated for E121 
(unknown) than for both E119 and E126 (GtfA), and that the escape mutants somehow 
bypass the requirement for this pathway for infection. 
To further support the E.O.P. results which suggest that all of the TP901-1erm 
escape mutants have overcome the phage resistant phenotype of E119, E121 and E126, 
lysogenization assays were performed. For this purpose, TP901-1erm was used instead 
of the TP901-1 WT when attempting to isolate TP901-1erm escape mutants as the Emr 
marker would allow us to determine the frequency of lysogenization achieved by the 
TP901-1erm escape mutants based on the number of Emr colonies obtained per 
infecting phage (see Materials and Methods). As expected, TP901-1erm 
lysogenization frequencies of the three L. lactis 3107 derivative strains, E119, E121 
and E126, were lower than that of the 3107 WT strain (10-3 vs. 10-6, Table 3.9). 
Interestingly, when the TP901-1erm escape mutants were applied, an increase by three 
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orders of magnitude in the frequency of lysogeny was observed for the E119, E121 
and E126 derivatives compared to the TP901-1erm WT (10-3 vs. 10-6, Table 3.9), 
showing a statistically significant increase (p-values <0.05). This suggests that the 
efficiency of infection and lysogeny frequency of the TP901-1erm escape mutants was 
restored to the level of the WT TP901-1erm phage.  
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Table 3.9: Testing TP901-1erm escape mutants on L. lactis subsp. cremoris 3107 and its derivatives; the E.O.P. and lysogenization frequency are 
indicated for each tested phage.  
          





























3107 1.65 1.65 1.65 1.65  
2.44 x 10-3 ±  
2.19 x 10-4 
 
2.41 x 10-3 ± 
1.20 x 10-4 
 
2.47 x 10-3 ± 
5.86 x 10-5 
5.53 x 10-3 ±  













5.49 x 10-3 ± 
1.27 x 10-4 
 
2.43 x 10-3 ± 
1.57 x 10-4 
 
2.47 x 10-3 ± 
1.78 x 10-4 
5.54 x 10-6 ±  













2.43 x 10-3 ± 
2.53 x 10-4 
 
2.45 x 10-3 ± 
1.29 x 10-4 
 
5.45 x 10-3 ± 
1.08 x 10-4 
5.31 x 10-6 ±  













2.45 x 10-3 ± 
1.51 x 10-4 
 
5.43 x 10-3 ± 
2.10 x 10-4 
 
2.46 x 10-3 ± 
1.87 x 10-4 
5.39 x 10-6 ±  
2.11 x 10-7 
 
*Similar results were observed for the three remaining TP901-1erm escape mutants, TP901-1erm_E119B, TP901-1erm_E121B, and TP901-1erm_E126B.  
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3.3.12 Genome sequencing and bioinformatic analysis of TP901-1erm escape 
mutants 
Analysis of the six escape mutant phages, i.e. TP901-1erm-E119_A/B, TP901-
1erm-E121_A/B and TP901-1erm-E126_A/B, showed that they have overcome the 
TP901-1 phage-resistant phenotype of the E119, E121 and E126 strains (Table 3.9). 
The genomes of these six TP901-1erm escape mutants as well as the genome of 
TP901-1erm WT, were sequenced in order to identify the mutated gene(s) that is (are) 
responsible for allowing the phage to overcome the phage-resistance phenotype. The 
genome of TP901-1 WT is 37.6 Kb in length with 56 predicted protein-coding regions 
and possesses 35.38 % G+C content (9). The genomes of the TP901-1erm derivatives 
as well as the WT exhibit similar characteristics to that of the parent phage. Following 
comparative genome analysis between the Illumina sequenced WT and derivatives, 
deletion or insertion events were not identified, and therefore a SNP analysis was 
performed to identify point mutations that may have caused the TP901-1erm escape 
mutants to overcome phage-resistance. Moreover, a SNP analysis was performed 
using the published TP901-1 data and the Illumina TP901-1erm WT data to rule out 
sequencing errors, thus confirming the integrity of the SNPs identified in the genomes 
on the TP901-1erm escape mutants.  
This resulted in the identification of 96, 178, 128, 45, 111 and 5 SNPs on the 
genomes of TP901-1erm_E119A, E119B, E121A, E121B, E126A and E126B, 
respectively. In total, 563 SNPs (Table S3.2) were identified with 113 of these SNPs 
occurring in more than one of the TP901-1erm escape mutant genomes, and with some 
genes containing more than one mutation in a given genome. Interestingly, the only 
gene mutated in all of the six TP901-1 mutant genomes was tal (tail-associated 
lysin/orf47), with each genome exhibiting one or more SNPs in the coding sequence 
of this 2,757 bp tal gene. Moreover, the genome of the TP901-1erm_E119B escape 
mutant contains 5 SNPs, all of which are located within the tal gene, thus clearly 
implicating Tal in the phage DNA injection process and suggesting that TP901-1 can 
undergo specific tal modification(s) to overcome the phage-insensitivity of the E119, 
E121 and E126 mutants.   
Interestingly, five of the TP901-1erm escape mutants, E119A/B, E121A/B, and 
E126A contain a single mutation in tal, with four of these mutants exhibiting the same 
SNP (T to C), while TP901-1erm_E126B contains five mutations in tal as detailed in 
Table 3.10. A comparative amino acid sequence analysis was performed between the 
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predicted protein sequence of each of the genetically altered Tal proteins and TalTP901-
1 which revealed the specific mutations caused in the encoded amino acids as shown 
in Table 3.10. HHpred modelling of TalTP901-1 predicts that this protein possesses a 
structural and lytic domain. Based on this analysis the observed mutations in the 
encoded amino acids of the altered Tal proteins appear to be located in the structural 
or lytic domains as shown in Table 3.10 and Figure 3.3. 
These findings indicate that a single nucleotide modification in the structural 
domain of tal or a small number of nucleotide modifications in the gene sequence 
encoding the lytic domain of tal is sufficient to modify the encoded TalTP901-1 in order 





Table 3.10: Analysis of confirmed SNPs in talTP901-1 demonstrating SNP position and 
nucleotide change, as well as the resulting mutation in the encoded amino acid and its 
domain location. 
















1,141 t to c W381R 
structural 
domain 
E126B 2,454 a to c G818G lytic domain 
E126B 2,481 t to a S827S lytic domain 
E126B 2,482 g to a G828N lytic domain 
E126B 2,483 g to a G828N lytic domain 






































Figure 3.3: HHpred modelling of TalTP901-1 exhibiting predicted (99.9 % probability) 
structural and lytic domains. Arrow represents encoded Tal protein with vertical lines 
representing the amino acid position of mutations in the encoded protein. The 
autoproteolytic site GGNSG/GG at amino acid positions 598-604 and the catalytic 












Previous studies have demonstrated that phage-host interactions may require 
the involvement of more than one bacterial receptor. For example, the model 
siphophage SPP1, initially binds reversibly to a carbohydrate moiety on the cell 
surface of B. subtilis, followed by irreversible binding to the ectodomain of the YueB 
protein (28), which then triggers DNA ejection (29). In a similar manner, it has been 
shown that phage c2 irreversibly binds to the L. lactis subsp. lactis C2 membrane 
protein, PIP (phage infection protein), following an initial reversible adsorption to a 
cell wall carbohydrate (30, 31). Furthermore, the PtsG (a membrane glucose 
transporter protein) and FkpA (a periplasmic chaperone) proteins in E. coli are known 
to act as phage receptors for phage HK97 (80).  
It has previously been suggested that the P335 temperate phages TP901-1 and 
LC3 either attach to different receptor(s) or utilize distinct pathways of injection (13, 
41). The delineation of five genetically and morphologically distinct P335 lactococcal 
phage sub-groups further strengthens this notion since TP901-1 and LC3 belong to 
distinct sub-groups (sub-groups II and III, respectively) (13), where TP901-1 
possesses a double-disc baseplate structure (81), while LC3 exhibits a “stubby” tail tip 
region (49, 82). Therefore, the distinct baseplate type of LC3 may represent a different 
receptor recognition platform that follows a specific host adsorption and DNA 
injection pathway (13). The results in the present study also support the notion that 
TP901-1 and LC3, either attach to different receptor(s) or utilize distinct pathways of 
DNA injection: expression of gtfA in the E119 and E126 mutant strains restored 
infectivity by phage TP901-1, yet had no effect on LC3 phage infection, while 
silencing of gtfA interfered with infection by phage TP901-1, yet had no impact on the 
infection ability of LC3. 
This current study shows that the resistance of strains E119 and E126 to 
infection by phage TP901-1 was caused by mutations in the predicted 
glycosyltransferase-encoding gene, gtfA. This conclusion is supported by 
complementation assays in which phage sensitivity to TP901-1 was restored in both 
mutants. Additionally, silencing of gtfA interfered with infection by phage TP901-1, 
indicating that gtfA is involved in the initial interactions between TP901-1 and its host 
L. lactis 3107.  
This study indicates that multiple genes are involved in phage-host interactions 
of TP901-1. The finding that the phage-resistant phenotype of only two out of the three 
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mutants was restored by the introduction of gtfA indicates that the third strain, E121, 
contains a mutation in a gene other than gtfA. It seems likely that gtfA is also involved 
in phage-host interactions of the rare lactococcal 949 phages (949 and WRP3) since 
E119 and E126 were shown to be less sensitive to these phages, while 
complementation assays fully restored infectivity by these phages. Interestingly, gtfA 
is ubiquitous among Lactococcus genomes. However, silencing and introducing a 
mutation (stop codon) in gtfANZ9000 had no effect on NZ9000-infecting 936 group 
phages.  
Interestingly, a homologue of gtfA identified in the genome of the lactococcal 
strain IL1403 with 84 % nucleotide identity was able to fully restore the phage-
sensitivity phenotype of E119 and E126, thus showing that a gtfA subspecies-specific 
sequence with reduced sequence identity is capable of acting as a target for TP901-1. 
It is noteworthy that P335 phages are not available for testing in this strain and it would 
be an interesting avenue of research to explore the effect of suppression of gtfA 
expression in lactococcal strains that are sensitive to (sub-group II) P335 phages. 
The generation of TP901-1 escape mutants capable of infecting phage-resistant 
derivatives of the host strain 3107 revealed that TP901-1 is capable of evolving over 
time in order to adapt to cells which have acquired phage resistance. Interestingly, 
despite the fact that strains E119 and E126 do not share the same mutation (gtfA) 
responsible for their TP901-1 resistant phenotype as E121, all of the TP901-1 escape 
mutants generated in this study infect each of the three TP901-1-resistant strains. This 
indicates that even though the mutations in these strains are involved in different steps 
of (producing the molecule required for) the TP901-1 infection pathway, escape 
mutants are capable of bypassing the requirement for this pathway of infection. 
Previous studies have demonstrated that the deletion of specific TP901-1 
phage genes prevents or reduces infection of the host (83). Previously, it has been 
shown that the tail-associated lysin-encoding gene (tal) encodes the tail fiber protein 
of the TP901-1 distal tail structure which is believed to be involved in the opening of 
the DNA ejection conduit through a conformational change during infection (84). 
Here, we demonstrate that regardless of the mutated gene responsible for TP901-1-
resistance, TP901-1 is capable of introducing specific mutation(s) in the coding 
sequence of tal allowing it to infect phage-resistant host cells. Interestingly, in order 
to overcome phage resistant strains TP901-1 appears to modify either the N-terminal 
or C-terminal part of Tal. The N-terminal part of TalTP901-1 may have a structural role, 
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whereas the C-terminal part of TalTP901-1 has been shown to encode a lytic domain 
necessary for the cleavage of peptidoglycan to allow DNA transfer into the cytoplasm 
of the host (19). This current study has demonstrated that alterations in the structural 
or lytic domain of Tal leads to successful infection of TP901-1 resistant strains. We 
hypothesize that the modified Tal is capable of recognizing a different host injection 
trigger or attaching to a modified host injection trigger, thereby generating the desired 
DNA release signal which is believed to trigger a cascade of conserved conformational 
changes in the tail tube to ultimately allow DNA release (84). This demonstrates that 
in a natural environment phages will adapt to host populations which have acquired 
phage resistance mechanism(s), and that phage evolution is continually driven by 
changes in the bacterial host population. 
In conclusion, we identified gtfA as a genetic component required for infection 
of the model phage TP901-1 to its host and have demonstrated that subsequent 
adaptation of TP901-1 to such phage-resistant host cells is achieved through the 
modification of tal. Currently it is not clear how GtfA is involved in triggering DNA 
injection of TP901-1; GtfA may act directly as a proteinaceous injection trigger or the 
saccharidic product of its predicted transferase activity may be a target for TP901-1. 
Chapter IV of this thesis will provide information on efforts to identify the possible 
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Predicted function of product  
(BLAST) 
Primers used for cloning (5’ to 3’) 
1 E126 40809 c to a Intergenic n/a  
2 E119 47852 g to a L3107_0037 
acetoin dehydrogenase complex E1 
component alpha subunit 
 
3 E119 78801 g to a L3107_0070 
ATPase component of ABC transporter 
with duplicated ATPase domains 
 
4 E121 112463 g to a L3107_0104 argininosuccinate synthase 
104_F AGCAGCGGTACCAGGAGGCACTCACATGATGGGAAACAAAAAA 
104_R AGCAGCTCTAGATTATTTGAGATTTACTTG 
5 E119 117593 c to t L3107_0109 Preprotein translocase subunit YidC 
109_F AGCAGCCTGCAGAGGAGGCACTCACTTGAAAAAGAAATTTAGT 
109_R AGCAGCTCTAGATTATTTTTTTCTTGCCTTC 
6 E119 139073 a to t Intergenic n/a  
7 E121 181584 t to a L3107_0174 hypothetical protein 
174_F AGCAGCCTGCAGAGGAGGCACTCACATGAAAATGAGTGTTATT 
174_R AGCAGCTCTAGACTAATCCTCAACCACCTTC 
8 E119 270693 g to a L3107_0263 hypothetical protein 
263_F AGCAGCCTGCAGAGGAGGCACTCACATGAAAATAATAAAAAAC 
263_R AGCAGCTCTAGACTATTCGAGGTTTTTGCT 
9 E119 291322 g to a L3107_0286 hypothetical protein 
286_F AGCAGCCTGCAGAGGAGGCACTCACATGGCAAAAAGACAGAACC 
286_R AGCAGCTCTAGATTAGCCGAAGTTAATGGTG 
10 E119 317385 c to t Intergenic n/a  
11 E119 393093 c to t L3107_0378 
C4-dicarboxylate transporter / malic acid 
transporter 
378_F F AGCAGCCTGCAGAGGAGGCACTCACATGATCTATTCAAAATTT 
378_R AGCAGCTCTAGATTAGATGCTTTCAGCAGA 
12 E119 475194 g to a L3107_0457 hypothetical protein 
457_F AGCAGCCTGCAGAGGAGGCACTCACATGAAAATAATTGGAAAT 
457_R AGCAGCTCTAGATTAGAGCGTCTTTTTATA 
13 E119 480099 c to t L3107_0464 
Predicted Rossmann fold nucleotide-
binding protein 




14 E119 480967 g to a Intergenic n/a  
15 E126 484073 g to a L3107_0468 
DNA polymerase III catalytic subunit 
DnaE type 
 
16 E119 527927 c to t L3107_0505 
ATP-binding subunit of Clp protease and 
DnaK / DnaJ chaperones 
 
17 E119 593696 g to a Intergenic n/a  
18 E119 636929 c to t L3107_0616 Branched-chain amino acid permease  
19 E119 649840 c to t L3107_0630 glycogen synthase (ADP-glucose) 
630_F AGCAGCCTGCAGAGGAGGCACTCACATGAAAGTTTTATTTGCG 
630_R AGCAGCTCTAGATTACTTTAATATTGTTTG 
20 E119 652014 g to a L3107_0631 Glucan phosphorylase  





22 E121 869757 c to t L3107_0866 hypothetical protein 
866_F AGCAGCGGTACCAGGAGGCACTCACATGTCAAAACAAAAAACA 
866_R AGCAGCTCTAGATTATACACCCGTAAATGT 






962789 c to t Intergenic n/a  
25 E121 973425 c to t L3107_0976 




26 E121 993617 a to t Intergenic Phosphopentomutase 
SNP26_F AGCAGCCTGCAGAGGAGGCACTCACAAAGATAAAAATCATTGGTC 








1133202 t to g Intergenic n/a  
29 E126 1158710 g to t L3107_1163 DNA-3-methyladenine glycosylase I 
1163_F AGCAGCCTGCAGAGGAGGCACTCACATGACTGAAAAAACAAGA 
1163_R AGCAGCTCTAGATCAATCCATTAATTCTAC 
30 E126 1169995 c to t L3107_1173 FAD synthase  
31 E121 1193427 c to t L3107_1195 Xanthine phosphoribosyltransferase 
1195_F AGCAGCCTGCAGAGGAGGCACTCACATGAAGTTATTAGAAGAC 
1195_R AGCAGCTCTAGATTAATCGAAAGCGATATC 





33 E119 1262123 c to t L3107_1265 3-isopropylmalate dehydrogenase  
34 E126 1272700 g to a L3107_1276 threonine dehydratase  
35 E126 1310588 a to t Intergenic n/a  
36 E121 1311194 g to a L3107_1311 hypothetical protein 
1311_F AGCAGCCTGCAGAGGAGGCACTCACATGATACTTTTCATTATT 
1311_R AGCAGCTCTAGATTAATCCTTGATTCCAAG 





38 E119 1425572 g to a L3107_1417 hypothetical protein  
39 E126 1452747 
c to t *L3107_1442  Glycosyltransferase 
1442_F AGCAGCCTGCAGAGGAGGCACTCACTTGTATCTTTGGTATAATAG 
40 E119 1453653 1442_R AGCAGCGGTACCTTAGCTTTCATTTTGCTGAC 
41 E126 1559076 g to t L3107_1546 Surface antigen  
42 E119 1680258 g to a L3107_1670 
Phosphotransferase system 
mannose/fructose-specific component IIA 
 
43 E119 1703015 a to t L3107_1694 Predicted O-methyltransferase  
44 E119 1734506 c to t L3107_1726 3-dehydroquinate synthase  
45 E119 1735828 c to t L3107_1727 shikimate dehydrogenase 
1727_F AGCAGCCTGCAGAGGAGGCACTCACATGAAAATTGACGGTTAC 
1727_R AGCAGCGGTACCTCATACTTCTCTCTCCAT 
46 E119 1777955 g to a L3107_1773 




47 E126 1785474 c to a L3107_1776 
DNA-directed RNA polymerase subunit 
beta 
 
48 E126 1789091 g to a L3107_1779 Oligoendopeptidase O  
49 E121 1833247 g to a L3107_1821 
ABC-type dipeptide/oligopeptide/nickel 














1900726 a to t L3107_1891 DNA polymerase IV  
53 E119 1946818 c to t L3107_1940 hypothetical protein 
1940_F AGCAGCCTGCAGAGGAGGCACTCACATGGAAAAATTGATTTCT 
1940_R AGCAGCTCTAGACTATCTTTTTCTCATCAT 
54 E119 1957802 c to t L3107_1955 head-tail joining protein  
160 
 
55 E126 1996872 g to a L3107_1994 Predicted membrane protein 
1994_F AGCAGCCTGCAGAGGAGGCACTCACATGGAAGTGATAAGCAGT 
1994_R AGCAGCTCTAGATTAATATTCTATTCTTGG 
56 E119 2017636 c to t L3107_2014 
phenylalanyl-tRNA synthetase beta 
subunit 
 






2081538 t to c L3107_2086 hypothetical protein 
2086_F AGCAGCCTGCAGAGGAGGCACTCACATGCCTACACAGGAAATA 
2086_R AGCAGCTCTAGACTATTTTCGCCATAGTCC 
59 E126 2176455 g to a L3107_2192 30S ribosomal protein S5  
60 E121 2197193 g to a Intergenic 




61 E121 2205536 c to a L3107_2235 Competence protein ComGB 
2235_F AGCAGCCTGCAGAGGAGGCACTCACATGGGGAATCTTTTGAAT 
2235_R AGCAGCTCTAGATTAAATTCCAGAACCCAT 
62 E121 2228548 a to g L3107_2253 DNA polymerase I 
2253_F AGCAGCCTGCAGAGGAGGCACTCACATGGAAGATAAGAATAGA 
2253_R AGCAGCGGTACCTCATTTGGCTTCATACCA 
63 E121 2274649 c to t L3107_2293 recombination regulator RecX 
2293_F AGCAGCCTGCAGAGGAGGCACTCACATGGGAAAAATCACAGCA 
2293_R AGCAGCGGTACCTTATTCTGGGAATGTGTA 
64 E126 2325916 c to t L3107_2342 
Activator of 2-hydroxyglutaryl-CoA 
dehydratase and two uncharacterized 
domains 
 











Table S3.2: Confirmed SNPs with proposed involvement in TP901-1 phage infection of bacteriophage insensitive mutants (BIMs). 






Predicted function of product (Blast) 
1 E119B/E121A/E126A 325 a to g ORF31 large terminase subunit (terL) 
2 E119B/E121A/E126A 326 t to c ORF31 large terminase subunit (terL) 
3 E119B/E121A/E126A 343 g to a ORF31 large terminase subunit (terL) 
4 E119B/E121A/E126A 364 c to t ORF31 large terminase subunit (terL) 
5 E119B/E121A/E126A 415 t to g ORF31 large terminase subunit (terL) 
6 E119B/E121A/E126A 466 c to t ORF31 large terminase subunit (terL) 
7 E119B/E121A/E126A 469 a to g ORF31 large terminase subunit (terL) 
8 E119B/E121A/E126A 496 a to g ORF31 large terminase subunit (terL) 
9 E119B/E121A/E126A 514 t to c ORF31 large terminase subunit (terL) 
10 E119B/E121A/E126A 524 c to a ORF31 large terminase subunit (terL) 
11 E119B/E121A/E126A 526 g to a ORF31 large terminase subunit (terL) 
12 E119B/E121A/E126A 538 a to t ORF31 large terminase subunit (terL) 
13 E119A/E119B/E121A/E126A 1771 g to a ORF32 portal protein 
14 E119A/E119B/E121A/E126A 1777 a to g ORF32 portal protein 
15 E119A/E119B/E121A/E126A 1780 c to t ORF32 portal protein 
16 E119A/E119B/E121A/E126A 1781 t to g ORF32 portal protein 
162 
 
17 E119A/E119B/E121A/E126A 1810 a to t ORF32 portal protein 
18 E119A/E119B/E121A/E126A 1834 g to a ORF32 portal protein 
19 E119A/E119B/E121A/E126A 1837 a to g ORF32 portal protein 
20 E119A/E119B/E121A/E126A 1843 a to c ORF32 portal protein 
21 E119A/E119B/E121A/E126A 1858 c to t ORF32 portal protein 
22 E119A/E119B/E121A/E126A 1870 c to t ORF32 portal protein 
23 E119A/E119B/E121A/E126A 1885 t to a ORF32 portal protein 
24 E119A/E119B/E121A/E126A 1891 a to g ORF32 portal protein 
25 E119A/E119B/E121A/E126A 1909 c to t ORF32 portal protein 
26 E119A/E119B/E121A/E126A 1918 t to c ORF32 portal protein 
27 E119A/E119B/E121A/E126A 1973 a to c ORF32 portal protein 
28 E119A/E119B/E121A/E126A 2189 t to g ORF33 minor capsid protein 1 (MCP1) 
29 E119A/E119B/E121A/E126A 2284 t to a ORF33 minor capsid protein 1 (MCP1) 
30 E119A/E119B/E121A/E126A 2285 c to g ORF33 minor capsid protein 1 (MCP1) 
31 E119A/E119B/E121A/E126A 2303 a to c ORF33 minor capsid protein 1 (MCP1) 
32 E119A/E119B/E121A/E126A 2377 t to c ORF33 minor capsid protein 1 (MCP1) 
33 E119A/E119B/E121A/E126A 2384 c to t ORF33 minor capsid protein 1 (MCP1) 
34 E119A/E119B/E121A/E126A 2386 g to a ORF33 minor capsid protein 1 (MCP1) 
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35 E119A/E119B/E121A/E126A 2389 g to a ORF33 minor capsid protein 1 (MCP1) 
36 E119A/E119B/E121A/E126A 2390 c to t ORF33 minor capsid protein 1 (MCP1) 
37 E119A/E119B/E121A/E126A 2392 t to g ORF33 minor capsid protein 1 (MCP1) 
38 E119A/E119B/E121A/E126A 2396 t to g ORF33 minor capsid protein 1 (MCP1) 
39 E119A/E119B/E121A/E126A 2407 t to c ORF33 minor capsid protein 1 (MCP1) 
40 E119A/E119B/E121A/E126A 2410 c to t ORF33 minor capsid protein 1 (MCP1) 
41 E119A/E119B/E121A/E126A 2431 t to g ORF33 minor capsid protein 1 (MCP1) 
42 E119A/E119B/E121A/E126A 2437 a to g ORF33 minor capsid protein 1 (MCP1) 
43 E119A/E119B/E121A/E126A 2441 t to g ORF33 minor capsid protein 1 (MCP1) 
44 E119A/E119B/E121A/E126A 2442 c to g ORF33 minor capsid protein 1 (MCP1) 
45 E119A/E119B/E121A/E126A 2453 a to g ORF33 minor capsid protein 1 (MCP1) 
46 E119A/E119B/E121A/E126A 2476 a to c ORF33 minor capsid protein 1 (MCP1) 
47 E119A/E119B/E121A/E126A 2479 t to a ORF33 minor capsid protein 1 (MCP1) 
48 E119A/E119B/E121A/E126A 2485 t to c ORF33 minor capsid protein 1 (MCP1) 
49 E119A/E119B/E121A/E126A 2486 t to c ORF33 minor capsid protein 1 (MCP1) 
50 E119A/E119B/E121A/E126A 2491 c to t ORF33 minor capsid protein 1 (MCP1) 
51 E119A/E119B/E121A/E126A 2497 a to c ORF33 minor capsid protein 1 (MCP1) 
52 E119A/E119B/E121A/E126A 2501 g to a ORF33 minor capsid protein 1 (MCP1) 
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53 E119A/E119B/E121A/E126A 2503 a to c ORF33 minor capsid protein 1 (MCP1) 
54 E119A/E119B/E121A/E126A 2506 a to t ORF33 minor capsid protein 1 (MCP1) 
55 E119A/E119B/E121A/E126A 2530 g to t ORF33 minor capsid protein 1 (MCP1) 
56 E119A/E119B/E121A/E126A 2533 a to t ORF33 minor capsid protein 1 (MCP1) 
57 E119A/E119B/E121A/E126A 2578 a to g ORF33 minor capsid protein 1 (MCP1) 
58 E119A/E119B/E121A/E121B/E126A 2660 a to g ORF33 minor capsid protein 1 (MCP1) 
59 E119A/E119B/E121A/E121B/E126A 2698 g to a ORF33 minor capsid protein 1 (MCP1) 
60 E119A/E119B/E121A/E126A 2716 a to t ORF33 minor capsid protein 1 (MCP1) 
61 E119A/E119B/E121A/E126A 2722 c to t ORF33 minor capsid protein 1 (MCP1) 
62 E119A/E119B/E121A/E126A 2725 a to t ORF33 minor capsid protein 1 (MCP1) 
63 E119A/E119B/E121A/E121B/E126A 2737 t to a ORF33 minor capsid protein 1 (MCP1) 
64 E119A/E119B/E121A/E121B/E126A 2740 g to t ORF33 minor capsid protein 1 (MCP1) 
65 E119A/E119B/E121A/E121B/E126A 2743 g to a ORF33 minor capsid protein 1 (MCP1) 
66 E119A/E119B/E121A/E121B/E126A 2920 t to c ORF33 minor capsid protein 1 (MCP1) 
67 E119A/E119B/E121A/E121B/E126A 2929 t to c ORF33 minor capsid protein 1 (MCP1) 
68 E119A/E119B/E121A/E121B/E126A 2938 g to a ORF33 minor capsid protein 1 (MCP1) 
69 E119A/E119B/E121A/E121B/E126A 2958 c to g ORF33 minor capsid protein 1 (MCP1) 
70 E119A 2994 a to c ORF33 minor capsid protein 1 (MCP1) 
165 
 
71 E119A 2995 a to g ORF33 minor capsid protein 1 (MCP1) 
72 E119A/E119B/E121A/E121B/E126A 3955 g to c ORF34 hypothetical protein 
73 E119A/E119B/E121A/E121B/E126A 3956 a to c ORF34 hypothetical protein 
74 E119A/E119B/E121A/E121B/E126A 3958 a to g ORF34 hypothetical protein 
75 E119A/E119B/E121A/E121B/E126A 3959 a to g ORF34 hypothetical protein 
76 E119A/E119B/E121A/E121B/E126A 3961 t to a ORF34 hypothetical protein 
77 E119A/E119B/E121A/E121B/E126A 3962 a to c ORF34 hypothetical protein 
78 E119A/E119B/E121A/E121B/E126A 3966 t to a ORF34 hypothetical protein 
79 E119A/E119B/E121A/E121B/E126A 3969 a to c ORF34 hypothetical protein 
80 E119A/E119B/E121A/E121B/E126A 3972 t to c ORF34 hypothetical protein 
81 E119A/E119B/E121A/E121B/E126A 3988 t to g Intergenic n/a 
82 E119A/E119B/E121A/E121B/E126A 4146 a to c ORF35 scaffolding protein (Sfp) 
83 E119A/E119B/E121A/E121B/E126A 4163 c to t ORF35 scaffolding protein (Sfp) 
84 E119A/E119B/E121A/E121B/E126A 4170 g to a ORF35 scaffolding protein (Sfp) 
85 E119A/E119B/E121A/E121B/E126A 4200 g to t ORF35 scaffolding protein (Sfp) 
86 E119A/E119B/E121A/E121B/E126A 4312 t to g ORF35 scaffolding protein (Sfp) 
87 E119A/E119B/E121A/E121B/E126A 4464 t to c ORF35 scaffolding protein (Sfp) 
88 E119A/E119B/E121A/E121B/E126A 4470 g to a ORF35 scaffolding protein (Sfp) 
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89 E119A/E119B/E121A/E121B/E126A 4494 g to a ORF35 scaffolding protein (Sfp) 
90 E119A/E119B/E121A/E121B/E126A 4548 c to t ORF35 scaffolding protein (Sfp) 
91 E119A/E119B/E121A/E121B/E126A 4617 a to g ORF35 scaffolding protein (Sfp) 
92 E119A/E119B/E121A/E121B/E126A 4778 g to a ORF36 major head protein (Mhp) 
93 E119A/E119B/E121A/E121B/E126A 4792 t to c ORF36 major head protein (Mhp) 
94 E119A/E119B/E121A/E121B/E126A 4841 a to c ORF36 major head protein (Mhp) 
95 E119A/E119B/E121A/E121B/E126A 4843 g to a ORF36 major head protein (Mhp) 
96 E119A/E119B/E121A/E121B/E126A 5020 g to t ORF36 major head protein (Mhp) 
97 E119A/E119B/E121A/E121B/E126A 5042 g to t ORF36 major head protein (Mhp) 
98 E119A/E119B/E121A/E121B/E126A 5043 c to t ORF36 major head protein (Mhp) 
99 E119A/E119B/E121A/E121B/E126A 5130 g to a ORF36 major head protein (Mhp) 
100 E119A/E119B/E121A/E121B/E126A 5131 c to a ORF36 major head protein (Mhp) 
101 E121A/E121B 5227 c to t ORF36 major head protein (Mhp) 
102 E119A/E119B 5290 c to t ORF36 major head protein (Mhp) 
103 E121A/E121B 5290 c to t ORF36 major head protein (Mhp) 
104 E119A/E119B 5384 g to a ORF36 major head protein (Mhp) 
105 E121A/E121B 5384 g to a ORF36 major head protein (Mhp) 
106 E119A/E119B 5385 g to a ORF36 major head protein (Mhp) 
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107 E121A/E121B 5385 g to a ORF36 major head protein (Mhp) 
108 E119A/E119B 5396 a to t ORF36 major head protein (Mhp) 
109 E121A/E121B 5396 a to t ORF36 major head protein (Mhp) 
110 E119A/E119B 5608 a to g ORF37 hypothetical protein 
111 E121A/E121B 5608 a to g ORF37 hypothetical protein 
112 E119A/E119B/E121A 5725 t to g ORF37 hypothetical protein 
113 E119A/E119B/E121A 5726 c to a ORF37 hypothetical protein 
114 E119B/E121A 5768 g to t ORF37 hypothetical protein 
115 E119B/E121A 5773 t to a ORF38 DNA packaging protein 
116 E119B/E121A 5774 t to a ORF38 DNA packaging protein 
117 E119B/E121A 5781 t to a ORF38 DNA packaging protein 
118 E119B/E121A 5799 t to c ORF38 DNA packaging protein 
119 E119B/E121A 5816 g to a ORF38 DNA packaging protein 
120 E119B/E121A 5839 c to a ORF38 DNA packaging protein 
121 E121A 5867 a to c ORF38 DNA packaging protein 
122 E119B 12698 g to c ORF47 tail-associated lysin (Tal) 
123 E119A/E121A/E121B/E126A 13186 t to c ORF47 tail-associated lysin (Tal) 
124 E126B 14499 a to c ORF47 tail-associated lysin (Tal) 
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125 E126B 14526 t to a ORF47 tail-associated lysin (Tal) 
126 E126B 14527 g to a ORF47 tail-associated lysin (Tal) 
127 E126B 14528 g to a ORF47 tail-associated lysin (Tal) 
128 E126B 14566 g to a ORF47 tail-associated lysin (Tal) 
129 E119B 34861 c to a ORF22 hypothetical protein 
130 E119B 34878 a to c ORF22 hypothetical protein 
131 E119B 34982 a to g ORF22 hypothetical protein 
132 E119B 35755 a to c ORF22 hypothetical protein 
133 E119B 35793 g to a ORF22 hypothetical protein 
134 E119B 35808 a to g ORF22 hypothetical protein 
135 E119B 35811 a to g ORF22 hypothetical protein 
136 E119B 35819 a to t ORF22 hypothetical protein 
137 E119B 35918 t to c Intergenic n/a 
138 E119B 35969 c to t Intergenic n/a 
139 E119B 36013 g to t Intergenic n/a 
140 E119B 36027 a to g Intergenic n/a 
141 E119B 36065 t to g Intergenic n/a 
142 E119B 36068 t to c Intergenic n/a 
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143 E119B 36071 t to a Intergenic n/a 
144 E119B 36687 t to c Intergenic n/a 
145 E119B 36722 a to c Intergenic n/a 
146 E119B 36727 g to a Intergenic n/a 
147 E119B 36729 c to a Intergenic n/a 
148 E119B 36742 t to g Intergenic n/a 
149 E119B 36821 c to t ORF29 activator of late transcription 
150 E119B 36857 c to t ORF29 activator of late transcription 
151 E119B 36866 a to g ORF29 activator of late transcription 
152 E119B 36887 g to a ORF29 activator of late transcription 
153 E119B 36917 g to a ORF29 activator of late transcription 
154 E119B 36937 a to t ORF29 activator of late transcription 
155 E119B 36938 c to a ORF29 activator of late transcription 
156 E119B 36943 a to g ORF29 activator of late transcription 
157 E119B 36945 c to t ORF29 activator of late transcription 
158 E119B 36947 c to a ORF29 activator of late transcription 
159 E119B 36949 a to g ORF29 activator of late transcription 
160 E119B 36953 c to a ORF29 activator of late transcription 
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161 E119B 36954 c to t ORF29 activator of late transcription 
162 E119B 36959 g to a ORF29 activator of late transcription 
163 E119B 36960 t to a ORF29 activator of late transcription 
164 E119B 36961 a to g ORF29 activator of late transcription 
165 E119B 36962 c to a ORF29 activator of late transcription 
166 E119B 36966 t to a ORF29 activator of late transcription 
167 E119B 36969 a to g ORF29 activator of late transcription 
168 E119B 36974 a to c ORF29 activator of late transcription 
169 E119B 38237 g to c ORF31 large terminase subunit (terL) 
170 E119B 38238 t to a ORF31 large terminase subunit (terL) 
171 E119B 38241 t to c ORF31 large terminase subunit (terL) 
172 E119B 38244 g to a ORF31 large terminase subunit (terL) 
173 E119B 38259 t to g ORF31 large terminase subunit (terL) 
174 E119B 38271 g to a ORF31 large terminase subunit (terL) 
175 E119B 38293 a to g ORF31 large terminase subunit (terL) 
176 E119B 38298 g to a ORF31 large terminase subunit (terL) 
177 E119B 38299 c to t ORF31 large terminase subunit (terL) 
178 E119B 38301 t to c ORF31 large terminase subunit (terL) 
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179 E119B/E121A/E126A 39183 a to g ORF31 large terminase subunit (terL) 
180 E119B/E121A/E126A 39184 t to c ORF31 large terminase subunit (terL) 
181 E119B/E121A/E126A 39201 g to a ORF31 large terminase subunit (terL) 
182 E119B/E121A/E126A 39222 c to t ORF31 large terminase subunit (terL) 
183 E119B/E121A/E126A 39273 t to g ORF31 large terminase subunit (terL) 
184 E119B/E121A/E126A 39324 c to t ORF31 large terminase subunit (terL) 
185 E119B/E121A/E126A 39327 a to g ORF31 large terminase subunit (terL) 
186 E119B/E121A/E126A 39354 a to g ORF31 large terminase subunit (terL) 
187 E119B/E121A/E126A 39372 t to c ORF31 large terminase subunit (terL) 
188 E119B/E121A/E126A 39382 c to a ORF31 large terminase subunit (terL) 
189 E119B/E121A/E126A 39384 g to a ORF31 large terminase subunit (terL) 
190 E119B/E121A/E126A 39396 a to t ORF31 large terminase subunit (terL) 
 
















Biochemical analysis of cell wall polysaccharides and 
teichoic acids in Lactococcus lactis subsp. cremoris strains 












Note: Cell wall polysaccharide (CWPS) analysis was performed by Dr. Marie-Pierre 
Chapot-Chartier, Dr. Simon Palussière and Dr. Pascal Courtin of Micalis Institute, 
INRA, Jouy-en-Josas, France. Teichoic acid analysis was performed by Dr. Irina 
Sadovskaya of the Université du Littoral Côte d’Opale, Boulogne-sur-Mer, France and 
Dr. Evgeny Vinogradov of the Institute of Biological Sciences, Ottawa, ON, Canada.  
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The predicted membrane-associated glycosyltransferase (GTF), GtfA3107, is 
required for one of the first host-interaction steps of certain members of the lactococcal 
P335 and 949 phage groups (see Chapter III). GtfA is presumed to glycosylate a 
substrate, which is likely to be a cell envelope-associated glycopolymer, such as cell 
wall polysaccharides (CWPS) or teichoic acids (TAs). In an attempt to identify the 
GtfA substrate, the biochemical composition and structure of CWPS components 
(rhamnan and polysaccharide pellicle (PSP)) and lipoteichoic acids (LTAs) of L. lactis 
strains 3107 and NZ9000, and a number of derivative strains were analysed. Results 
show that derivatives possessing a non-functional gtfA do not possess any structural 
modifications in either the rhamnan or PSP components of the CWPS as compared to 
their parent strains, while LTA analysis revealed that gtfA is not responsible for 




 4.1 Introduction 
Lactococcal phage-encoded receptor binding protein(s) (RBPs) recognize and 
attach to host-encoded receptor molecule(s), such as the cell wall polysaccharide 
(CWPS) or a surface-exposed protein and/or TA (1), an event that acts as a prelude to 
phage genome injection into the host cell cytoplasm (1, 2). Structural details of the 
CWPS have previously been investigated in certain lactococcal strains (3-9). The 
lactococcal CWPS consists of two covalently-linked constituents: the surface-exposed 
polysaccharide pellicle (PSP) and the recently described rhamnan polysaccharide, 
which is embedded within the peptidoglycan layer (3). The first PSP structure to be 
resolved was that of L. lactis subsp. cremoris strain MG1363 (4, 5), followed by that 
of L. lactis subsp. cremoris (L. lactis) 3107 (6) and SMQ-388 (7). These PSP structures 
exhibit subtle differences in their biochemical make-up and, interestingly, act as 
receptors to determine host specificity of many lactococcal phages (6). The receptor 
for the industrially significant P335 (6, 10) and 936 (5, 6, 11) phage groups, as well as 
the 1358 (7), 949 (12) and P087 (12) phage groups is saccharidic in nature, and the 
variable PSP has been identified as the principal phage receptor in a number of cases 
(6, 7, 10, 12). Interestingly, the c2 group of lactococcal phages appears to utilize both 
a carbohydrate receptor as well as a proteinaceous receptor moiety to achieve 
successful attachment and subsequent infection (13, 14).  
Phage-host interaction studies in Gram-positive bacteria have demonstrated 
that also teichoic acids (TAs) may act as receptors for specific phages (15-19). In the 
cell wall of Gram-positive bacteria, such as Bacillus subtilis, Listeria monocytogenes, 
and Staphylococcus aureus, TAs are present as wall teichoic acids (WTA) (covalently 
attached to peptidoglycan) and/or lipoteichoic acids (LTA) (anchored in the 
cytoplasmic membrane by means of a lipid attachment) (20-22). LTA is a polyglycerol-
phosphate (GroP) chain decorated with D-alanine or/and sugar residues (23-28). The 
enzymes involved in the D-alanylation and glycosylation process have been 
characterized for certain bacterial species (21, 29, 30). The LTA glycosylation process 
in B. subtilis and L. monocytogenes is instigated by a cytoplasmic glycosyltransferase 
(GTF) named CsbB and GtlA, which are presumed to transfer N-acetylglucosamine 
(GlcNAc) and galactose (Gal) residues, respectively, onto the undecaprenyl lipid 
carrier. The sugar-lipid intermediate is then re-oriented to the other side of the 
membrane by an as yet to be identified flippase enzyme. The GlcNAc/Gal residues are 
then transferred onto the GroP chain of the LTA by a second membrane-associated 
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GTF identified as YfhO and GtlB in B. subtilis and L. monocytogenes, respectively. 
Glycosylation of the GroP chain of LTA thus occurs at the periplasmic side of the 
membrane (31). WTA is also a GroP chain decorated with molecules such as glycosyl 
or D-alanyl, and unlike LTA, the GroP chain of WTA is attached to a “linkage unit” 
composed of N-acetylmannosaminy1β-(1-4)glucosamine which allows covalent 
attachment to the peptidoglycan (32). WTA glycosylation was initially thought to 
occur on the cytoplasmic side of the cell membrane as WTA subunit biosynthesis takes 
place at this location in S. aureus (33-36) and B. subtilis (37, 38). However, WTA 
glycosylation was recently proposed to be an extracellular process in L. 
monocytogenes and other Gram-positive bacteria (31). In L. monocytogenes, the 
glycosylation process of WTA has been suggested to be similar to that of LTA where 
Lmo2550 represents a GTF required for undecaprenyl glycosylation, while Lmo1079 
is the GTF involved in periplasmic glycosylation of WTA (31).  
Currently it is not known if L. lactis strains synthesize WTA and to what extent 
this structure is involved in phage infection. LTA extraction related to L. lactis subsp. 
cremoris SK110 was shown to contain galactosyl-containing LTA which was linked 
to phage infection (18). Subsequent to this study LTA isolated from Lactococcus lactis 
CRL 526 was chemically analysed, revealing (not surprisingly) a GroP chain (39). The 
first complete LTA structure from an L. lactis strain to be characterized was that of L. 
lactis subsp. lactis IL1403 as shown in Figure 4.1 (8). Biochemical analysis of this 
particular LTA showed that following LTA polymerization, the GroP chain of LTA is 
substituted with single α-galactose (α-Gal) or alanine (Ala) residues (8, 40).    
In Chapter III of this thesis, we demonstrated that gtfA3107, which encodes a 
predicted membrane-associated GTF protein, is required for injection of L. lactis strain 
3107 by lactococcal phage TP901-1 (a member of the P335 phage group). Our current 
hypothesis is that GtfA3107 catalyses the glycosidic modification of a cell envelope-
associated polysaccharide component, which acts as an injection trigger for TP901-1 
following its initial adsorption to a CWPS component. The presumed GtfA substrates 
may include the PSP, rhamnan, LTA, WTA (if present), peptidoglycan or a 
glycoprotein. The aim of this study is to determine if the substrate for GtfA is a CWPS 
component (PSP and/or rhamnan) or LTA, this was analysed by determining if the 
expression of gtfA3107 evokes modification of LTA or CWPS components (PSP and/or 
rhamnan). This was assessed through the comparative biochemical analysis of 
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extracted LTA and/or CWPS from L. lactis strains 3107 and NZ9000, and their gtfA-
mutated derivatives.   
 
 
Figure 4.1 Composition of lipoteichoic acid structure of L. lactis IL1403; figure taken 
from (8). The LTA tructure is composed of a glycerol-phosphate polymer [-3-Gro-1-
P] partially glycosylated with α-galactose (α-Gal) or acylated with alanine (Ala). The 
LTA mean [-3-Gro-1-P] chain length is 16, following polymerization 11.8 ± 1.6 % of 
the chain is substituted with galactose and 28.5 ± 6.6 % is substituted with D-Alanine, 
while 59.8 ± 5.2 % of the chain remains non-substituted (8, 40). 
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4.2 Materials and Methods  
 
4.2.1 Bacterial strains and growth conditions  
Strains employed in this study are listed in Table 4.1. L. lactis strains were 
grown at 30 °C in M17 broth/agar (Oxoid, U.K.) supplemented with 0.5 % (v/v) 
glucose (GM17) and 5 µg ml-1 chloramphenicol (Cm), where necessary. 
 
Table 4.1 Bacterial strains used in this study.  
   Bacterial Strains Description  Source 
Lactococcus lactis subsp. 
cremoris 
  
 3107 Host strain for model P335 phage TP901-1 (41) 
 E119 TP901-1-resistant derivative of 3107 (42) 
 E121 TP901-1-resistant derivative of 3107 (42) 
 E126 TP901-1-resistant derivative of 3107 (42) 
 E126_pNZgtfA 
E126 harbouring complementing plasmid pNZgtfA; 
pNZ44 vector harbouring gtfA from L. lactis 3107 
Chapter III 
 3107_pNZ44 3107 harbouring the empty vector pNZ44 Chapter III 
 3107_pNZSgtfA 
3107 harbouring the silencing plasmid pNZSgtfA; pNZ44 
vector harbouring gtfA from L. lactis 3107 in the anti-
sense orientation 
Chapter III 
 3107_pNZgtfA 3107 harbouring the over-expressing plasmid pNZgtfA Chapter III 
 3107_pNZ1441-1443 
3107 harbouring the over-expressing plasmid pNZ1441-
1443; pNZ44 containing L3107_1441, gtfA and 
L3107_1443 from L. lactis 3107. 
Chapter III 
 NZ9000 
MG1363 derivative in which the nisRK genes have been 
inserted in the chromosome  
(43) 
 NZ9000Δ8915 
NZ9000 harbouring a non-sense mutation in 
LLNZ_08915, homologue of L3107_1441 
Chapter III 
 NZ9000ΔgtfA 
NZ9000 harbouring a non-sense mutation in 
LLNZ_08920, homologue of gtfA3107 
Chapter III 
 NZ9000Δ8915_ gtfA 
NZ9000 harbouring a non-sense mutation in 
LLNZ_08915 as well as LLNZ_08920, homologues of 
L3107_1441 and gtfA3107, respectively.  
Chapter III 





4.2.2 Cell wall polysaccharide (CWPS) extraction, purification and analysis 
        CWPS was extracted as described previously (3). Briefly, cells from an 
exponentially growing culture (corresponding to an OD600nm between 0.6 and 0.8) 
were harvested by centrifugation at 1,900 × g for 15 minutes at 4 °C and washed twice 
with deionized ice-cold water. CWPS was then extracted by 48 % hydrofluoric acid 
(HF) treatment for 48 h at 4 °C. After drying, rhamnan and PSP oligosaccharides 
released by HF treatment were separated by size exclusion chromatography (SEC) 
with a high-performance liquid chromatography (HPLC) system (SEC-HPLC) as 
described previously (3). Elution was performed with Milli-Q H2O and detection of 
eluted compounds was performed with a refractometer (2414 Refractive Index 
Detector, Waters) and/or UV detector at 206 nm. Fractions corresponding to peaks 
containing rhamnan and PSP oligosaccharides were collected and dried under vacuum 
and further analyzed for composition and mass as described previously (3). 
Monosaccharide composition was determined after trifluoroacetic acid (TFA) 
hydrolysis by high performance anion exchange chromatography coupled with pulse-
amperometric detection (HPAEC-PAD) (ICS5000 system, Thermo Fisher scientific).  
 
4.2.3 Lipoteichoic acid (LTA) extraction and analysis  
Strains L. lactis 3107 and its mutant derivative E126 were grown overnight in 
4 L of GM17, after which cells were harvested by centrifugation at 1900 × g for 15 
minutes at 4 °C and washed twice with deionized ice-cold water. LTA (anchored in the 
cytoplasmic membrane) was extracted from cells with hot aqueous phenol as 
previously described (18). Briefly, the cell pellet (~5 g) was suspended in Chloroform-
Methanol-Water (30:15:2.5, v/v) and stirred overnight. Following centrifugation at 
3,000 x g for 30 minutes, the defatted cells were suspended in 20 ml of 0.1 M sodium 
acetate buffer (pH 5) and 20 ml of 40 % hot aqueous phenol was added. The 
suspension was stirred at 65 °C for 1 h, cooled and transferred into teflon centrifuge 
tubes. The suspension was further cooled by placing the tubes in ice for the separation 
phase. The cooled suspension was then centrifuged to separate the aqueous and phenol 
phases; the aqueous phase (which is expected to contain LTA) was collected and re-
extracted with chloroform. Crude aqueous extracts were further de-proteinated by the 
addition of trichloroacetic acid (TCA) to a final concentration of 5 %. Following 
centrifugation, the clear supernatant was dialyzed and lyophilized to obtain a crude 
LTA preparation. Crude extracts (5 mg) were subjected to composition and 
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methylation analyses by gas chromatography (GC) and gas chromatography-mass 
spectrometry (GC-MS) after treatment with 48 % HF (4 °C, 24 h), acid hydrolysis and 
conversion into alditol acetates, as described previously (44). For the detection of 







4.3.1 Bioinformatic analysis and predicted function of GtfA  
       The gtfA3107 gene encodes a putative membrane-associated GTF protein, GtfA, 
which is predicted to possess fourteen transmembrane helices and a large extracellular 
loop containing the catalytic site of the protein (Chapter III). These topological 
characteristics are similar to those of YfhO and Lmo1079 which are members of the 
GT-C family of GTFs, and which exhibit 19 % amino acid sequence identity to GtfA. 
The GT-C family of GTFs are characterized by 8 – 13 transmembrane helices and an 
extracellular loop (45). GtfA is thus predicted to be a member of the GT-C family of 
GTFs, which are known to be involved in glycosylation of substrates at the periplasmic 
side of the cytoplasmic membrane, e.g. YfhO and Lmo1079 of B. subtilis and L. 
monocytogenes glycosylate the GroP chain of LTA and WTA, respectively.  
       Based on the above, we predicted that GtfA catalyses a glycosylation event in 
L. lactis 3107 by transferring a mono/oligo-saccharide from its undecaprenyl carrier 
to its extracytoplasmic substrate. This proposed glycosylation process is schematically 
depicted in Figure 4.2. The presumed substrate for GtfA is TA (WTA or LTA), CWPS 
components (PSP or rhamnan), peptidoglycan or a glycoprotein of L. lactis 3107. 
Here, to identify the substrate of GtfA, candidates of which are LTA, PSP or rhamnan, 
biochemical analysis of LTA structures in the 3107 strain and a gtfA mutant (stop 
codon) derivative (E126) of 3107 was performed as described in more detail below. 
Furthermore, as described below, biochemical analysis of PSP and rhamnan structures 





Figure 4.2: Model for TA (LTA or WTA) glycosylation in L. lactis. The LTA or WTA glycosylation process in L. lactis initially requires an as yet unidentified 
cytoplasmic GTF (blue) which transfers a sugar residue (red) onto an undecaprenyl-phosphate which acts as a lipid carrier (Step 1). The sugar-lipid intermediate 
is then transported across the membrane by an unknown flippase enzyme (Step 2). The sugar residue is then transferred by a second extracellular GTF proposed 
to be GtfA (pink) onto the GroP chain (green) of the LTA which is anchored in the cytoplasmic membrane by means of a lipid attachment (brown) or WTA 
which is covalently attached to peptidoglycan (purple) (Step 3).  
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4.3.2 Analysis of CWPS from L. lactis 3107 and its derivatives 
To assess the predicted role of gtfA3107 in glycosylation of a particular cell wall-
associated glycan, the two components of CWPS (rhamnan and PSP) from L. lactis 
3107 and its derivatives were purified and analysed. Rhamnan and PSP 
oligosaccharides were extracted from cell walls by HF treatment and purified by SEC-
HPLC (Figs. 4.3, 4.4 and 4.5). Following this, the monosaccharide composition of the 
extracted rhamnan and PSP oligosaccharides was determined and analyzed by Maldi-
Tof MS according to previously described protocols (3). No significant differences 
were detected at the level of rhamnan and PSP structures, between the L. lactis 3107 
strain and its phage-resistant derivatives E119 and E126 (gtfA mutants), or the 
complemented versions of these strains. Furthermore, L. lactis 3107 containing the 
following plasmids were also analysed; plasmid pNZgtfA, which causes constitutive 
(over)expression of gtfA3107, plasmid pNZSgtfA in which expression of gtfA3107 was 
silenced, plasmid pNZgtfA_1443 causing constitutive (over)expression of 
L3107_1441, gtfA3107 and L3107_1443, as well as the empty pNZ44 vector as a 
control. All these L. lactis 3107 derivatives also displayed identical PSP and rhamnan 
structures to the parent strain (Figs. 4.6 and 4.7). Figures 4.6 and 4.7 provides data on 
the monosaccharide composition analysis of extracted rhamnan and PSP, respectively, 
from 3107 and some of its analysed derivatives relative to the amount of Glucosamine 
(GlcNH2) present. Deacetylation of N-acetylglucosamine (GlcNAc) leads to the 
presence of GlcNH2, thus an alteration on the level of GlcNH2 present would be 
indicative of rhamnan or PSP modification. Furthermore, the composition of extracted 
rhamnan was also analysed relative to the amount of rhamnose, galactose and glucose 
(data not shown). Although variation was observed between the individual extraction 
attempts (Figs. 4.3 to 4.5) in PSP and rhamnan, the compositional analysis of these 
extracted structures exhibited no variation. These results therefore demonstrate that 
neither the PSP nor the rhamnan were structurally modified, and that gtfA3107 is not 




Figure 4.3: Size exclusion chromatography with high-performance liquid chromatography (SEC-HPLC) purification of rhamnan and PSP 










Figure 4.4: Size exclusion chromatography with high-performance liquid chromatography (SEC-HPLC) purification of rhamnan and PSP 




3107 WT (365µg) / E126 (388µg) / 3107_pNZ44 (387µg) / 3107_pNZ1441-1443 (437µg) 
 
Figure 4.5: Size exclusion chromatography with high-performance liquid chromatography (SEC-HPLC) purification of rhamnan and PSP 
oligosaccharides extracted from cell walls of L. lactis 3107 and its derivatives, E126, 3107_pNZ44 and 3107_pNZ1441-1443 by hydrofluoric acid 
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Figure 4.6: Monosaccharide composition of rhamnan peak relative to Glucosamine (GlcNH2 = 1) following SEC-HPLC purification of rhamnan 










































Figure 4.7: Monosaccharide composition of polysaccharide pellicle (PSP) peak relative to Glucosamine (GlcNH2 = 1) following SEC-HPLC 




4.3.3 CWPS analysis of L. lactis NZ9000 and its derivatives. 
The results presented above indicate that GtfA is not involved in PSP or 
rhamnan modification in L. lactis 3107 (Section 4.3.2). L. lactis subsp. cremoris 
NZ9000 harbours almost identical (99 % identity) homologues of the L3107_1441 and 
gtfA3107 genes on its genome, referred to here as LLNZ_08915 and gtfANZ9000 
(corresponding to locus tag LLNZ_08920), respectively. Thus if these genes are 
involved in the modification of CWP components, the inactivation of these genes 
should generate mutant strains deficient in the glycosylation of PSP or rhamnan. Stop 
codons were introduced into the coding sequence of LLNZ_08915 and gtfANZ9000 by 
targeted mutagenesis [32, 35] either individually or in combination, thereby generating 
NZ9000Δ8915, NZ9000ΔgtfA and NZ9000Δ8915_gtfA, respectively (Chapter III). 
Analysis of the biochemical composition and architecture of rhamnan and PSP 
structures in NZ9000 and its derivatives (data not shown) demonstrated results 
consistent with 3107 and its derivatives, thus corroborating the earlier finding for L. 




4.3.4 Analysis of LTA from L. lactis 3107 and its derivatives 
Since GtfA is not involved in modification of PSP nor rhamnan in 3107 or 
NZ9000, it may catalyse the extracellular glycosylation of LTA (or WTA if present). 
LTA analysis of L. lactis IL1403 has previously shown that the GroP chain of LTA is 
substituted with single α-Gal residues (8, 40) which can be identified after LTA 
depolymerization with HF and methylation analysis. Thus, assuming that the 
glycosylation process of LTA in strain 3107 is identical to that of L. lactis IL1403, the 
level of glycosylation can be analysed by the assessment of terminal Galactose (t-Gal) 
residues. The PSP and rhamnan components of the CWPS of L. lactis 3107 do not 
contain t-Gal, therefore, the presence of minor amounts of these polymers in TA 
preparations would not affect the analysis.   
LTA extracts from L. lactis 3107, its derived mutant E126 (which does not 
produce GtfA3107) and L. lactis IL1403 (as a positive control) were subjected to 
composition and methylation analyses. As expected, the positive control strain L. lactis 
IL1403 contained t-Gal in all preparations. In contrast, t-Gal was absent in LTA 
preparations from both 3107 and its E126 mutant (Fig. 4.8). This result indicates an 
absence of galactosylation of the retrieved LTAs of 3107. Thus, on the basis of current 
data we conclude that GtfA is not involved in LTA galactosylation in L. lactis 3107. 
Further analysis is ongoing to determine if GtfA is involved in LTA glycosylation, but 












Figure 4.8: Gas chromatography (GC) profiles corresponding to methylation analysis of LTA preparations of L. lactis IL1403 (as a control), L. 
lactis 3107 and its mutant E126 following phenol extraction. Presence of terminal-Galactose (t-Gal) shown with “t-Gal”, and absence of t-Gal 
shown with a blue arrow.   
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4.4 Discussion   
GtfA3107 has been shown to be specifically involved in phage-host interactions 
of TP901-1, 949 and WRP3 (Chapter III). Previous studies have shown that 
differences in the PSP component of the CWPS play a crucial role in determining the 
phage adsorption and host range (6). Based on these findings, a possible substrate for 
GtfA was the CWPS, represented by its constituent components rhamnan and PSP. 
Thus, the structures of rhamnan and PSP, of L. lactis strains 3107 and NZ9000, and 
various derivatives were biochemically analysed. The obtained results clearly 
demonstrate that GtfA is not involved in the modification of rhamnan or PSP in these 
L. lactis strains. This suggests that the substrate for the GtfA encoded by gtfA3107 is 
another cell wall glycopolymer, possibly LTA (or WTA if present).  
Here, GtfA is predicted to exhibit the same GT-C fold as YfhO and Lmo1079, 
which catalyse the substitution of LTA (with GlcNAc) and WTA (with Gal) in B. 
subtilis and L. monocytogenes, respectively. Thus, in L. lactis 3107, GtfA is proposed 
to transfer a sugar from undecaprenyl-phosphate to its extracytoplasmic TA substrate. 
Assuming that TP901-1, 949 and WRP3 phages attach to such a glycosylated TA 
(WTA or LTA) on the surface of L. lactis 3107, the presence of a non-functional GtfA 
protein would result in 3107 mutant strains resistant to these lactococcal phages due 
to their deficiency in TA glycosylation.   
Phage-host interaction studies have indeed demonstrated that bacterial WTA 
or LTA of B. subtilis, L. lactis and Lactobacillus delbrueckii can act as host-receptors 
for specific phages (15-19). Studies have also shown that modification of the WTA or 
LTA structures can result in phage-resistance (18, 46, 47). For example, it has been 
shown previously that the LTA composition of an L. lactis phage-resistant strain 
differed from its phage-sensitive variant by the presence of a galactosyl-containing 
component (18). Certain B. subtilis-infecting phages require glucosylated polyglycerol 
TA for adsorption, and thus B. subtilis phage-resistant mutant strains have been shown 
to be deficient in glucosylation of their TAs (46). Furthermore, a phage-resistant 
Listeria strain was shown to lack GlcNac in its TA (47). Additionally, using WTA 
biochemical and structural analysis, phage was previously shown to directly adsorb to 
galactosylated WTA in L. monocytogenes (48).  
Our analysis shows that the LTAs present in 3107 or its phage-resistant 
derivative E126 do not appear to contain a Gal substitution. Therefore, no definite 
conclusion can be drawn on the involvement of GtfA in TA glycosylation in L. lactis 
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3107 as yet. Further biochemical analysis of TA (both LTA and, if present, WTA) 
composition in L. lactis 3107 has to be performed in order to identify the GtfA 
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5 Abstract  
When phage LC3 is present as a lysogenic phage in the chromosome of 
Lactococcus lactis subsp. cremoris (L. lactis) 3107 it provides resistance against 
multiple phages belonging to the P335 lactococcal phage group. This phage resistance 
was shown to be caused by the LC3-prophage encoded superinfection exclusion (Sie) 
protein Sie2009/LC3, an identical homologue of the previously identified Sie system 
Sie2009. Furthermore, the LC3-prophage-encoded repressor protein RepLC3 was shown 
to exhibit superinfection immunity (Sii) against certain phages belonging to the P335 
group. Additionally, Sie2009/LC3 and other previously identified Sie systems, SieT712, 
Siemg2 and Sie309 were evaluated for their activity spectrum against 3107-infecting 
phages belonging to distinct lactococcal phage groups. Results demonstrated that 
Sie2009/LC3, when expressed using a high copy number plasmid and a strong 
constitutive promoter, elicit a broad activity spectrum in providing resistance against 






The quality of many fermented dairy products relies on the application of 
Lactococcus lactis starter cultures, though this may be jeopardized by their 
susceptibility to bacteriophage (phage) infection (1-4). The vast majority of isolated 
phages infecting industrially important L. lactis starter strains (5) either belong to the 
936 or c2 phage groups whose members are strictly virulent, or to the P335 phage 
group which consists of virulent or temperate phages (6, 7). Significant research 
efforts have been undertaken to define and unravel lactococcal phage-host interactions 
(8-14), as well as to identify and characterize natural phage defense mechanisms 
acquired by lactococcal strains (15-21). The expression of specific prophage-encoded 
genes has been shown to prevent secondary infection by phages in a variety of both 
Gram-positive and Gram-negative bacteria. Depending on the type of immunity that 
the lysogenized host confers, these systems can be classified into superinfection 
immunity (Sii) (22, 23), superinfection exclusion (Sie) (24-26), phage abortive 
infection (Abi) (27) and adsorption inhibition (Adi) (25, 26, 28). Abi systems use a 
variety of different mechanisms to achieve killing of the host cell in order to disrupt 
phage development following phage infection (21, 27). Adi systems alter the cell 
surface or other cell envelope components thus preventing attachment of homologous 
phages to the cell (25, 26, 28). Sie proteins interfere with the phage DNA injection 
process following phage adsorption to the cell (29). Sii systems protect the cell from 
phage infection by preventing initiation of the lytic life cycle (22, 23).  
The first characterized Sii system was the prophage λ-encoded repressor 
protein which blocks the expression of genes required for lytic development by 
binding to the PL and PR promoters which control expression of CI and Cro, 
respectively (30-32). Constitutive expression of repressor proteins therefore confers 
Sii against (typically) homologous phages (22, 23). The repressor of the Bacillus 
subtilis prophage 105 was the first such protein to be characterized in a Gram-positive 
host (22). The A2 prophage-encoded repressor was also shown to confer self-
immunity in lysogenised Lactobacillus casei and Lactobacillus paracasei strains (23). 
In addition, a repressor from the lytic P335 phage 31 was shown to confer Sii against 
a number of related, yet genetically distinct P335 phages including 31, 31.1, 31.2, 
ul36, ul37, Q30, Q33, Q36, A1, B1, CS and D1 (32).   
Examples of prophages encoding Adi systems include the D3 prophage from 
Pseudomonas aeruginosa which harbours a three gene operon encoding proteins that 
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modify the O-antigen of the cell surface lipopolysaccharide (LPS) of its host (28). This 
results in an alteration of the D3 receptor, thus preventing this phage to attach to its 
host and consequently foiling phage infection (33). Similarly, Escherichia coli 
prophages 80 and N15 encode the Cor protein which physically interacts with FhuA, 
thereby preventing infection by phages that employ FhuA as their receptor (25, 26).  
HK97, an E. coli prophage, contains gene 15 which encodes an inner 
membrane protein that blocks (secondary) HK97 DNA entry into the cytoplasm, thus 
rendering this an Sie system (34). Sie systems encoded by prophages of Gram-positive 
lactic acid bacteria (LAB) species include the well characterized system Sie2009 
encoded by the P335 group phage Tuc2009. The sie2009 gene is located between the 
repressor and integrase-encoding genes within the lysogeny module of Tuc2009. 
Sie2009 is a membrane-associated protein that allows phage adsorption to occur while 
preventing DNA injection of particular phages belonging to the lactococcal 936 group 
(17). Prophage-encoded Sie systems of lactococcal strains L. lactis subsp. cremoris 
MG1363 and L. lactis subsp. lactis IL1403 exhibit a similar spectrum of activity 
against (particular) members of the 936 group (35). Interestingly, the Streptococcus 
thermophilus prophage TP-J34 expresses a small lipoprotein, named Ltp, that provides 
phage resistance by DNA injection blocking against the 936 lytic lactococcal phage 
P008, as well as self-immunity, suggesting that the molecule targeted by these 
streptococcal and lactococcal Sie systems is identical (36). 
In the current chapter, we show that LC3 lysogens of L. lactis subsp. cremoris 
3107 exhibit resistance against lactococcal phages belonging to the P335 group. The 
lysogeny module of the temperate lactococcal P335 phage LC3 consists of an 
integrase- (int), putative Sie- (sie2009/LC3) and repressor (repLC3)-encoding gene. 
Sie2009/LC3 (homologue of Sie2009) and RepLC3 were assessed for their role in the 
observed phage-resistance of LC3 lysogens. Furthermore, anti-phage activities of 
Sie2009/LC3 and other previously identified Sie systems SieT712, Siemg2 and Sie309 were 
also assessed in L. lactis 3107 using a high-copy, high-expression vector.  
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5.2 Materials and Methods  
 
5.2.1 Bacterial strains, growth conditions, phage preparations, and plasmids  
Strains, phages and plasmids employed in this study are listed in Table 5.1. L. 
lactis strains were grown at 30 °C in M17 broth/agar (Oxoid, U.K.) supplemented with 
0.5 % (v/v) glucose (GM17) and 5 µg ml-1 chloramphenicol (Cm), where necessary. 
Lactococcal phages were propagated in GM17 broth cultured with the host strain at an 
approximate OD600nm of 0.2 and supplemented with 10 mM CaCl2. SM buffer (10 mM 
CaCl2, 100 mM NaCl, 10 mM MgSO4, 50 mM Tris-HCl at pH 7.5) was used as the 
diluent in all phage assays.   
 
5.2.2 Phage assays 
 
5.2.2.1 Phage enumeration assays 
To determine the phage sensitivity profile of L. lactis 3107 and its derivatives, 
solid and semi-solid agar was prepared using GM17 broth supplemented with 1.5 % 
(w/v) or 0.7 % (w/v) bacteriological agar, respectively. 10 mM CaCl2 and 0.5 % 
glycine (w/v) was also incorporated where necessary, and solid and semi-solid agar 
media were employed according to a previously described method (37). To perform 
spot assays, an overlay was created by seeding semi-solid agar with the relevant 
indicator/test strain and spotting 10 µl of 108 pfu/ml phage lysate on the overlay. The 
plates were incubated overnight at 30 °C. Plaque assays were performed by creating 
an overlay by seeding semi-solid agar with the corresponding indicator/test strain and 
10 µl of 108 pfu/ml phage lysate from 10-fold phage dilutions that had been prepared 
in SM buffer. The plates were incubated overnight at 30 °C. The efficiency of plaquing 
(E.O.P.) was determined as the ratio of the titre obtained from the test strain to that of 
the control strain (L. lactis 3107).  
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Table 5.1: Bacteria, phages, and plasmids used in this study. 
    Description/purpose Source 
Bacterial Strains   
 




Host to TP901-1, LC3, Dub35A, C41431, 58601, 63301, 86501, 
50101, 62604, 62601, 66901, 66902, 66903, 949 and WRP3 
(38) 




MG1363 derivative in which nisRK are inserted in the 






Cloning host (40) 
       
Bacteriophages    
 TP901-1 
Temperate P335 group phage induced from L. lactis subsp. 
cremoris 901-1 
(41) 
 LC3 Temperate P335 group phage grown lytically on L. lactis 3107 (42) 
 Dub35A P335 phage group (43) 
 63301 P335 phage group (43) 
 58601 P335 phage group (43) 
 86501 P335 phage group (43) 
 50101 P335 phage group (43) 
 C41431 P335 phage group (43) 
 62604 936 phage group (44) 
 62601 936 phage group (44) 
 66901 936 phage group (44) 
 66902 936 phage group (44) 
 66903 936 phage group (44) 
 949 949 phage group (45) 
 WRP3 949 phage group (46) 
        
Plasmids    
 pNZ44 
E. coli–L. lactis high copy number shuttle vector containing the 
constitutive P44 promoter; Cmr  
(47) 




pNZ44 vector harbouring the sie gene from L. lactis subsp. 
cremoris UC509 prophage Tuc2009 
(35) 
 pNZsieT712 
pNZ44 vector harbouring the sie gene from L. lactis subsp. 
cremoris MG1363 prophage T712 
(35) 
 pNZsiemg2 
pNZ44 vector harbouring the sie gene from L. lactis subsp. 
cremoris MG1363 prophage MG2 
(35) 
 pNZsie309 
pNZ44 vector harbouring the sie gene from L. lactis subsp. 






5.2.2.2 Reversible and irreversible adsorption assays  
Reversible and irreversible adsorption assays were performed as previously 
described (48) with the following modifications. Briefly, 10 mL GM17 broth was 
inoculated with 2 % of the appropriate strain until an approximate OD600nm of 0.5 was 
reached. The culture was supplemented with 10 mM CaCl2, following this 700 µl of 
the mixture was added to an equal volume of phage lysate (at a multiplicity of infection 
[MOI] of 0.01), and the mixture was incubated at 30 °C for 10 minutes. As a control 
700 µl GM17 broth supplemented with 10 mM CaCl2 was mixed with 700 µl of the 
phage lysate and incubated at 30 °C for 10 minutes. Following incubation, irreversible 
adsorption was determined by diluting samples 1:100 in ice-cold quarter-strength 
Ringer’s solution supplemented with 1 M NaCl. Cell-free supernatants were prepared 
by centrifugation of the samples at 6,000 × g for 1 minute and phage numbers in the 
supernatants were determined by standard plaque assays using L. lactis 3107 as the 
indicator strain. Following incubation, reversible adsorption was also determined, 
samples were centrifuged at 6,000 × g for 1 minute to pellet cells and the supernatant 
was diluted 1:100 in quarter strength Ringer’s solution supplemented with 1 M NaCl. 
Phage numbers in the supernatant were determined by standard plaque assays using L. 
lactis 3107 as the host strain. Adsorption was measured as percentage of total phages 
attached to the host when compared to control phage titre (which lacks bacterial cells) 
using the following formula: [(Control phage titre – Free phage titre in supernatant) / 
Control phage titre] x 100.  
 
5.2.3 Generation of L. lactis subsp. cremoris 3107 mutants resistant to phage LC3.  
A single colony of L. lactis 3107 was cultured overnight at 30 °C, this culture 
was stocked in 20 % (v/v) glycerol and stored at -20 °C for further DNA extraction 
(see section 5.2.4 below for details). L. lactis 3107 was subcultured in 10 mL GM17 
broth. When the culture reached an OD600nm of 0.2 it was supplemented with 10 mM 
CaCl2 and 200 µl of a 10
8 pfu/ml LC3 lysate. Every 30 minutes for two hours, 100 µl 
of the culture was spread-plated on GM17 agar plates following a series of 10-fold 
dilutions that had been prepared in GM17 broth. The plates were then incubated at 30 
°C for 48 h. 200 colonies from each time point were cultured overnight and spot assays 
were performed against phages LC3 and TP901-1. Isolates that displayed resistance 
to LC3 and sensitivity to TP901-1 were cultured overnight and stocked in 20 % (v/v) 
glycerol at -20 °C until required for further analysis. The LC3-resistant isolates were 
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verified as L. lactis 3107 derivatives using multiplex-PCR primers (Table 5.2) which 
target each of the six 3107 plasmids (described in Chapter II). Following 
amplification, agarose gel electrophoresis using a 1 % agarose gel (49) was performed 
to visualise the generated amplicons with each product corresponding to one of the six 
3107 plasmids.  
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Table 5.2: Primers used in this study; restriction sites, where included, are underlined. 




p3107_AF GGAAGGTGGCAGAGCATA  
857 




p3107_BF GGGAGTGAACCAGTAACA  
740 




p3107_CF CGTCCCAATACCAACTGT  
417 




p3107_DF GCGTATCTATGGCTGTCA  
228 




p3107_EF GCCGTGTCTTGCATTGAT  
1,012 pL3107E Chapter II 
p3107_ER GGCTTGCACCTTTACCTC 
p3107_FF CCGAAGAGCCACCGAAAG  
616 




repLC3_F AGCAGCCTGCAGAGGAGGCACTCAATGGAAATTGAACAAATC  







multiple coning site 







5.2.4 Genome sequencing, assembly and bioinformatic analysis.  
L. lactis subsp. cremoris 3107 and its LC3-resistant derivatives 3107A, 3107B, 
and 3107C were grown overnight in GM17 broth. 5 µg chromosomal DNA from L. 
lactis 3107 was extracted using phenol-chloroform based extractions as previously 
described (50). The chromosomal DNA extracted from each strain was sequenced by 
the commercial sequencing service provider Probiogenomics (University of Parma, 
Italy) using an Illumina MiSeq platform. Genomic libraries were constructed using the 
TruSeq DNA PCR-Free LT Kit (Illumina®) and 2.5 μg of genomic DNA, which was 
fragmented with a Bioruptor NGS ultrasonicator (Diagenode, USA) followed by size 
evaluation using Tape Station 2200 (Agilent Technologies). Library samples were 
loaded into a Flow Cell V3 600 cycles (Illumina®) and draft genome Illumina 
sequencing was performed on a MiSeq genomic platform (Illumina, UK) at GenProbio 
srl (Parma, Italy). Fastq files of the paired-end reads obtained from the genome 
sequencing were used as input for genome assemblies through the MEGAnnotator 
pipeline (51). The MIRA program (version 4.0.2) was used for de novo assembly of 
genome sequence data (52). Following final genome assembly, putative protein-
encoding genes were identified using the prediction software Prodigal (version 2.0) 
(53). Protein-encoding genes were automatically annotated using a BLASTP v2.2.26 
(cut-off E-value of 0.0001) sequence alignments against the non-redundant protein 
(nr) database curated by NCBI (ftp://ftp.ncbi.nih.gov/blast/db/). 
The complete genome sequence of L. lactis 3107 has previously been 
determined (54). Here, the L. lactis 3107 culture from which the phage-resistant 
derivatives were generated (as described in section 5.2.3) was sequenced to verify the 
3107 published genome sequence, thus creating an updated 3107 reference genome. 
This was performed in order to ensure the integrity of mutations identified on the 
genomes of the L. lactis 3107 derivatives. Subsequently, using the multiple genome 
alignment software Mauve v2.4.0 (55) a comparative genome analysis of L. lactis 
3107 (i.e. the reference genome) and its derivatives was undertaken in order to identify 
the genomic changes that may have caused the observed phage-resistance. Mauve 
v2.4.0 (55) was used to identify the position of the integrated LC3 prophage within 
the chromosome of L. lactis 3107. The LC3 genetic att elements (attachment sites) 
had previously been identified as 5’-TTCTTCATG’-3 (56). Consequently, using 
Artemis v16 (57) the presence of this common region within the 3107 chromosome 




5.2.5 Construction of pNZrepLC3  
Primers (Table 5.2) were generated to amplify the gene LC3p03 from LC3, 
here renamed repLC3 (861 bp). Primers repLC3_F and repLC3_R, were designed to 
contain the PstI and XbaI recognition sequence, respectively. The generated amplicon 
and the high copy, high expression, Cmr plasmid pNZ44 (3,396 bp) were restricted 
with PstI and XbaI. Restriction enzyme digestions, DNA ligation and agarose gel 
electrophoresis using a 1 % agarose gel were performed following standard procedures 
(49). The ligated construct was introduced into electrocompetent E. coli EC101 cells 
prepared using a previously described protocol (40). E. coli EC101 transformants 
expected to harbour the recombinant vector were selected using LB agar plates (40) 
supplemented with 5 µg ml-1 Cm. Transformants containing the desired recombinant 
plasmid, designated pNZrepLC3 were identified by PCR using primers pNZ44_F and 
_R (Table 5.2). The sequence integrity of the generated construct was determined by 
Sanger sequencing of the inserted sequence (performed by MWG Eurofins Genomics, 
Ebersberg, Germany) and subsequent analysis using the Seqman Pro program 
(DNAstar v7.0) (58). The verified recombinant plasmid was isolated using a Pure Link 
DNA Purification (Thermofisher Scientific) kit and introduced into competent cells of 
L. lactis 3107 which were prepared and transformed as described in Chapter II. To 
confirm the presence of the desired construct, PCR using insert-specific primers (Table 
5.2) were performed on the resulting Cmr isolates.   
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5.3 Results  
 
5.3.1 Isolation of L. lactis 3107 mutants resistant to phage LC3 
The dairy starter strain L. lactis 3107 is sensitive to the temperate lactoccocal 
phage LC3. In an attempt to obtain LC3-resistant derivatives of 3107, L. lactis 3107 
was exposed to LC3. Following LC3 exposure, surviving cells were plated and, using 
spot assays, eight hundred colonies were then tested for LC3 resistance. Three such 
isolates, designated here as 3107A, 3107B and 3107C, were shown to possess the 
desired LC3 phage-resistance phenotype, while they had remained sensitive to 
infection by the P335 phage TP901-1. As described in Chapter II, L. lactis 3107 
harbours six plasmids and their associated sequences were used to develop a multiplex 
PCR system to amplify specific regions of each plasmid. Thus, using this multiplex 
PCR system on strains 3107A, 3107B and 3107C, these isolates were confirmed to be 
3107 derivatives as their plasmid profiles were shown to be identical to that of L. lactis 








Figure 5.1: Agarose gel image of amplicons generated following multiplex-PCR 
targeting L. lactis 3107 plasmids. Lane A represents a DNA Ladder (relevant sizes are 
indicated; Fisher BioReagents, Ireland); Lanes B, C, D and E show amplicons from L. 
lactis strains 3107, 3107A, 3107B and 3107C, respectively, representing each of the 
six L. lactis 3107 plasmids: p3107E (amplicon size 1,012 bp), p3107A (amplicon size 
857 bp), p3107B (amplicon size 740 bp), p3107F (amplicon size 616 bp), p3107C 





















5.3.2 Genome sequencing and bioinformatic analysis of L. lactis 3107 derivatives 
3107A, 3107B and 3107C  
As outlined above, screening of L. lactis 3107 survivors following exposure of 
this strain to phage LC3 resulted in the isolation of three LC3-resistant 3107 
derivatives. The genomes of L. lactis 3107A, 3107B and 3107C were sequenced in 
order to identify which genomic changes were responsible for the observed phage-
resistance phenotype. Previous genome analysis of L. lactis 3107 revealed a genome 
length of 2,378,982 bp and a G+C content of 36 %, in addition to six plasmids ranging 
in size from 2,232 to 60,216 bp (54). Genome analysis of the three sequenced 3107 
derivatives revealed different characteristics to that of the parent strain while carrying 
an identical plasmid complement. The genomes of the three 3107 derivatives are 
2,411,154 ± 1,080 bp in length indicating a genomic insertion. Comparative genome 
analysis using the multiple genome alignment software Mauve v2.4.0 (55) was 
undertaken to further assess the genomic insertion present in the genomes of 3107A, 
3107B and 3107C. This comparative genomic analysis identified the 32,172 ± 1,080 
bp insertion to be present at positions 1,295,942-1,295,950 on the 
3107A/3107B/3107C chromosome, representing the complete LC3 prophage genome 
(42). Previously the attachment site for integration of LC3 into the chromosome of L. 
lactis subsp. cremoris IMN-C1819 was identified as 5’-TTCTTCATG’-3 (56). Here, 
following the identification of the LC3 position in the 3107 chromosome, the same 9-
bp common core region or attachment site (attP or attB: 5’-TTCTTCATG-3’) was 
identified in the LC3 and 3107 genomes. This common core region is therefore 
assumed to have facilitated insertion of the LC3 genome into the 3107 chromosome. 
The attB sequence is located within L3107_1090 which is predicted to encode a redox-
sensing transcriptional repressor Rex (56). Furthermore, the LC3 integrase-encoding 
gene, which specifies the LC3 site-specific recombinase, is located adjacent to attP. 
Based on these findings we conclude that the observed LC3-resistance phenotype in 
L. lactis strains 3107A, 3107B and 3107C is due to the presence of an integrated LC3 
genome and that these three strains therefore represent L. lactis 3107 lysogens.  
  
5.3.3 Assessment of the phage-resistance spectrum of the L. lactis 3107 lysogens 
In order to assess the phage-resistance profile of L. lactis 3107A, 3107B and 
3107C, quantitative plaque assays were performed using a selection of lactoccocal 
phages that infect 3107 (Table 5.3). The E.O.P. of the lactococcal phages belonging to 
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the P335 (LC3, TP901-1, Dub35A, C41431, 50101, 58601, 63301 and 86501), 936 
(62604, 62601, 66901, 66902 and 66903), and the 949 groups (949 and WRP3) were 
tested on 3107 (as a control) and the lysogenised derivatives (Table 5.3). As before, 
LC3 was unable to form visible plaques on the lysogens. Interestingly, complete phage 
resistance was also observed for the P335 group phages 50101, 58601 and 86501. 
Furthermore, phages Dub35A, C41431 and 63301 were shown to infect the LC3 
lysogens of 3107, although a low, yet consistent level of phage resistance was 
observed as the E.O.P. of these phages exhibited a statistically significant reduction 
(p-values < 0.05) and an obvious visual reduction in plaque size in comparison to the 
3107 strain (Table 5.3). These results indicate that the infection pathway of these 
lactococcal phages is negatively affected by LC3 prophage-encoded phage-resistance 
mechanism(s). Whether this is due to an Sie or Sii mechanism will be further 
investigated below (section 5.4). No obvious changes in E.O.P. were observed for the 
assessed 936 group phages, P335 group phage TP901-1, nor for 949 group phages 949 
and WRP3, though a reduction in plaque size was observed for these lactococcal 




Table 5.3: Testing P335, 936 and 949 phages on L. lactis 3107 and its derivatives; the 
E.O.P. of phage applied is shown. 















0.07 ± 0.02  
(0.5 mm) 
0.08 ± 0.06  
(0.5 mm) 









0.05 ± 0.19 
(0.5 mm) 
0.09 ± 0.12  
(0.5 mm) 





0.83 ± 0.47  
 (0.8 mm) 
0.84 ± 0.49  
 (0.8 mm) 





0.06 ± 0.08  
(0.5 mm) 
0.09 ± 0.06  
(0.5 mm) 










0.86 ± 0.03  
(2.5 mm) 
0.85 ± 0.10  
(2.5 mm) 





0.86 ± 0.07  
(1.0 mm) 
0.82 ± 0.02  
(1.0 mm) 





0.80 ± 0.16  
(2.0 mm) 
0.89 ± 0.10  
(2.0 mm) 





0.85 ± 0.10  
(3.0 mm) 
0.84 ± 0.10  
(3.0 mm) 





0.89 ± 0.41  
(3.0 mm) 
0.86 ± 0.60  
(3.0 mm) 






0.76 ± 0.19    
(0.5 mm) 
0.71 ± 0.02  
(0.5 mm) 





0.81 ± 0.08  
(1.0 mm) 
0.81 ± 0.22  
(1.0 mm) 
0.85 ± 0.16  
(1.0 mm) 




5.3.4 Contribution of the LC3 prophage-contained genes sie2009/LC3 and repLC3, to 
phage resistance.  
The LC3p02 gene, here renamed sie2009/LC3 for clarity purpose, is 100 % 
identical in sequence to sie2009, being 522 bp in length, specifying a polypeptide of 173 
amino acids, and predicted to encode a protein harboring a single amino-terminal 
transmembrane domain (17). Furthermore, similar to sie2009, sie2009/LC3 is located 
between the genes encoding the integrase and repressor on the lysogeny module of 
LC3. Sie2009 has previously been shown to confer resistance against particular 
members of the 936 phage group and given the identical sequence of Sie2009 to 
Sie2009/LC3, it was expected that Sie2009 exerts the same activity spectrum as Sie2009/LC3. 
Additionally, upstream of sieLC3, is a repressor-encoding gene repLC3 specifying a 
polypeptide of 286 amino acids. Repressor proteins have previously been shown to 
confer resistance against homologous phages by superinfection immunity (22, 23).  
To determine if expression of sie2009/LC3 (sequence 100 % identical to sie2009) 
or repLC3 is responsible for the phage resistance phenotype observed in the three L. 
lactis 3107-derived LC3 lysogens, the previously constructed plasmid pNZsie2009 (35) 
and newly constructed pNZrepLC3 were introduced into 3107. pNZsie2009 and 
pNZrepLC3 are expected to overexpress Sie2009/LC3 and RepLC3, respectively, due to the 
high copy number and strong, constitutive P44 promoter of pNZ44 (47). Subsequently, 
the E.O.P. values of P335 (TP901-1, Dub35A, C41431, 50101, 58601, 63301 and 
86501), 936 (62604, 62601, 66901, 66902 and 66903) and 949 group phages (949 and 
WRP3) were determined for the Sie- and repressor-expressing strains and compared 
to the E.O.P. of these phages on the 3107 strain (Table 5.4). These phages were also 
tested against L. lactis 3107A harbouring the empty pNZ44 plasmid as a control (Table 
5.4). 
Expression of repLC3 in L. lactis 3107 confers resistance against certain P335 
group phages as complete resistance against LC3, 50101, 58601, and 86501 was 
observed (Table 5.4). As expected, RepLC3 elicited no protective effect against tested 
936 or 949 group phages (Table 5.4). The expression of Sie2009/LC3 exerts complete 
phage resistance against all of the 3107-infecting phages tested, except for TP901-1 
although with a reduced E.O.P. exhibiting a small (10-fold) but statistically significant 
reduction (p-values < 0.05) in comparison to 3107 harbouring the empty pNZ44 vector 
(Table 5.4). Thus the low level of phage resistance observed for 3107A when exposed 
to P335 phages Dub35A, C41431 and 63301 is likely due to activity of Sie2009/LC3 
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(Table 5.4), which is likely expressed at a much lower level in the lysogen as compared 
to when the sie2009/LC3 gene is placed under control of the p44 promoter in the 
multicopy plamid pNZ44. When 936 phages 62604, 62601, 66901, 66902 and 66903, 
and 949 phages 949 and WRP3 were used to infect 3107A using a plaque assay, a 
reduction in plaque size was noticed (except for WRP3), yet no phage resistance was 
observed. However, (over)expression of sie2009/LC3 when present on plasmid 
pNZsie2009 in 3107 confers complete resistance against all these lactococcal phages 
(Table 5.4). More than likely the higher level of expression of Sie2009/LC3 from the 
pNZ44 plasmid in comparison to that in 3107A is responsible for the increased level 
of phage-resistance activity (Table 5.4).   
 
5.3.5 Phage-resistance exerted by SieT712, Siemg2 and Sie309 against representatives 
of the P335, 936 and 949 lactococcal phage groups.   
Like Sie2009, previously identified lactococcal prophage-encoded Sie systems 
including SieT712, Siemg2 and Sie309 have demonstrated activity against certain 936 
group phages capable of infecting L. lactis subsp. cremoris NZ9000 (35). To 
determine if the (over)expression of these Sie proteins exert phage resistance against 
3107-infecting phages, plasmids pNZsieT712, pNZsiemg2 and pNZsie309, which 
(over)express SieT712, Siemg2 and Sie309, respectively, were introduced into L. lactis 
3107. Subsequently, the E.O.P. of P335 (TP901-1, Dub35A, C41431, 50101, 58601, 
63301 and 86501), 936 (62604, 62601, 66901, 66902 and 66903) and 949 group 
phages (949 and WRP3) was determined for these strains (Table 5.4), as well as for L. 
lactis 3107 harbouring the empty pNZ44 plasmid as a control.     
Siemg2 is active against the 936 phages 66903, 66901 and 66902. Siemg2 confers 
complete resistance against phage 66903, while eliciting a remarkably low level of 
resistance (11-12-fold) against the 936 group phages 66901 and 66902 in comparison 
to 3107 harbouring the empty pNZ44 vector (Table 5.4). This differs from SieT712 and 
Sie309 which have no impact on the infectivity of any of the 3107-infecting phages 
tested (Table 5.4). 
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Table 5.4: Testing P335, 936, and 949 phages on L. lactis 3107 and its derivatives; the E.O.P. of phage applied is shown. 
 
L. lactis subsp. 
cremoris 







0.87 ± 0.05 
(1.5 mm) 
≤10-8 ≤10-8 ≤10-8 
0.96 ± 0.55 
(1.5 mm) 
1.38 ± 0.48 
(1.5 mm) 





0.87 ± 0.05 
(1.5 mm) 
≤10-8 ≤10-8 ≤10-8 
0.96 ± 0.55 
(1.5 mm) 
1.38 ± 0.48 
(1.5 mm) 





0.83 ± 0.04     
(1.5 mm)                
0.04 ± 0.05 
(0.5 mm) 
1.87 ± 0.58 
(1.5 mm) 
≤10-8 
1.16 ± 0.18 
(1.5 mm) 
1.08 ± 0.93 
(1.5 mm) 





0.87 ± 0.02 
(1 mm) 
≤10-8 ≤10-8 ≤10-8 
1.14 ± 0.58 
(1 mm) 
1.37 ± 0.63 
(1 mm) 





0.95 ± 0.06 
(1.5 mm) 
0.06 ± 0.13 
(0.5 mm) 
0.99 ± 0.58 
(1.5 mm) 
≤10-8 
1.26 ± 0.21 
(1.5 mm) 
0.99 ± 0.90 
(1.5 mm) 





0.80 ± 0.02 
(1 mm) 
0.74 ± 0.06 
(0.8 mm) 
1.02 ± 0.53 
(1 mm) 
0.02 ± 0.01 
(0.8 mm) 
0.43 ± 0.26 
(1 mm) 
0.39 ± 0.11 
(1 mm) 





0.84 ± 0.02 
(1.5 mm) 
0.03 ± 0.01 
(0.5 mm) 
1.07 ± 0.65 
(1.5 mm) 
≤10-8 
1.87 ± 0.17 
(1.5 mm) 
1.18 ± 0.45 
(1.5 mm) 





0.93 ± 0.01 
(1.5 mm) 
≤10-8 ≤10-8 ≤10-8 
1.07 ± 0.7 
(1.5 mm) 
1.68 ± 0.94 
(1.5 mm) 






0.81 ± 0.03 
(4 mm) 
0.82 ± 0.10 
(2.5 mm) 
1.52 ± 1.22 
(4 mm) 
≤10-8 
1.13 ± 0.61 
(4 mm) 
1.77 ± 0.43 
(4 mm) 





0.87 ± 0.01 
(2 mm) 
1.00 ± 0.30         
(1 mm) 
1.95 ± 0.95 
(2 mm) 
≤10-8 
1.08 ± 0.05 
(2 mm) 
1.89 ± 0.93 
(2 mm) 





0.70 ± 0.02 
(3 mm) 
0.87 ± 0.06 
(2 mm) 
1.20 ± 0.41 
(3 mm) 
≤10-8 
1.82 ± 0.25 
(3 mm) 
3.40 x 10-4 ±  
1.76 x 10-4 
(1 mm) 





0.92 ± 0.06 
(4 mm) 
0.84 ± 0.34 
(3 mm) 
1.22 ± 0.21 
(4 mm) 
≤10-8 
1.65 ± 0.91 
(4 mm) 
3.76 x 10-5 ±  
2.90 x 10-5 
(1.5 mm) 





0.93 ± 0.04 
(4 mm) 
0.84 ± 0.17 
(3 mm) 
1.16 ± 1.59 
(4 mm) 
≤10-8 
1.93 ± 0.91 
(4 mm) 
≤10-8 






0.86 ± 0.04 
(1 mm) 
0.84 ± 0.44 
(0.5 mm) 
1.68 ± 0.28 
(1 mm) 
≤10-8 
1.35 ± 0.20 
(1 mm) 
1.82 ± 1.02 
(1 mm) 





0.81 ± 0.10 
(1 mm) 
0.77 ± 0.64 
(1 mm) 
1.92 ± 0.96 
(1 mm) 
≤10-8 
1.25 ± 0.51 
(1 mm) 
1.31 ± 0.08 
(1 mm) 
1.31 ± 0.18 
(1 mm) 
ND: not determined  
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5.3.6 Effect of LC3 prophage-encoded SieLC3 and RepLC3 on phage adsorption  
LC3-prophage expressed genes (such as sie2009/LC3 and repLC3) may interfere 
with the first stages of infection, such as adsorption of the phage to the host, or the 
DNA injection process of the phage. In order to determine if lysogenized LC3 
interferes with adsorption or a subsequent phage infection step, reversible and 
irreversible adsorption assays were perfomed on L. lactis 3107, its derivative 3107A, 
and L. lactis NZ9000 as a negative control (Table 5.5). Adsorption assays were 
performed using the 3107-infecting lactoccocal phages which are not able to infect the 
3107-derived LC3-carrying lysogens (Table 5.3). These phages included the P335 
group phages LC3, 50101, 58601 and 86501. The results show that all of these 
lactococcal phages adsorb reversibly and irreversibly to L. lactis 3107 and its LC3 
lysogenised derivative 3107A with a high efficiency. Therefore, as expected, the 
presence of the LC3 prophage does not appear to have a significant impact on the 




Table 5.5: Adsorption (%) of P335 group phages to L. lactis 3107 and its derivatives.  
 
  L. lactis subsp. cremoris  Adsorption (%) 3107 3107A NZ9000 
Adsorption of P335 
phages                                                   
LC3 
R 99.30 ± 0.45 97.69 ± 1.92 19.12 ± 1.40 
I 97.42 ± 0.92 96.82 ± 1.31 14.18 ± 1.92 
50101 
R 85.00 ± 1.13 84.58 ± 1.40 15.48 ± 1.85 
I 84.39 ± 1.72 83.87 ± 1.29 10.75 ± 1.62 
58601 
R 84.17 ± 1.40 83.98 ± 1.29 12.48 ± 1.33  
I 83.24 ± 1.33 82.87 ± 1.19 8.75 ± 1.40 
86501 
R 86.42 ± 1.19 85.98 ± 1.90 16.48 ± 1.72 
I 85.17 ± 1.92 84.87 ± 1.8 9.82 ± 1.18 
R = reversible, I = irreversible
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5.4 Discussion  
The temperate phage LC3 originates from the dairy-associated L. lactis subsp. 
cremoris strain IMN-C1819 (42) and utilizes the common core region 5’-
TTCTTCATG’-3 for site-specific integration into the chromosome of its host (56). In 
this chapter the isolation of three LC3 lysogens of L. lactis 3107 is described. These 
lysogens do not only provide resistance against LC3 itself, but are also resistant to 
other 3107-infecting phages belonging to the P335 lactococcal phage group. Available 
whole genome sequences of temperate phages and strains carrying prophages have 
permitted the identification of Sie- and repressor-encoding genes that confer phage-
resistance (17, 22, 23, 35). LC3 encodes the Sie protein Sie2009/LC3 which was 
previously shown to be an identical homologue of Sie2009 (35). In addition, LC3 
harbours repLC3 directly upstream of sie2009/LC3 in its lysogeny module. Here, Sie2009/LC3 
and RepLC3 were shown to be responsible for the phage-resistance phenotype observed 
in L. lactis 3107 lysogens of LC3. Sie proteins have been shown to interfere with phage 
DNA injection (35), whereas repressor proteins maintain lysogeny and prevent lytic 
proliferation of certain superinfecting phages (59). Thus, as expected, adsorption 
assays (Table 5.5) demonstrated that Sie2009/LC3 and RepLC3 proteins interfere with a 
step in the phage cycle that is beyond host adsorption (17, 22, 23).  
Sie2009/LC3 was shown to confer complete phage resistance activity against all 
tested phages belonging to the P335 group (LC3, Dub35A, C41431, 50101, 58601, 
63301 and 86501), except for TP901-1. The genetically diverse P335 lactococcal 
group phages have been classified into nine subgroups (IA/B/C, IIA/B, IIIA/B, IV and 
V) based on their distinct morphological features and genetic lineages of their tail tip 
region which is presumed to be involved in interactions with the bacterial host (10, 
60). TP901-1 belongs to the P335 subgroup IIA; LC3, Dub35A, 50101, 63301 and 
86501 belong to subgroup IIIA, C41431 belongs to subgroup I (60), while the genome 
of 58601 has not been sequenced to date. Sie2009/LC3 appears to be quite effective 
against P335 subgroup IIIA and I phages, while it did not provide significant levels of 
resistance against subgroup IIA phages indicating that there may be related DNA 
injection/infection pathways between subgroup I and III phages that is distinct to those 
of subgroup II phages, which would be consistent with previous studies (48). The level 
of phage-resistance has previously been shown to be dependent on the level of 
expression of Sie proteins (35). This is consistent with the finding that LC3 lysogens 
of 3107, which carry a single genomic copy of sie2009/LC3, exhibit a low level of 
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resistance against the P335 phages Dub35A, C41431 and 63301. In contrast, plasmid-
driven expression of Sie2009/LC3 in L. lactis 3107 (with sie2009/LC3 located on a multi-
copy plasmid and transcribed by the strong constitutive p44 promoter) was shown to 
elicit complete phage resistance against these lactococcal phages.  
In addition, Sie2009/LC3 was also shown to provide complete phage resistance 
activity against all tested 936 (62601, 62604, 66901, 66902 and 66903) and 949 group 
phages (949 and WRP3). This data is comparable with previously reported anti-phage 
activity of Sie2009 against specific phage members of the 936 group (35). Interestingly, 
LC3 lysogens of 3107 do not elicit resistance against any of the 936 or 949 lactococcal 
phages tested. This may be consistent with the observation that the level of expression 
of Sie proteins is positively correlated to the level of phage-resistance activity (35). 
Like Sie2009, other lactococcal prophage-encoded Sie systems such as SieT712, 
Siemg2 and Sie309 have previously been shown to exert activity against a particular 
subset of the 936 phage group (35). Interestingly, in the current study SieT712 and Sie309 
did not mediate a phage-resistance phenotype against any of the 3107-infecting 
phages, whereas Siemg2 was shown to exert phage resistance against 936 group phages 
66901, 66902 and 66903. These results demonstrate that the Sie proteins SieT712, Sie309 
and Siemg2 are active against specific members of the 936 phage group as previously 
observed (17, 35).  
Here, the LC3 repressor protein RepLC3 was also tested to assess its phage 
resistance activity against 3107-infecting lactococcal phages. RepLC3 prevented 
superinfection of phages LC3, 50101, and 86501 which belong to the P335 subgroup 
IIIA, as well as the P335 phage 58601 (unknown subgroup). Lactococcal phages 
50101 and 86501 harbour a repressor gene which is 99 % identical to that of repLC3, 
thereby explaining the observed immunity. The repLC3 gene is presumed to be 
constitutively expressed to maintain the lysogenic state of the temperate LC3 phage 
genome in 3107. The RepLC3 protein is presumed to provide superinfection immunity 
against LC3 itself and specific members of the P335 lactococcal group which encode 
a near identical Rep repressor. The phages that were unaffected by RepLC3 and for 
which the genome sequence is available (TP901-1, Dub35A, C41431, 63301 and 
WRP3) do indeed not harbour a close homologue of repLC3, thereby explaining the 
lack of immunity. 
In conclusion, the activity of a lactococcal prophage-encoded Sie and repressor 
from the same prophage was assessed against 15 lactococcal phages belonging to 
223 
 
either the P335, 936 or 949 group. The data in this current study suggests that the 
phage-resistance phenotype of the LC3 lysogens of 3107 against phage members of 
the P335 groups is largely due to superinfection exclusion (mediated by Sie2009/LC3) 
rather than superinfection immunity (mediated by RepLC3). The current study has 
provided further insights into the importance and activity of Sie systems and repressor 
genes as potential phage-control mechanisms in the dairy fermentation industry. 
Starter cultures that harbour prophages expressing sie and/or repressor-encoding genes 
may therefore be protected against superinfecting phages, though they may at the same 
time be under threat by such prophages in case they become induced. Using genetic 
engineering, starter cultures harbouring desired sie or repressor-encoding systems 
could be constructed, thus providing phage resistance and consequently preventing 
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Dairy fermentation facilities are under constant threat by phage infections. It 
is now widely accepted that phage proliferation in fermentation processes will 
continue to be a problem as phages cannot be completely eliminated, though their 
multiplication and dispersal may be controlled. In order to better comprehend how a 
lactococcal phage recognizes and infects its host, it is imperative that functional 
genomic studies and structural characterisation of both the phage and host components 
involved in these interactions is undertaken (1-9).  
The overall aim of the work described in this thesis was to identify bacterial 
and phage-encoded protein(s) required for, or interfering with, the infection process of 
the dairy starter strain Lactococcus lactis subsp. cremoris (L. lactis) 3107 by 
lactococcal phages TP901-1 and LC3, both of which belong to the so-called P335 
group of lactococcal phages. Previously, the injection processes of TP901-1 and LC3 
have been suggested to be distinct (10). The interaction of phage TP901-1 with its 
host, L. lactis 3107, commences with the adsorption of the phage to the polysaccharide 
pellicle (PSP) component of the cell wall polysaccharide (CWPS) of its host (2). The 
ability to genetically manipulate a strain as well as the availability of its sequenced 
genome are key elements to facilitate studies of the interactions between a phage and 
its host at a molecular level. L. lactis 3107 displays a low efficiency of transformation 
using currently available methods (11, 12). Therefore, the lack of refined protocols for 
the efficient transfer of DNA into this dairy-associated strain has limited its genetic 
manipulation. This thesis describes an optimised transformation protocol for L. lactis 
3107, thereby improving its genetic manipulation, while we furthermore determined 
its genome sequence to facilitate further exploration of the molecular interactions 
between phages TP901-1 and LC3 with their host L. lactis 3107.  
Following attachment of phage TP901-1 to the host-specified saccharidic 
receptor, DNA injection of this phage is triggered by the product of gtfA or, more likely 
based on our current data, its glycosylated substrate. Currently, the identity of the 
substrate for the predicted membrane-associated glycosyltransferase GtfA is not 
known, nor is it clear how GtfA is involved in triggering DNA injection of TP901-1. 
Previous phage-host interaction studies involving Gram-positive infecting phages 
have demonstrated that phages may recognize various host-encoded receptor 
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molecule(s), such as a CWPS, teichoic acid (TA) and/or a surface-exposed protein (13, 
14). GtfA may therefore act as an injection trigger by itself or indirectly through the 
saccharidic product of its predicted transferase activity. Based on the predicted 
function of GtfA, this thesis proposes that the DNA injection trigger of TP901-1 is the 
(as yet unknown) cell envelope-associated substrate for GtfA. Following confirmation 
that neither the PSP nor rhamnan is the substrate for GtfA, possible GtfA substrates 
include LTA, WTA, peptidoglycan or a glycoprotein. The analysis of TAs as possible 
substrates for GtfA performed as part of this thesis was compromised by the lack of 
knowledge regarding the glycosylation process (if any) of LTAs of L. lactis 3107 and 
our ignorance regarding (the existence of) WTA in L. lactis strains. Analysis of the 
composition of lactococcal cell wall components is therefore necessary for the 
identification of components acting as DNA injection triggers required by their 
infecting phages. Analysis of the biosynthetic pathway of each component of the L. 
lactis 3107 cell envelope can determine if GtfA is involved in the glycosylation 
process of one of these components. If the substrate for GtfA does not represent the 
DNA injection trigger for TP901-1, it may be that (presumed) membrane-associated 
GtfA acts directly as a proteinaceous injection trigger. For example, following initial 
attachment, the model Bacillus subtilis siphophage SPP1 irreversibly binds to the 
ectodomain of the membrane-associated YueB protein, thereby triggering DNA 
injection (13). Similar to YueB, GtfA exhibits an ectodomain which may represent the 
actual injection trigger for TP901-1. In order to test this notion, expression and 
isolation of the ectodomain of GtfA will need to be pursued, followed by an assessment 
of the ability of such a protein to falsely trigger DNA injection of TP901-1 phages.  
Three TP901-1 resistant derivatives of L. lactis 3107, known as E119, E121 
and E126, were isolated of which two (E119 and E126) were complemented by gtfA, 
demonstrating the involvement of GtfA in DNA injection of TP901-1. GtfA is 
hypothesized to be part of an extracellular glycosylation pathway (as shown in Fig. 1, 
which was previously discussed in Chapter IV) which typically involves (i) an enzyme 
required to produce an UDP-sugar intermediate (possibly the gene upstream of gtfA, 
which possesses such a predicted function), (ii) an enzyme that transfers the sugar 
from its UDP-linked form to membrane-associated undecaprenyl, (iii) a flippase 
enzyme that re-orients this undecaprenyl-sugar from a cytoplasmic- to an 
extracellular-facing membrane location, and (iv) an enzyme, in this case GtfA, which 
transfers the sugar from the undecaprenyl-carrier to its presumed cell wall-associated 
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substrate. If the TP901-1 DNA injection trigger is the GtfA substrate, it follows that 
mutations in the genes for the enzymes that are responsible for steps (i) through to (iv) 
will cause insensitivity to TP901-1. Since two of the mutants (i.e. E191 and E126) 
were defective in step (iv) we hypothesize that the third mutant (E121) carries a 
mutation in a gene responsible for step (i), (ii) or (iii). Candidates for such genes (for 
steps i-iii) have been identified and future work will focus on determining their 
involvement in TP901-1 DNA injection (for example by cloning/expressing such 
candidates into the E121 mutant). The generation of TP901-1 escape mutants, being 
capable of infecting all three phage-resistant 3107 derivatives of which two harbour a 
defective gtfA gene and one harbours a functional gtfA gene, further suggests that a 
component of the biosynthetic pathway involved in the production of the DNA 
injection trigger for TP901-1 other than GtfA is mutated in E121. Future studies could 
focus on optimising the recombineering system for application in L. lactis 3107 to 
allow targeted mutagenesis in this strain (15-17). Improving the genetic manipulation 
of L. lactis 3107 is an important element in identifying genes, in addition to gtfA, as a 
genetic component of L. lactis 3107 responsible for triggering DNA injection of phage 
TP901-1.  
This thesis also showed that subsequent adaptation of phage TP901-1 to phage-
resistant host cells is achieved through acquisition of particular mutations in the tal 
gene. Currently it is not clear how these tal mutations in TP901-1 allow the 
corresponding mutant phages to overcome the barriers presented by GtfA-negative L. 
lactis 3107 derivatives. Perhaps the modified Tal is capable of recognizing or attaching 
to a modified injection trigger, thereby opening the DNA ejection conduit through 
conformational changes in the tail tube allowing DNA release. Future studies could 
focus on introducing targeted mutations to the sequence of tal in order to determine 
the exact nucleotide alteration(s) that is (are) responsible for the TP901-1 DNA 
injection trigger. Generation of TP901-1 escape mutants reinforces the fact that 
lactococcal phages can adapt to phage-resistant dairy host strains.  
This thesis revealed that gtfA is ubiquitous among Lactococcus lactis genomes 
and that it is specifically involved in TP901-1 DNA injection as well as that of other 
lactococcal phages such as certain members of the rare 949 phages, i.e. phages 949 
and WRP3. This study was limited by the number of available lactoccocal P335 group 
phages capable of infecting L. lactis NZ9000, thus making it impossible to assess the 
impact of a non-functional gtfA in this genetically accessible strain. It has previously 
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been demonstrated that following reversible adsorption, a number of c2-like 
lactococcal phages irreversibly bind to PIP (phage infection protein), triggering 
ejection of the phage genome (18). Further screening studies of lactococcal phages 
capable of infecting L. lactis NZ9000 are necessary to facilitate studying the role of 
gtfA in phage DNA injection.  
Significant research efforts have been undertaken to identify and characterize 
natural phage defense mechanisms acquired by lactococcal strains in order to identify 
potential phage-control mechanisms in the dairy sector (19-25). This thesis also aimed 
to generate LC3-resistant derivatives of L. lactis 3107 and to identify gene(s) involved 
in the acquired phage resistance. Following the exposure of LC3 to L. lactis 3107 we 
obtained lysogens of LC3 which exhibit resistance to a number of P335 phages. The 
LC3-prophage-encoded superinfection exclusion (Sie) protein Sie2009/LC3 and 
repressor protein RepLC3 were shown to be responsible for such LC3 lysogens to 
confer resistance to various P335 phages. In addition, the plasmid-driven expression 
of Sie2009/LC3 did not only result in complete resistance against phages belonging to the 
P335 group, but also against phage members of the lactococcal 936 or 949 groups. 
This thesis further demonstrates the importance of lactococcal Sie and/or repressor 
proteins as mechanisms that could be introduced in the dairy fermentation industry to 
help control phage contamination. It would be interesting to determine if escape 
mutants can be generated which are capable of overcoming Sie or superinfection 
immunity in order to assess the robustness of such phage resistance systems. The TP-
J34 prophage in Streptococcus thermophilus has previously been shown to encode the 
lipoprotein LtpTP-J34, which prevents (secondary) infection by 936 group phages. This 
streptococcal Sie system is predicted to directly interact with and block entry of the 
tape measure protein (TMP) into the bacterial membrane from the phage tail tube, thus 
inhibiting DNA injection (26). Escape mutant phages overcoming LtpTP-J34 exhibit 
mutations within the tmp gene which resulted in the assembly of shorter tails (27). The 
TMP is important for tail assembly, ion-channel formation, and DNA passage into the 
cell, thus, like TP-J34, TP901-1 may need to mutate its TMP to overcome the 
Sie2009/LC3 system. Starter cultures could be genetically engineered to construct strains 
harbouring desired sie or repressor-encoding systems, thus preventing phage 
contamination and consequently avoiding the negative implications of phage infection 
of dairy starter cultures. However, such genetically engineered strains will as yet not 
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find their way to the food fermentation industry due to restrictive regulations with 
regards to the use of genetically modified organisms (GMOs) in food products. 
In conclusion, this thesis analysed how the lactococcal P335 phage TP901-1 
interacts with its L. lactis 3107 host at a molecular level, and has introduced new 
possibilities for future studies focused on such phage-host interactions. The 
importance of identifying host-encoded genes involved in phage-host interactions is 
abundantly clear as genetic manipulation of such genes can help reduce phage 
contamination in the dairy fermented sector. In addition, the importance of prophage-
associated sie and rep genes as phage-defence mechanisms for phage contamination 
has been highlighted. 
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Figure 1: Model for TA (LTA or WTA) glycosylation in L. lactis. The LTA or WTA glycosylation process in L. lactis initially requires an, as yet, unidentified 
cytoplasmic GTF (blue) which transfers a sugar residue (red) onto an undecaprenyl-phosphate which acts as a lipid carrier (Step 1). The sugar-lipid intermediate 
is then transported across the membrane by an unknown flippase enzyme (Step 2). The sugar residue is then transferred by a second extracellular GTF proposed 
to be GtfA (pink) onto the GroP chain (green) of the LTA which is anchored in the cytoplasmic membrane by means of a lipid attachment (brown) or WTA 
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Abi - Abortive infection 
Adi - Adsorption inhibition 
Ala - Alanine 
BIM - Bacteriophage insensitive mutant 
BLAST - Basic local alignment search tool 
BP - Baseplate  
CFSN - Cell free supernatant  
CFU – Colony forming unit 
Cm - Chloramphenicol 
COG - Clusters of orthologous groups 
CWPS - Cell wall polysaccharides 
DHB - 2,5-dihydroxy-benzoic acid  
ds-DNA - Double-stranded DNA 
E.O.P. - Efficiency of plaquing 
Em - Erythromycin 
EPS - Extracellular polysaccharides 
Gal - Galactose  
Gal-t - Galactose-1-phosphate-uridylyltransferase 
GC - Gas chromatography  
GC-MS - Gas chromatography-mass spectrometry 
GlcNac - N-acetyl-glucosamine 
GMO - Genetically modified organism 
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GTF - Glycosyltransferase 
HF - Hydrofluoric acid 
HPAEC-PAD - High performance anion exchange chromatography coupled with 
pulse-amperometric detection  
HPLC - High-performance liquid chromatography  
ICTV - International committee on taxonomy of viruses 
IS - Insertion sequence 
LAB - Lactic acid bacteria 
LPS - Lipopolysaccharides   
LTA - Lipoteichoic acid 
MALDI-TOF MS - Matrix-assisted laser desorption ionization-time of flight mass 
spectrometry  
MCP - Minor capsid protein 
MTase - Methyltransferase  
MOI - Multiplicity of infection 
MTP - Major tail protein 
MurNac - N-acetyl-muramic acid  
N/A - Not applicable  
NCBI - National center for biotechnology information 
ND - Not determined   
NGS - Next generation sequencing 
Nt - N-terminal 
ORF - Open reading frame 
PIP - Phage infection protein 
PMF - Proton motive force 
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PS - Polysaccharide 
PSP - Polysaccharide pellicle 
RBP - Receptor-binding protein 
RCR - Rolling circle replication 
REase - Restriction endonuclease 
R-M - Restriction-modification  
rRNA -  Ribosomal RNA 
SEC - Size exclusion chromatography 
Sie - Superinfection exclusion 
Sii - Superinfection immunity 
SMRT - Single molecule real time 
SNP - Single nucleotide polymorphism 
SRA - Sequence Read Archive 
TA - Teichoic acid 
Tal - Tail-associated lysin 
TCA - Trichloroacetic acid 
TFA - Trifluoroacetic acid  
TMP - Tape measure protein  
tRNA -  Transfer RNA 
UDP - 5’-diphosphate 
UMP - Uridine 5’-monophosphate 
Usp - Universal stress protein 
WT - Wild type 
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